Document:

Exhibit
      10.1

    CONFORMED
      COPY

     

    AGREEMENT
      AND PLAN OF MERGER

     

    BY
      AND AMONG

     

    RHAPSODY
      ACQUISITION CORP.,

     

    PRIMORIS
      CORPORATION

     

    and

     

    CERTAIN
      OF THE SHAREHOLDERS OF

     

    PRIMORIS
      CORPORATION

     

    DATED
      AS OF FEBRUARY 19, 2008

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    AGREEMENT
      AND PLAN OF MERGER 

     

    THIS
      AGREEMENT AND PLAN OF MERGER is made and entered into as of February 19, 2008,
      by and among Rhapsody Acquisition Corp., a Delaware corporation (“Delcorp”),
      Primoris Corporation, a Nevada corporation (“Company”),
      and
      each of the persons listed under the caption “Signing Shareholders” on the
      signature page hereof, such persons being certain of the shareholders of the
      Company (each a “Signing
      Shareholder”
and,
      collectively, the “Signing
      Shareholders.”)
      

     

    RECITALS

     

    A.       Upon
      the terms and subject to the conditions of this Agreement (as defined in
Section 1.2)
      and in
      accordance with the General Corporation Law of the State of Delaware (the
“DGCL”)
      and
      the Nevada General Corporation Law (the “NGCL”)
      and
      other applicable law, Delcorp and Company intend to enter into a business
      combination transaction by means of a merger in which the Company will merge
      with Delcorp and Delcorp will be the surviving entity, through an exchange
      of
      all the issued and outstanding shares of capital stock of the Company for shares
      of common stock of Delcorp.

     

    B.       The
      Boards of Directors of each of the Company and Delcorp have determined that
      the
      Merger (as defined in Section 1.1)
      is fair
      to, and in the best interests of, their respective companies and their
      respective stockholders.

     

    C.       The
      parties intend, by executing this Agreement, to adopt a plan of reorganization
      within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code of
      1986, as amended (the “Code”).

     

    NOW,
      THEREFORE, in consideration of the covenants, promises and representations
      set
      forth herein, and for other good and valuable consideration, the receipt and
      sufficiency of which are hereby acknowledged, the parties agree as follows
      (defined terms used in this Agreement are listed alphabetically in Article IX,
      together with the Section and, if applicable, paragraph number in which the
      definition of each such term is located):

     

    ARTICLE
      I

    THE
      MERGER

     

    1.1       The
      Merger.
      At the
      Effective Time (as defined in Section 1.2)
      and
      subject to and upon the terms and conditions of this Agreement and the
      applicable provisions of the NGCL, the Company shall be merged with and into
      Delcorp (the “Merger”),
      the
      separate corporate existence of the Company shall cease and Delcorp shall
      continue as the surviving corporation. Delcorp as the surviving corporation
      after the Merger is hereinafter sometimes referred to as the “Surviving
      Corporation.”

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    1.2       Effective
      Time; Closing.
      Subject
      to the conditions of this Agreement, the parties hereto shall cause the Merger
      to be consummated by (a) filing Articles of Merger (the “Articles
      of Merger”)
      with
      the Secretary of State of the State of Nevada in accordance with the applicable
      provisions of Nevada law and (b) filing with the Secretary of State of the
      State
      of Delaware in accordance with applicable provisions of the DGCL a Certificate
      of Merger (the “Certificate of Merger”) (the time of such filing with the
      Secretary of State of the State of Delaware, or such later time as may be agreed
      in writing by Company and Delcorp and specified in the Certificate of Merger,
      being the “Effective
      Time”)
      as
      soon as practicable on or after the Closing Date (as herein defined). The term
      “Agreement”
as
      used
      herein refers to this Agreement and Plan of Merger, as the same may be amended
      from time to time, and all schedules hereto (including the Company Schedule
      and
      the Delcorp Schedule, as defined in the preambles to Articles
      II and III
      hereof,
      respectively). Unless this Agreement shall have been terminated pursuant to
      Section 8.1,
      the
      closing of the Merger (the “Closing”)
      shall
      take place at the offices of Graubard Miller, counsel to Delcorp, 405 Lexington
      Avenue, New York, New York 10174-1901 or at such other place as the parties
      mutually agree in writing at a time and date to be specified by the parties,
      which shall be no later than the second business day after the satisfaction
      or
      waiver of the conditions set forth in Article VI,
      or at
      such other time, date and location as the parties hereto agree in writing (the
      “Closing
      Date”).
      Closing signatures may be transmitted by facsimile.

     

    1.3       Effect
      of the Merger.
      At the
      Effective Time, the effect of the Merger shall be as provided in this Agreement
      and the applicable provisions of the DGCL and NGCL and other applicable
      provisions of Nevada law (together, with the NGCL, “Applicable
      Nevada Law”).
      Without limiting the generality of the foregoing, and subject thereto, at the
      Effective Time all the property, rights, privileges, powers and franchises
      of
      the Company shall vest in the Surviving Corporation, and all debts, liabilities
      and duties of the Company shall become the debts, liabilities and duties of
      the
      Surviving Corporation.

     

    1.4       Certificate
      of Incorporation; Bylaws.

     

    (a)       At
      the Effective Time, the Certificate of Incorporation of Delcorp shall be amended
      and restated in the form of Exhibit A,
      and
      which shall be the Certificate of Incorporation of the Surviving Corporation
      until thereafter amended as provided by law.

     

    (b)       Also,
      at the Effective Time, the Bylaws of Delcorp shall be amended and restated
      in
      the form of Exhibit B
      and
      which shall be the Bylaws of the Surviving Corporation.

     

    1.5       Effect
      on Capital Stock.
      Subject
      to the terms and conditions of this Agreement, at the Effective Time, by virtue
      of the Merger and this Agreement and without any action on the part of the
      Company or the holders of any of the securities of the Company, the following
      shall occur:

     

    
      
        
        

      

      
        -
          2 -

        
          

        

      

      
        
        

      

    

     

    (a)       Conversion
      of Company Common Stock.
      Other
      than any shares to be canceled pursuant to Section 1.5(c),
      each
      share of common stock, par value $.001, of the Company (“Company
      Common Stock”)
      issued
      and outstanding immediately prior to the Effective Time will be automatically
      converted (subject to Section 1.5(e))
      into
      (i) the number of shares of common stock, par value $0.0001, of Delcorp
      (“Delcorp
      Common Stock”)
      equal
      to (A) 24,094,800 divided by (B) the Outstanding Common Stock Number plus (ii)
      the right to receive that number of EBITDA Shares (as defined in Section 1.18(c))
      for
      each year with respect to which EBITDA Shares are issuable equal to (C) the
      number of EBITDA Shares issuable with respect to such year divided by (D) the
      Outstanding Common Stock Number as set forth in the attached Exhibit C.
      As used
      herein, “Outstanding
      Common Stock Number”
means
      the number of shares of Company Common Stock outstanding immediately prior
      to
      the Effective Time plus additional shares in the amount of eighty-one (81)
      shares for Roger Newnham (“Born”) and thirteen (13) shares for Albert Morteboy
      (“Morteboy”) to treat them, for purposes of calculating the Outstanding Common
      Stock Number, as if they had been shareholders prior to the Closing. Born and
      Morteboy are hereinafter collectively referred to as the “Foreign Managers”. The
      numbers of shares of Delcorp Common Stock that would otherwise be issuable
      pursuant to this Section 1.5(a)
      (including EBITDA Shares) to Persons who hold Dissenting Shares (as defined
      in
Section 1.17(b))
      and
      exercise their dissenters’ rights pursuant to Applicable Nevada Law shall not be
      issued to such Persons and shall be canceled.

     

    (b)       Certificates
      for Shares.
      Certificates representing the shares of Delcorp Common Stock issuable pursuant
      to clause (i) of Section 1.5(a)
      (“Base
      Shares”)
      shall
      be issued to the holders of certificates representing the shares of Company
      Common Stock (“Company
      Certificates”)
      upon
      surrender of the Company Certificates in the manner provided in Section 1.6
      (or in
      the case of a lost, stolen or destroyed certificate, upon delivery of an
      affidavit (and indemnity, if required) in the manner provided in Section 1.8).
      Each
      holder shall be issued separate certificates for such holder’s Escrow Shares (as
      defined in Section 1.11)
      and for
      the remaining number of shares of Delcorp Common Stock to which such holder
      is
      entitled. Certificates for shares of Delcorp Common Stock representing EBITDA
      Shares shall be issued to the Persons who have surrendered Company Certificates
      within five business days following the release of the audited financial
      statements of Delcorp for the year with respect to which such EBITDA Shares
      are
      issuable.

     

    (c)       Cancellation
      of Treasury and Delcorp-Owned Stock.
      Each
      share of Company Common Stock held by the Company or owned by Delcorp or any
      direct or indirect wholly-owned subsidiary of the Company or of Delcorp
      immediately prior to the Effective Time shall be canceled and extinguished
      without any conversion or payment in respect thereof.

     

    (d)       Adjustments
      to Exchange Ratios.
      The
      numbers of shares of Delcorp Common Stock that the holders of the Company Common
      Stock are entitled to receive as a result of the Merger (including but not
      limited to the Base Shares and EBITDA Shares) shall be equitably adjusted to
      reflect appropriately the effect of any stock split, reverse stock split, stock
      dividend (including any dividend or distribution of securities convertible
      into
      Delcorp Common Stock or Company Common Stock), extraordinary cash dividends
      (other than the distributions referred to in Section 5.24
      hereof),
      reorganization, recapitalization, reclassification, combination, exchange of
      shares or other like change with respect to Delcorp Common Stock or Company
      Common Stock occurring on or after the date hereof and prior to the Effective
      Time.

     

    
      
        
        

      

      
        -
          3 -

        
          

        

      

      
        
        

      

    

     

    (e)       Fractional
      Shares.
      No
      fraction of a share of Delcorp Common Stock will be issued by virtue of the
      Merger, and each holder of shares of Company Common Stock who would otherwise
      be
      entitled to a fraction of a share of Delcorp Common Stock (after aggregating
      all
      fractional shares of Delcorp Common Stock that otherwise would be received
      by
      such holder) shall, upon compliance with Section 1.6,
      receive
      from Delcorp, in lieu of such fractional share, one (1) share of Delcorp Common
      Stock.

     

    1.6       Surrender
      of Certificates.

     

    (a)       Exchange
      Procedures.
      Upon
      surrender of Company Certificates at the Closing, the holders of such Company
      Certificates shall receive in exchange therefor certificates representing the
      Base Shares into which their shares of Company Common Stock shall be converted
      at the Effective Time, less the Escrow Shares, and the Company Certificates
      so
      surrendered shall forthwith be canceled. Until so surrendered, outstanding
      Company Certificates will be deemed, from and after the Effective Time, to
      evidence only the right to receive the applicable number of shares of Delcorp
      Common Stock issuable pursuant to Section 1.5(a).

     

    (b)       Distributions
      With Respect to Unexchanged Shares.
      No
      dividends or other distributions declared or made after the date of this
      Agreement with respect to Delcorp Common Stock with a record date after the
      Effective Time will be paid to the holders of any unsurrendered Company
      Certificates with respect to the shares of Delcorp Common Stock to be issued
      upon surrender thereof until the holders of record of such Company Certificates
      shall surrender such Company Certificates. Subject to applicable law, following
      surrender of any such Company Certificates with a properly completed letter
      of
      transmittal, Delcorp shall promptly deliver to the record holders thereof,
      without interest, the certificates representing shares of Delcorp Common Stock
      issued in exchange therefor and the amount of any such dividends or other
      distributions with a record date after the Effective Time theretofore paid
      with
      respect to such shares of Delcorp Common Stock.

     

    (c)       Transfers
      of Ownership.
      If
      certificates representing shares of Delcorp Common Stock are to be issued in
      a
      name other than that in which the Company Certificates surrendered in exchange
      therefor are registered, it will be a condition of the issuance thereof that
      the
      Company Certificates so surrendered will be properly endorsed and otherwise
      in
      proper form for transfer and that the persons requesting such exchange will
      have
      paid to Delcorp or any agent designated by it any transfer or other taxes
      required by reason of the issuance of certificates representing shares of
      Delcorp Common Stock in any name other than that of the registered holder of
      the
      Company Certificates surrendered, or established to the satisfaction of Delcorp
      or any agent designated by it that such tax has been paid or is not
      payable.

     

    (d)       Required
      Withholding.
      Delcorp
      and the Surviving Corporation shall each be entitled to deduct and withhold
      from
      any consideration payable or otherwise deliverable pursuant to this Agreement
      to
      any holder or former holder of Company Common Stock such amounts as are required
      to be deducted or withheld therefrom under the Code or under any provision
      of
      state, local or foreign tax law or under any other applicable legal requirement.
      To the extent such amounts are so deducted or withheld, such amounts shall
      be
      treated for all purposes under this Agreement as having been paid to the person
      to whom such amounts would otherwise have been paid.

     

    
      
        
        

      

      
        -
          4 -

        
          

        

      

      
        
        

      

    

     

    (e)       No
      Liability.
      Notwithstanding anything to the contrary in this Section 1.6,
      neither
      Delcorp, the Company, the Surviving Corporation nor any other party hereto
      shall
      be liable to a holder of shares of Delcorp Common Stock or Company Common Stock
      for any amount properly paid to a public official pursuant to any applicable
      abandoned property, escheat or similar law.

     

    1.7       No
      Further Ownership Rights in Company Stock.
      All
      shares of Delcorp Common Stock issued in accordance with the terms hereof shall
      be deemed to have been issued in full satisfaction of all rights pertaining
      to
      shares of Company Common Stock and there shall be no further registration of
      transfers on the records of the Surviving Corporation of shares of Company
      Common Stock that were outstanding immediately prior to the Effective Time.
      If,
      after the Effective Time, Company Certificates are presented to the Surviving
      Corporation for any reason, they shall be canceled and exchanged as provided
      in
      this Article I.

     

    1.8       Lost,
      Stolen or Destroyed Certificates.
      In the
      event that any Company Certificates shall have been lost, stolen or destroyed,
      Delcorp shall issue in exchange for such lost, stolen or destroyed Company
      Certificates, upon the making of an affidavit of that fact by the holder
      thereof, the certificates representing the shares of Delcorp Common Stock that
      the shares of Company Common Stock formerly represented by such Company
      Certificates were converted into and any dividends or distributions payable
      pursuant to Section 1.6(b);
      provided, however, that, as a condition precedent to the issuance of such
      certificates representing shares of Delcorp Common Stock and other
      distributions, the owner of such lost, stolen or destroyed Company Certificates
      shall indemnify Delcorp against any claim that may be made against Delcorp
      or
      the Surviving Corporation with respect to the Company Certificates alleged
      to
      have been lost, stolen or destroyed.

     

    1.9       Tax
      Consequences.
      It is
      intended by the parties hereto that the Merger shall constitute a reorganization
      within the meaning of Section 368(a)(1)(A) of the Code and the regulations
      thereunder. The parties hereto adopt this Agreement as a “plan of
      reorganization” within the meaning of the United States Income Tax Regulations
      issued with respect to Section 368.

     

    1.10     Taking
      of Necessary Action; Further Action.
      If, at
      any time after the Effective Time, any further action is necessary or desirable
      to carry out the purposes of this Agreement and to vest the Surviving
      Corporation with full right, title and possession to all assets, property,
      rights, privileges, powers and franchises of the Company, the officers and
      directors of the Company will take all such lawful and necessary
      action.

     

    
      
        
        

      

      
        -
          5 -

        
          

        

      

      
        
        

      

    

     

    1.11     Escrow.
      As the
      sole remedy for the indemnity obligations set forth in Article VII,
      at the
      Closing, the Persons receiving shares of Delcorp Common Stock to be issued
      as a
      result of the Merger shall deposit in escrow an aggregate of
      1,807,110 of
      the
      Base Shares received by such Persons as a result of the Merger (the
“Escrow
      Shares”),
      which
      shares shall be allocated among the Persons entitled to receive them in the
      same
      proportions as the shares of Delcorp Common Stock are allocated among them,
      all
      in accordance with the terms and conditions of the Escrow Agreement to be
      entered into at the Closing between Delcorp, the Company, the Representative
      appointed pursuant to Section 1.14(b)
      and
      Continental Stock Transfer & Trust Company (“Continental”),
      as
      Escrow Agent, in the form annexed hereto as Exhibit D
      (the
“Escrow
      Agreement”).
      On
      the date (the “Basic
      Escrow Termination Date”)
      that
      is the later of (i) thirty (30) days after the date on which Delcorp has filed
      its Report on Form 10-K pursuant to the Securities Exchange Act of 1934, as
      amended (“Exchange
      Act”),
      for
      its 2008 fiscal year or (ii) one year after the Closing Date, the Escrow Agent
      shall release 1,445,688 of the original number of Escrow Shares, less that
      number of Escrow Shares applied in satisfaction of or reserved with respect
      to
      indemnification claims made prior to such date, to the shareholders of the
      Company in the same proportions as originally deposited into escrow. The
      remaining Escrow Shares (the “T/E
      Indemnity Shares”)
      shall
      be available for indemnification only with respect to Tax Indemnification Claims
      and Environmental Indemnification Claims (each as hereinafter defined). On
      the
      date (the “T/E
      Escrow Termination Date”)
      that
      is the first business day following the date that is the third anniversary
      of
      the Closing Date, the Escrow Agent shall deliver the T/E Indemnity Shares,
      less
      any of such shares applied in satisfaction of a Tax Indemnification Claim or
      an
      Environmental Indemnification Claim and any of such shares related to a Tax
      Indemnification Claim or an Environmental Indemnification Claim that is then
      unresolved, to each shareholder of the Company in the same proportions as
      initially deposited in escrow. Any Escrow Shares held with respect to any
      unresolved claim for indemnification and not applied as indemnification with
      respect to such claim upon its resolution shall be delivered to such Persons
      promptly upon such resolution. “Tax
      Indemnification Claim”
means
      a
      claim for indemnification pursuant to Article VII
      with
      respect to (x) a breach of the representations and warranties set forth in
Section 2.15
      and (y)
      the matters referred to in Schedule 2.15. “Environmental
      Indemnification Claim”
means
      a
      claim for indemnification pursuant to Article VII
      with
      respect to a breach of the representations and warranties set forth in
Section 2.16.

     

    1.12     Rule
      145.
      All
      shares of Delcorp Common Stock issued pursuant to this Agreement to “affiliates”
of the Company listed in Schedule 1.12 will be subject to certain resale
      restrictions under Rule 145 promulgated under the Securities Act and all
      certificates representing such shares shall bear an appropriate restrictive
      legend.

     

    1.13     Signing
      Shareholder Matters.

     

    (a)       By
      his, her or its execution of this Agreement, each Signing Shareholder, in his,
      her or its capacity as a shareholder of the Company, hereby agrees to vote
      in
      favor of the approval and adoption of this Agreement and to authorize the
      Company, its directors and officers to take all actions necessary for the
      consummation of the Merger and the other transactions contemplated by the
      provisions of this Agreement and its Exhibits at a meeting of the shareholders
      of the Company to be held promptly after distribution of the Proxy
      Statement/Prospectus (as defined in Section 5.1(a)) to the shareholders of
      the
      Company and the stockholders of Delcorp.

     

    
      
        
        

      

      
        -
          6 -

        
          

        

      

      
        
        

      

    

     

    (b)       Each
      Signing Shareholder, for himself, herself or itself only, represents and
      warrants as follows: (i) all Delcorp Common Stock to be acquired by such Signing
      Shareholder pursuant to this Agreement will be acquired for his, her or its
      account and not with a view towards distribution thereof other than, with
      respect to Signing Shareholders that are entities, transfers to its
      stockholders, partners or members; (ii) he, she or it understands that he,
      she
      or it must bear the economic risk of the investment in the Delcorp Common Stock,
      which cannot be sold by he, she or it unless it is registered under the
      Securities Act, or an exemption therefrom is available thereunder; (iii) he,
      she
      or it has had both the opportunity to ask questions and receive answers from
      the
      officers and directors of Delcorp and all persons acting on Delcorp’s behalf
      concerning the business and operations of Delcorp and to obtain any additional
      information to the extent Delcorp possesses or may possess such information
      or
      can acquire it without unreasonable effort or expense necessary to verify the
      accuracy of such information; and (iv) he, she or it has had access to the
      Delcorp SEC Reports filed prior to the date of this Agreement. Each Signing
      Shareholder acknowledges, as to himself, herself or itself only, that (v) he,
      she or it is either (A) an “accredited investor” as such term is defined in Rule
      501(a) promulgated under the Securities Act or (B) a person possessing
      sufficient knowledge and experience in financial and business matters to enable
      it to evaluate the merits and risks of an investment in Delcorp; and (vi) he,
      she or it understands that the certificates representing the Delcorp Common
      Stock to be received by he, she or it may bear legends to the effect that the
      Delcorp Common Stock may not be transferred except upon compliance with (C)
      the
      registration requirements of the Securities Act of 1933, as amended (the
“Securities
      Act”),
      or an
      exemption therefrom, and (D) the provisions of this Agreement. Each Signing
      Shareholder that is an entity, for itself, represents, warrants and
      acknowledges, with respect to each holder of its equity interests, to the same
      effect as the foregoing provisions of this Section 1.13(b).

     

    (c)       Each
      Signing Shareholder, for himself, herself or itself, represents and warrants
      that the execution and delivery of this Agreement by such Signing Shareholder
      does not, and the performance of his, her or its obligations hereunder will
      not,
      require any consent, approval, authorization or permit of, or filing with or
      notification to, any court, administrative agency, commission, governmental
      or
      regulatory authority, domestic or foreign (a “Governmental
      Entity”),
      except (i) for applicable requirements, if any, of the Securities Act, the
      Exchange Act, state securities laws (“Blue
      Sky Laws”),
      and
      the rules and regulations thereunder, and (ii) where the failure to obtain
      such
      consents, approvals, authorizations or permits, or to make such filings or
      notifications, would not, individually or in the aggregate, reasonably be
      expected to have a Material Adverse Effect (as defined in Section 10.2(a))
      on such
      Signing Shareholder or the Company or, after the Closing, the Delcorp, or
      prevent consummation of the Merger or otherwise prevent the parties hereto
      from
      performing their obligations under this Agreement.

     

    (d)       Each
      Signing Shareholder, for himself, herself or itself, represents and warrants
      that he, she or it owns the shares of Company Common Stock listed on Exhibit
      C
      as being owned by him, her or it free and clear of all Liens.

     

    
      
        
        

      

      
        -
          7 -

        
          

        

      

      
        
        

      

    

     

    1.14     Committee
      and Representative for Purposes of Escrow Agreement.

     

    (a)       Delcorp
      Committee.
      Prior
      to the Closing, the Board of Directors of Delcorp shall appoint a committee
      consisting of one or more of its then members to act on behalf of Delcorp to
      take all necessary actions and make all decisions pursuant to the Escrow
      Agreement regarding Delcorp’s right to indemnification pursuant to Article VII
      hereof.
      In the event of a vacancy in such committee, the Board of Directors of Delcorp
      shall appoint as a successor a Person who was a director of Delcorp prior to
      the
      Closing Date or some other Person who would qualify as an “independent” director
      of Delcorp and who has not had any relationship with the Company prior to the
      Closing. Such committee is intended to be the “Committee”
      referred to in Article VII
      hereof
      and the Escrow Agreement.

     

    (b)       Representative.
      The
      Signing Shareholders hereby designate Brian Pratt to represent the interests
      of
      the Persons entitled to receive Delcorp Common Stock as a result of the Merger
      for purposes of the Escrow Agreement (such designee and any successor, the
      “Representative”).
      If
      such Person ceases to serve in such capacity, for any reason, the Signing
      Shareholders shall designate his or her successor. Failing such designation
      within 10 business days after the Representative has ceased to serve, those
      members of the Board of Directors of Delcorp who were directors of the Company
      prior to the Closing shall appoint as successor a Person who was a former
      shareholder of the Company or such other Person as such members shall designate.
      Such Person or successor is intended to be the “Representative” referred to in
Section 1.11
      and
Article VII
      hereof
      and the Escrow Agreement.

     

    1.15     Outstanding
      Company Derivative Securities.
      The
      Company shall arrange that the holders of all outstanding options, warrants
      and
      other derivative securities of the Company exercise such securities after the
      Special Meeting but prior to the Effective Time without the payment of any
      consideration therefor by the Company other than the issuance of shares of
      Company Common Stock and cash that is owed to any of the Foreign Managers
      pursuant to the Termination Agreements each of the Foreign Managers has entered
      into with Delcorp, the Company and certain other Persons. Such exercise may
      be
      made contingent upon the occurrence of the Closing.

     

    1.16     Intentionally
      Omitted.

     

    1.17     Shares
      Subject to Dissenters’ Rights.

     

    (a)       Notwithstanding
      Section 1.5
      hereof,
      Dissenting Shares shall not be converted into a right to receive Delcorp Common
      Stock and the holders thereof shall be entitled only to such rights as are
      granted by Applicable Nevada Law. Each holder of Dissenting Shares who becomes
      entitled to payment for such shares pursuant to Applicable Nevada Law shall
      receive payment therefor from the Surviving Corporation in accordance with
      Applicable Nevada Law, provided, however, that (i) if any shareholder of the
      Company who asserts dissenters’ rights in connection with the Merger (a
“Dissenter”)
      shall
      have failed to establish his entitlement to such rights as provided in
      Applicable Nevada Law, or (ii) if any such Dissenter shall have effectively
      withdrawn his demand for payment for such shares or waived or lost his right
      to
      payment for his shares under the appraisal rights process under Applicable
      Nevada Law, the shares of Company Common Stock held by such Dissenter shall
      be
      treated as if they had been converted, as of the Effective Time, into a right
      to
      receive Delcorp Common Stock and as provided in Section 1.5.
      The
      Company shall give Delcorp prompt notice of any demands for payment received
      by
      the Company from a person asserting appraisal rights, and Delcorp shall have
      the
      right to participate in all negotiations and proceedings with respect to such
      demands. The Company shall not, except with the prior written consent of
      Delcorp, make any payment with respect to, or settle or offer to settle, any
      such demands.

     

    
      
        
        

      

      
        -
          8 -

        
          

        

      

      
        
        

      

    

     

    (b)       As
      used herein, “Dissenting
      Shares”
means
      any shares of Company Common Stock held by shareholders of the Company who
      are
      entitled to rights to receive payment for their shares under Chapter 92A of
      the
      Nevada Revised Statutes and who have properly exercised, perfected and not
      subsequently withdrawn or lost or waived their rights to demand payment with
      respect to their shares in accordance therewith. 

     

    1.18     EBITDA
      Shares.

     

    (a)       If,
      for the fiscal year of Delcorp ending December 31, 2008, Delcorp has EBITDA
      equal to or greater than $39,300,000, Delcorp shall issue to the holders of
      Company Certificates, in the aggregate, pursuant to Section 1.5(b),
      2,500,000 shares of Delcorp Common Stock.

     

    (b)       Regardless
      of whether Delcorp has EBITDA equal to or greater than $39,300,000 for its
      fiscal year ending December 31, 2008, if for the fiscal year of Delcorp ending
      December 31, 2009, Delcorp has EBITDA equal to or greater than $46,000,000,
      Delcorp shall issue to the holders of Company Certificates, in the aggregate,
      pursuant to Section 1.5(b),
      2,500,000 shares of Delcorp Common Stock.

     

    (c)       As
      used herein,

     

    (i)       “EBITDA”
means
      for the applicable fiscal year, using results taken from the audited financial
      statements of the Company, subject to certain adjustments, the following
      calculation: income before provision for income taxes, plus interest expense,
      less interest income, plus depreciation and amortization, plus amortization
      of
      intangible assets, plus any expenses arising solely from the Merger charged
      to
      income in such fiscal year, plus expense relating to the Termination Agreements
      with Born and Morteboy of $1,277,340 in 2008 only, plus any GAAP expense
      relating to the issuance of Rhapsody common stock to Born and Morteboy as part
      of the Termination Agreements in 2008 only, plus any expense (non-cash only)
      relating to the Delcorp Plan (as defined in Section
      5.1(a)).
      In
      addition, any Rhapsody expenses prior to the Closing that are included in the
      Surviving Corporation’s 2008 income statement will be excluded for purposes of
      EBITDA calculation. Attached as Exhibit E
      is a
      sample calculation. 

     

    
      
        
        

      

      
        -
          9 -

        
          

        

      

      
        
        

      

    

     

    (ii)       “EBITDA
      Shares”
means
      shares of Delcorp Common Stock issuable pursuant to either Section 1.18(a)
      or
Section 1.18(b).

     

    1.19     Registration
      of Shares.
      Delcorp
      shall file as soon as possible after the Closing, and use its best efforts
      to
      cause to become effective, within 12 months after the Closing Date, a
      registration statement under the Securities Act with respect to the shares
      of
      Delcorp Common Stock issued pursuant to this Agreement prior to the expiration
      of such 12-month period, including EBITDA shares issued pursuant to Section
      1.18(a),
      to
      those shareholders of the Company who are listed on Schedule
      1.12.
      

     

    1.20     Sale
      Restriction.
      No
      public market sales of shares of Delcorp Common Stock whether or not issued
      as a
      result of the Merger, including EBITDA Shares, shall be made for a period of
      twelve months following the Closing Date. No private sales of shares of Delcorp
      Common Stock issued as a result of the Merger shall be made unless the purchaser
      acknowledges and agrees to the restriction stated in the preceding sentence
      by
      delivery to Delcorp of a written document to such effect. Certificates
      representing shares of Delcorp Common Stock issued as a result of the Merger
      shall bear a prominent legend to such effect.

     

    ARTICLE
      II

    REPRESENTATIONS
      AND WARRANTIES REGARDING THE COMPANY

     

    Subject
      to the exceptions set forth in Schedule 2 attached hereto (the
“Company
      Schedule”),
      the
      Company and the Signing Shareholders hereby represent and warrant to, and
      covenant with, Delcorp as follows (as used in this Article II,
      and
      elsewhere in this Agreement, the term “Company”
      includes the Subsidiaries, as hereinafter defined, unless the context clearly
      otherwise indicates):

     

    2.1    
       Organization
      and Qualification.

     

    (a)       The
      Company is a corporation duly incorporated, validly existing and in good
      standing under the laws of the State of Nevada and has the requisite corporate
      power and authority to own, lease and operate its assets and properties and
      to
      carry on its business as it is now being or currently planned by the Company
      to
      be conducted. The Company is in possession of all franchises, grants,
      authorizations, licenses, permits, easements, consents, certificates, approvals
      and orders (“Approvals”)
      necessary to own, lease and operate the properties it purports to own, operate
      or lease and to carry on its business as it is now being or currently planned
      by
      the Company to be conducted, except where the failure to have such Approvals
      could not, individually or in the aggregate, reasonably be expected to have
      a
      Material Adverse Effect on the Company. Complete and correct copies of the
      certificate of incorporation and by-laws (or other comparable governing
      instruments with different names) (collectively referred to herein as
“Charter
      Documents”)
      of the
      Company, as amended and currently in effect, have been heretofore made available
      to Delcorp or Delcorp’s counsel. The Company is not in violation of any of the
      provisions of the Company’s Charter Documents.

     

    
      
        
        

      

      
        -
          10 -

        
          

        

      

      
        
        

      

    

     

    (b)       The
      Company is duly qualified or licensed to do business as a foreign corporation
      and is in good standing in each jurisdiction where the character of the
      properties owned, leased or operated by it or the nature of its activities
      makes
      such qualification or licensing necessary, except for such failures to be so
      duly qualified or licensed and in good standing that could not, individually
      or
      in the aggregate, reasonably be expected to have a Material Adverse Effect
      on
      the Company. Each jurisdiction in which the Company is so qualified or licensed
      is listed in Schedule 2.1.

     

    (c)       The
      minute books of the Company contain true, complete and accurate records of
      all
      written minutes for meetings and written consents in lieu of meetings of its
      Board of Directors (and any committees thereof), similar governing bodies and
      stockholders (“Corporate
      Records”)
      since
      the time of the Company’s organization. Copies of such Corporate Records of the
      Company have been made available to Delcorp or Delcorp’s counsel. 

     

    (d)       The
      stock transfer, warrant and option transfer and ownership records of the Company
      contain true, complete and accurate records of the securities ownership as
      of
      the date of such records and the transfers involving the capital stock and
      other
      securities of the Company since the time of the Company’s incorporation. Copies
      of such records of the Company have been made available to Delcorp or Delcorp’s
      counsel.

     

    2.2       Subsidiaries.

     

    (a)       The
      Company has no direct or indirect subsidiaries or participations in joint
      ventures or other entities other than those listed in Schedule 2.2 (the
“Subsidiaries”).
      Except as set forth in Schedule 2.2, the Company owns all of the
      outstanding equity securities of the Subsidiaries, free and clear of all Liens
      (as defined in Section 10.2(e)).
      Except
      for the Subsidiaries, the Company does not own, directly or indirectly, any
      ownership, equity, profits or voting interest in any Person or has any agreement
      or commitment to purchase any such interest, and has not agreed and is not
      obligated to make nor is bound by any written, oral or other agreement,
      contract, subcontract, lease, binding understanding, instrument, note, option,
      warranty, purchase order, license, sublicense, insurance policy, benefit plan,
      commitment or undertaking of any nature, as of the date hereof or as may
      hereafter be in effect under which it may become obligated to make, any future
      investment in or capital contribution to any other entity.

     

    (b)       Each
      Subsidiary that is a corporation is duly incorporated, validly existing and
      in
      good standing under the laws of its state of incorporation (as listed in
      Schedule 2.2) and has the requisite corporate power and authority to own,
      lease and operate its assets and properties and to carry on its business as
      it
      is now being or currently planned by the Company to be conducted. Each
      Subsidiary that is a limited liability company is duly organized or formed,
      validly existing and in good standing under the laws of its state of
      organization or formation (as listed in Schedule 2.2) and has the requisite
      power and authority to own, lease and operate its assets and properties and
      to
      carry on its business as it is now being or currently planned by the Company
      to
      be conducted. Each Subsidiary is in possession of all Approvals necessary to
      own, lease and operate the properties it purports to own, operate or lease
      and
      to carry on its business as it is now being or currently planned by the Company
      to be conducted, except where the failure to have such Approvals could not,
      individually or in the aggregate, reasonably be expected to have a Material
      Adverse Effect on the Company or such Subsidiary. Complete and correct copies
      of
      the Charter Documents of each Subsidiary, as amended and currently in effect,
      have been heretofore delivered to Delcorp or Delcorp’s counsel. No Subsidiary is
      in violation of any of the provisions of its Charter Documents.

     

    
      
        
        

      

      
        -
          11 -

        
          

        

      

      
        
        

      

    

     

    (c)       Each
      Subsidiary is duly qualified or licensed to do business as a foreign corporation
      or foreign limited liability company and is in good standing in each
      jurisdiction where the character of the properties owned, leased or operated
      by
      it or the nature of its activities makes such qualification or licensing
      necessary, except for such failures to be so duly qualified or licensed and
      in
      good standing that could not, individually or in the aggregate, reasonably
      be
      expected to have a Material Adverse Effect on the Company or such Subsidiary.
      Each jurisdiction in which each Subsidiary is so qualified or licensed is listed
      in Schedule 2.2.

     

    (d)       The
      minute books of each Subsidiary contain true, complete and accurate records
      of
      all written minutes for meetings and written consents in lieu of meetings of
      its
      Board of Directors (and any committees thereof), similar governing bodies and
      stockholders. Copies of the Corporate Records of each Subsidiary have been
      heretofore made available to Delcorp or Delcorp’s counsel.

     

    2.3       Capitalization.

     

    (a)       The
      authorized capital stock of the Company consists of 250,000 shares of Company
      Common Stock, of which 4,368 shares are issued and outstanding as of the date
      of
      this Agreement, all of which shares of Company Common Stock are validly issued,
      fully paid and nonassessable. Through Termination Agreements with the Foreign
      Managers, at the time of the Closing of the Merger, Rhapsody will issue common
      stock which would have represented an equivalent of an additional 94 shares
      in
      the aggregate to the Foreign Managers which would have resulted in 4,462 shares
      of Company Common Stock outstanding as of the date of the Closing. Other than
      Company Common Stock, the Company has no class or series of securities
      authorized by its Charter Documents. Schedule 2.3(a) hereto contains a list
      of all of the shareholders of the Company and the Foreign Managers, the number
      of shares of Company Common Stock owned, or to be owned at the time of the
      Closing, by each shareholder and Foreign Manager and each shareholder’s state of
      residence. Except as set forth in Schedule 2.3(a) hereto, as of the date of
      this Agreement, no shares of Company Common Stock are reserved for issuance
      upon
      the exercise of outstanding options to purchase Company Common Stock granted
      to
      employees of Company or other parties (“Company
      Stock Options”)
      other
      than those issued by Rhapsody to the Foreign Managers. No shares of Company
      Common Stock are reserved for issuance upon the exercise of outstanding warrants
      or other rights (other than Company Stock Options) to purchase Company Common
      Stock other than to the Foreign Managers. All shares of Company Common Stock
      subject to issuance as aforesaid, upon issuance on the terms and conditions
      specified in the instrument pursuant to which they are issuable, will be duly
      authorized, validly issued, fully paid and nonassessable. There are no
      commitments or agreements of any character to which Company is bound obligating
      Company to accelerate the vesting of any Company Stock Option as a result of
      the
      Merger. All outstanding shares of Company Common Stock and all outstanding
      Company Stock Options have been issued and granted in compliance with (x) all
      applicable securities laws and (in all material respects) other applicable
      laws
      and regulations, and (y) all requirements set forth in any applicable Company
      Contracts (as defined in Section 2.19).
      The
      Company has heretofore delivered to Delcorp or Delcorp’s counsel true and
      accurate copies of the forms of documents used for the issuance of Company
      Stock
      Options and shares to the Foreign Managers and a true and complete list of
      the
      holders thereof, including their names and the numbers of shares of Company
      Common Stock underlying such holders’ Company Stock Options or in the
      alternative the names of the Foreign Managers.

     

    
      
        
        

      

      
        -
          12 -

        
          

        

      

      
        
        

      

    

     

    (b)       Except
      as set forth in Schedule 2.3(b) hereto or as set forth in Section 2.3(a)
      hereof,
      there are no subscriptions, options, warrants, equity securities, partnership
      interests or similar ownership interests, calls, rights (including preemptive
      rights), commitments or agreements of any character to which the Company is
      a
      party or by which it is bound obligating the Company to issue, deliver or sell,
      or cause to be issued, delivered or sold, or repurchase, redeem or otherwise
      acquire, or cause the repurchase, redemption or acquisition of, any shares
      of
      capital stock, partnership interests or similar ownership interests of the
      Company or obligating the Company to grant, extend, accelerate the vesting
      of or
      enter into any such subscription, option, warrant, equity security, call, right,
      commitment or agreement.

     

    (c)       Except
      as contemplated by this Agreement and except as set forth in
      Schedule 2.3(c) hereto, there are no registration rights, and there is no
      voting trust, proxy, rights plan, antitakeover plan or other agreement or
      understanding to which the Company is a party or by which the Company is bound
      with respect to any equity security of any class of the Company.

     

    (d)       Except
      as set forth in Schedule 2.3(d), no outstanding shares of Company Common Stock
      are unvested or subjected to a repurchase option, risk of forfeiture or other
      condition under any applicable agreement with the Company.

     

    (e)       The
      authorized and outstanding capital stock or membership interests of each
      Subsidiary are set forth in Schedule 2.3(e) hereto. Except as set forth in
      Schedule 2.3(e), the Company owns all of the outstanding equity securities
      of each Subsidiary, free and clear of all Liens, either directly or indirectly
      through one or more other Subsidiaries. There are no outstanding options,
      warrants or other rights to purchase securities of any Subsidiary.

     

    
      
        
        

      

      
        -
          13 -

        
          

        

      

      
        
        

      

    

     

    2.4       Authority
      Relative to this Agreement.
      The
      Company has all necessary corporate power and authority to execute and deliver
      this Agreement and to perform its obligations hereunder and, to consummate
      the
      transactions contemplated hereby (including the Merger). The execution and
      delivery of this Agreement and the consummation by the Company of the
      transactions contemplated hereby (including the Merger) have been duly and
      validly authorized by all necessary corporate action on the part of the Company
      (including the approval by its Board of Directors and shareholders, subject
      in
      all cases to the satisfaction of the terms and conditions of this Agreement,
      including the conditions set forth in Article VI),
      and no
      other corporate proceedings on the part of the Company or its shareholders
      are
      necessary to authorize this Agreement or to consummate the transactions
      contemplated hereby pursuant to Applicable Nevada Law and the terms and
      conditions of this Agreement. This Agreement has been duly and validly executed
      and delivered by the Company and, assuming the due authorization, execution
      and
      delivery thereof by the other parties hereto, constitutes the legal and binding
      obligation of the Company, enforceable against the Company in accordance with
      its terms, except as may be limited by bankruptcy, insolvency, reorganization
      or
      other similar laws affecting the enforcement of creditors’ rights generally and
      by general principles of equity.

     

    2.5       No
      Conflict; Required Filings and Consents.
      Except
      as set forth in Schedule 2.5 hereto:

     

    (a)       The
      execution and delivery of this Agreement by the Company do not, and the
      performance of this Agreement by the Company shall not, (i) conflict with or
      violate the Company’s Charter Documents, (ii) subject to obtaining the adoption
      of this Agreement and the Merger by the stockholders of the Company, conflict
      with or violate any Legal Requirements (as defined in Section 10.2(b)),
      (iii)
      result in any breach of or constitute a default (or an event that with notice
      or
      lapse of time or both would become a default) under, or materially impair the
      Company’s rights or alter the rights or obligations of any third party under, or
      give to others any rights of termination, amendment, acceleration or
      cancellation of, or result in the creation of a lien or encumbrance on any
      of
      the properties or assets of the Company pursuant to, any Company Contracts
      or
      (iv) result in the triggering, acceleration or increase of any payment to any
      Person pursuant to any Company Contract, including any “change in control” or
      similar provision of any Company Contract, except, with respect to clauses
      (ii),
      (iii) or (iv), for any such conflicts, violations, breaches, defaults,
      triggerings, accelerations, increases or other occurrences that would not,
      individually and in the aggregate, have a Material Adverse Effect on the
      Company.

     

    (b)       The
      execution and delivery of this Agreement by the Company does not, and the
      performance of its obligations hereunder will not, require any consent,
      approval, authorization or permit of, or filing with or notification to, any
      Governmental Entity or other third party (including, without limitation, lenders
      and lessors), except (i) for applicable requirements, if any, of the Securities
      Act, the Exchange Act or Blue Sky Laws, and the rules and regulations
      thereunder, and appropriate documents received from or filed with the relevant
      authorities of other jurisdictions in which the Company is licensed or qualified
      to do business, (ii) for the filing of any notifications required under the
      Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the
“HSR
      Act”),
      if
      required upon advice of counsel, and the expiration of the required waiting
      period thereunder, (iii) the consents, approvals, authorizations and permits
      described in Schedule 2.5, and (iv) where the failure to obtain such
      consents, approvals, authorizations or permits, or to make such filings or
      notifications, would not, individually or in the aggregate, reasonably be
      expected to have a Material Adverse Effect on the Company or, after the Closing,
      the Delcorp or the Surviving Corporation, or prevent consummation of the Merger
      or otherwise prevent the parties hereto from performing their obligations under
      this Agreement.

     

    
      
        
        

      

      
        -
          14 -

        
          

        

      

      
        
        

      

    

     

    2.6       Compliance.
      Except
      as disclosed in Schedule 2.6, during the ten year period prior to the date
      of
      the Closing the Company has complied with and is not in violation of any Legal
      Requirements with respect to the conduct of its business, or the ownership
      or
      operation of its business, except for failures to comply or violations which,
      individually or in the aggregate, have not had and are not reasonably likely
      to
      have a Material Adverse Effect on the Company. The businesses and activities
      of
      the Company have not been and are not being conducted in violation of any Legal
      Requirements. The Company is not in default or violation of any term, condition
      or provision of any applicable Charter Documents. Except as set forth in
      Schedule 2.6, during the ten year period prior to the date of the Closing
      no written notice of non-compliance with any Legal Requirements has been
      received by the Company (and the Company has no knowledge of any such notice
      delivered to any other Person). The Company is not in violation of any term
      of
      any Company Contract, except for failures to comply or violations which,
      individually or in the aggregate, have not had and are not reasonably likely
      to
      have a Material Adverse Effect on the Company.

     

    2.7       Financial
      Statements.

     

    (a)       The
      Company has provided to Delcorp a correct and complete copy of the audited
      consolidated financial statements (including any related notes thereto) of
      the
      Company for the fiscal years ended December 31, 2006, December 31, 2005 and
      December 31, 2004 (the “Audited
      Financial Statements”).
      The
      Audited Financial Statements were prepared in accordance with generally accepted
      accounting principles of the United States (“U.S.
      GAAP”)
      applied on a consistent basis throughout the periods involved (except as may
      be
      indicated in the notes thereto), and each fairly presents in all material
      respects the financial position of the Company at the respective dates thereof
      and the results of its operations and cash flows for the periods
      indicated.

     

    (b)       The
      Company has provided to Delcorp a correct and complete copy of the unaudited
      consolidated financial statements of the Company for the nine month period
      ended
      September 30, 2007 (including any notes related thereto) (the “Unaudited
      Financial Statements”).
      The
      Unaudited Financial Statements comply as to form in all material respects,
      and
      were prepared in accordance with U.S. GAAP applied on a consistent basis
      throughout the periods involved and in a manner consistent with the preparation
      of the Audited Financial Statements, and fairly present in all material respects
      the financial position of the Company at the date thereof and the results of
      its
      operations and cash flows for the period indicated, except that such statements
      are subject to normal audit adjustments that are not expected to have a Material
      Adverse Effect on the Company.

     

    
      
        
        

      

      
        -
          15 -

        
          

        

      

      
        
        

      

    

     

    (c)       The
      books of account, minute books, stock certificate books and stock transfer
      ledgers and other similar books and records of the Company have been maintained
      in accordance with good business practice, are complete and correct in all
      material respects and there have been no material transactions that are required
      to be set forth therein and which have not been so set forth.

     

    (d)       Except
      as otherwise noted in the Audited Financial Statements or the Unaudited
      Financial Statements, the accounts and notes receivable of the Company reflected
      on the balance sheets included in the Audited Financial Statements and the
      Unaudited Financial Statements: (i) arose from bona fide sales transactions
      in
      the ordinary course of business and are payable on ordinary trade terms, (ii)
      are legal, valid and binding obligations of the respective debtors enforceable
      in accordance with their terms, except as such may be limited by bankruptcy,
      insolvency, reorganization, or other similar laws affecting creditors’ rights
      generally, and by general equitable principles, (iii) are not subject to any
      valid set-off or counterclaim except to the extent set forth in such balance
      sheet contained therein other than possible back charges which to the Company’s
      knowledge do not exist at this time, which back charges, to the Company’s
      knowledge, either individually or in the aggregate, would not reasonably be
      expected to have a Material Adverse Effect upon the Company and its Subsidiaries
      taken as a whole, (iv) are collectible in the ordinary course of business
      consistent with past practice in the aggregate recorded amounts thereof, net
      of
      any applicable reserve reflected in such balance sheet referenced above, and
      (v)
      are not the subject of any actions or proceedings brought by or on behalf of
      the
      Company. The parties to this Agreement agree that the representations contained
      in this Section
      2.7(d)
      are not
      intended to imply or represent that any job or project of the Company or its
      Subsidiaries under contract as of the Closing Date will have any level of
      profitability or may not result in a loss.

     

    2.8       No
      Undisclosed Liabilities.
      Except
      as set forth in Schedule 2.8 hereto, the Company and its Subsidiaries have
      no liabilities (absolute, accrued, contingent or otherwise) of a nature required
      to be disclosed on a balance sheet or in the related notes to financial
      statements that are, individually or in the aggregate, material to the business,
      results of operations or financial condition of the Company and its
      Subsidiaries, except: (i) liabilities provided for in or otherwise disclosed
      in
      the interim balance sheet included in the Unaudited Financial Statements or
      in
      the notes to the Audited Financial Statements, and (ii) such liabilities arising
      in the ordinary course of the Company’s business since December 31, 2006, none
      of which, individually or in the aggregate, would have a Material Adverse Effect
      on the Company.

     

    
      
        
        

      

      
        -
          16 -

        
          

        

      

      
        
        

      

    

     

    2.9       Absence
      of Certain Changes or Events.
      Except
      as set forth in Schedule 2.9 hereto or in the Unaudited Financial
      Statements, since December 31, 2006, there has not been: (i) any Material
      Adverse Effect on the Company and its Subsidiaries, (ii) any declaration,
      setting aside or payment of any dividend on, or other distribution (whether
      in
      cash, stock or property) in respect of, any of the Company’s stock, or any
      purchase, redemption or other acquisition by the Company of any of the Company’s
      capital stock or any other securities of the Company or any options, warrants,
      calls or rights to acquire any such shares or other securities, (iii) any split,
      combination or reclassification of any of the Company’s capital stock, (iv) any
      granting by the Company or its Subsidiaries of any increase in compensation
      or
      fringe benefits, except for normal increases of cash compensation in the
      ordinary course of business consistent with past practice, or any payment by
      the
      Company or any of its Subsidiaries of any bonus, except for bonuses made in
      the
      ordinary course of business consistent with past practice, or any granting
      by
      the Company or any of its Subsidiaries of any increase in severance or
      termination pay or any entry by the Company or any of its Subsidiaries into
      any
      currently effective employment, severance, termination or indemnification
      agreement or any agreement the benefits of which are contingent or the terms
      of
      which are materially altered upon the occurrence of a transaction involving
      the
      Company of the nature contemplated hereby, (v) entry by the Company or any
      of
      its Subsidiaries into any licensing or other agreement with regard to the
      acquisition or disposition of any Intellectual Property (as defined in
Section 2.18
      hereof)
      other than licenses in the ordinary course of business consistent with past
      practice or any amendment or consent with respect to any licensing agreement
      filed or required to be filed by the Company or any of its Subsidiaries with
      respect to any Governmental Entity, (vi) any material change by the Company
      or
      any of its Subsidiaries in its accounting methods, principles or practices,
      (vii) any change in the auditors of the Company, (viii) any issuance of capital
      stock of the Company, (ix) any revaluation by the Company of any of its assets,
      including, without limitation, writing down the value of capitalized inventory
      or writing off notes or accounts receivable or any sale of assets of the Company
      other than in the ordinary course of business, or (x) any agreement, whether
      written or oral, to do any of the foregoing.

     

    2.10     Litigation.
      Except
      as disclosed in Schedule 2.10 hereto, there are no claims, suits, actions
      or proceedings pending or, to the knowledge of the Company, threatened against
      the Company or any of its Subsidiaries before any court, governmental
      department, commission, agency, instrumentality or authority, or any arbitrator
      that involve (a) a worker compensation claim in excess of $100,000 or (a) any
      other claim in excess of $250,000.

     

    2.11     Employee
      Benefit Plans.

     

    (a)       Schedule 2.11(a)
      lists all employee compensation, incentive, fringe or benefit plans, programs,
      policies, commitments or other arrangements (whether or not set forth in a
      written document) covering any active or former employee, director or consultant
      of the Company or any of its Subsidiaries, or any trade or business (whether
      or
      not incorporated) which is under common control with the Company or any of
      its
      Subsidiaries, with respect to which the Company has liability (individually,
      a
“Plan,”
and,
      collectively, the “Plans”).
      All
      Plans have been maintained and administered in all material respects in
      compliance with their respective terms and with the requirements prescribed
      by
      any and all statutes, orders, rules and regulations which are applicable to
      such
      Plans, and all liabilities with respect to the Plans have been properly
      reflected in the financial statements and records of the Company or any of
      its
      Subsidiaries. No suit, action or other litigation (excluding claims for benefits
      incurred in the ordinary course of Plan activities) has been brought, or, to
      the
      knowledge of the Company, is threatened, against or with respect to any Plan.
      There are no audits, inquiries or proceedings pending or, to the knowledge
      of
      the Company, threatened by any governmental agency with respect to any Plan.
      All
      contributions, reserves or premium payments required to be made or accrued
      as of
      the date hereof to the Plans have been timely made or accrued. The Company
      or
      any of its Subsidiaries do not have any plan or commitment to establish any
      new
      Plan, to modify any Plan (except to the extent required by law or to conform
      any
      such Plan to the requirements of any applicable law, in each case as previously
      disclosed to Delcorp in writing, or as required by this Agreement), or to enter
      into any new Plan. Except as disclosed in Schedule 2.11(a), each Plan can
      be amended, terminated or otherwise discontinued after the Closing in accordance
      with its terms, without liability to Delcorp, the Company or any of its
      Subsidiaries (other than ordinary administration expenses and expenses for
      benefits accrued but not yet paid).

     

    
      
        
        

      

      
        -
          17 -

        
          

        

      

      
        
        

      

    

     

    (b)       Except
      as disclosed in Schedule 2.11(b) hereto, neither the execution and delivery
      of this Agreement nor the consummation of the transactions contemplated hereby
      will (i) result in any payment (including severance, unemployment compensation,
      golden parachute, bonus or otherwise) becoming due to any stockholder, director
      or employee of the Company and its Subsidiaries under any Plan or otherwise,
      (ii) materially increase any benefits otherwise payable under any Plan, or
      (iii)
      result in the acceleration of the time of payment or vesting of any such
      benefits.

     

    2.12     Labor
      Matters.

     

    (a)       Except
      as set forth on Schedule 2.12, the Company and its Subsidiaries are not a
      party to any collective bargaining agreement or other labor union contract
      applicable to persons employed by the Company and its Subsidiaries nor, to
      the
      Company’s knowledge, are there any activities or proceedings of any labor union
      to organize any such employees. There are no pending grievance or similar
      proceedings involving the Company and its Subsidiaries and any of its employees
      subject to a collective bargaining agreement or other labor union contract
      and
      there are no continuing obligations of the Company and its Subsidiaries pursuant
      to the resolution of any such proceeding that is no longer pending.

     

    (b)       Except
      as provided for in the collective bargaining agreements and labor union
      contracts set forth on Schedule 2.12, each employee and consultant of the
      Company and its Subsidiaries is terminable “at will” subject to applicable
      notice periods as set forth by law or in the employment agreement, but in any
      event not more than ninety (90) days, and there are no agreements or
      understandings between the Company and its Subsidiaries and any of their
      employees or consultants that their employment or services will be for any
      particular period. The Company has no knowledge that any of its officers or
      key
      employees intends to terminate his or her employment with the Company or any
      of
      its Subsidiaries. The Company and any of it Subsidiaries are in compliance
      in
      all material respects and, to the Company’s knowledge, each of the Company’s and
      its Subsidiaries’ employees and consultants is in compliance in all material
      respects, with the terms of the respective employment and consulting agreements
      between the Company or its Subsidiaries and such individuals. Except as
      otherwise disclosed in Schedule 2.12, there are not, and there have not
      been, any oral or informal arrangements, commitments or promises between the
      Company or its Subsidiaries and any employees or consultants of the Company
      or
      its Subsidiaries that have not been documented as part of the formal written
      agreements between any such individuals and the Company or its Subsidiaries
      that
      have been made available to Delcorp.

     

    
      
        
        

      

      
        -
          18 -

        
          

        

      

      
        
        

      

    

     

    (c)       The
      Company and its Subsidiaries are in compliance in all material respects with
      all
      Legal Requirements applicable to its employees, respecting employment,
      employment practices, terms and conditions of employment and wages and hours
      and
      is not liable for any arrears of wages or penalties with respect thereto. The
      Company’s and its Subsidiaries’ obligations to provide statutory severance pay
      to their employees are fully funded or accrued on the Unaudited Financial
      Statements and the Company has no knowledge of any circumstance that could
      give
      rise to any valid claim by a current or former employee for compensation on
      termination of employment (beyond the statutory severance pay to which employees
      are entitled). All amounts that the Company is legally or contractually required
      either (x) to deduct from its employees’ salaries or to transfer to such
      employees’ pension or provident, life insurance, incapacity insurance,
      continuing education fund or other similar funds or (y) to withhold from its
      employees’ salaries and benefits and to pay to any Governmental Entity as
      required by applicable Legal Requirements have, in each case, been duly
      deducted, transferred, withheld and paid, and the Company and its Subsidiaries
      do not have any outstanding obligation to make any such deduction, transfer,
      withholding or payment. There are no pending, or to the Company’s knowledge,
      threatened or reasonably anticipated claims or actions against the Company
      and
      its Subsidiaries by any employee in connection with such employee’s employment
      or termination of employment by the Company or any of its
      Subsidiaries.

     

    (d)       No
      employee or former employee of the Company and its Subsidiaries is owed any
      wages, benefits or other compensation for past services (other than wages,
      benefits and compensation accrued in the ordinary course of business during
      the
      current pay period and any accrued benefits for services, which by their terms
      or under applicable law, are payable in the future, such as accrued vacation,
      recreation leave and severance pay).

     

    2.13     Restrictions
      on Business Activities.
      Except
      as disclosed in Schedule 2.13 hereto, there is no agreement, commitment,
      judgment, injunction, order or decree binding upon the Company or its
      Subsidiaries or their assets or to which the Company or its Subsidiaries is
      a
      party which has or could reasonably be expected to have the effect of
      prohibiting or materially impairing any business practice of the Company or
      its
      Subsidiaries, any acquisition of property by the Company or its Subsidiaries
      or
      the conduct of business by the Company or its Subsidiaries as currently
      conducted other than such effects, individually or in the aggregate, which
      have
      not had and could not reasonably be expected to have a Material Adverse Effect
      on the Company or its Subsidiaries.

     

    
      
        
        

      

      
        -
          19 -

        
          

        

      

      
        
        

      

    

     

    2.14     Title
      to Property.

     

    (a)       All
      real property owned by the Company and its Subsidiaries (including improvements
      and fixtures thereon, easements and rights of way) is shown or reflected on
      the
      balance sheet of the Company included in the Unaudited Financial Statements
      and
      is listed on Schedule 2.14(a) hereto. The Company and its Subsidiaries have
      good, valid and marketable fee simple title to the real property respectively
      owned by each such entity, and except as set forth in the Audited Financial
      Statements or on Schedule 2.14(a) hereto, all of such real property is held
      free and clear of (i) all leases, licenses and other rights to occupy or use
      such real property and (ii) all Liens, rights of way, easements, restrictions,
      exceptions, variances, reservations, covenants or other title defects or
      limitations of any kind, other than liens for taxes not yet due and payable
      and
      such liens or other imperfections of title, if any, as do not materially detract
      from the value of or materially interfere with the present use of the property
      affected thereby. Schedule 2.14(a) hereto also contains a list of all
      options or other contracts under which the Company and its Subsidiaries have
      a
      right to acquire or the obligation to sell any interest in real
      property.

     

    (b)       Except
      as otherwise disclosed on Schedule 2.14(b), all leases of real property
      held by the Company and its Subsidiaries, and all personal property and other
      property and assets of the Company and its Subsidiaries owned, used or held
      for
      use in connection with the business of the Company and its Subsidiaries (the
      “Personal
      Property”)
      are
      shown or reflected on the balance sheet included in the Audited Financial
      Statements or the Unaudited Financial Statements, to the extent required by
      U.S.
      GAAP, as of the dates of such Audited Financial Statements and Unaudited
      Financial Statements, other than those entered into or acquired on or after
      the
      date of the Unaudited Financial Statements in the ordinary course of business.
      Schedule 2.14(b) hereto contains a list of all leases of real property and
      Personal Property held by the Company and its Subsidiaries where the annual
      lease payments are greater than $100,000 (other than leases of vehicles, office
      equipment, or operating equipment made in the ordinary course of business).
      The
      Company and its Subsidiaries have good and marketable title to the Personal
      Property owned respectively by each such entity, and all such Personal Property
      is in each case held free and clear of all Liens, except for Liens disclosed
      in
      the Audited Financial Statements or in Schedule 2.14(b) hereto, none of
      which Liens is reasonably expected to have, individually or in the aggregate,
      a
      Material Adverse Effect on such property or on the present or contemplated
      use
      of such property in the businesses of the Company or any of its
      Subsidiaries.

     

    (c)       All
      leases pursuant to which the Company an/or its Subsidiaries lease from others
      material real property or Personal Property are valid and effective in
      accordance with their respective terms, and there is not, under any of such
      leases, any existing material default or event of default of the Company or
      its
      Subsidiaries or, to the Company’s knowledge, any other party (or any event which
      with notice or lapse of time, or both, would constitute a material default),
      except where the lack of such validity and effectiveness or the existence of
      such default or event of default could not reasonably be expected to have a
      Material Adverse Effect on the Company or its Subsidiaries.

     

    
      
        
        

      

      
        -
          20 -

        
          

        

      

      
        
        

      

    

     

    (d)       The
      Company and its Subsidiaries are in possession of, or has valid and effective
      rights to, all properties, assets and rights (including Intellectual Property)
      required, in all material respects for the effective conduct of its business,
      as
      it is currently operated and expected to be operated in the future, in the
      ordinary course.

     

    2.15     Taxes.

     

    (a)       Definition
      of Taxes.
      For the
      purposes of this Agreement, “Tax”
or
      “Taxes”
refers
      to any and all federal, state, local and foreign taxes, including, without
      limitation, gross receipts, income, profits, sales, use, occupation, value
      added, ad valorem, transfer, franchise, withholding, payroll, recapture,
      employment, excise and property taxes, assessments, governmental charges and
      duties together with all interest, penalties and additions imposed with respect
      to any such amounts and any obligations under any agreements or arrangements
      with any other Person with respect to any such amounts and including any
      liability of a predecessor entity for any such amounts.

     

    (b)       Tax
      Returns and Audits.
      Except
      as set forth in Schedule 2.15 hereto:

     

    (i)       The
      Company and its Subsidiaries have timely filed all federal, state, local and
      foreign returns, estimates, information statements and reports relating to
      Taxes
      (“Returns”)
      required to be filed by the Company or its Subsidiaries with any Tax authority
      prior to the date hereof, except such Returns that are not material to the
      Company or its Subsidiaries. All such Returns are true, correct and complete
      in
      all material respects. The Company and its Subsidiaries have paid all Taxes
      shown to be due and payable on such Returns.

     

    (ii)       All
      Taxes that the Company and its Subsidiaries are required by law to withhold
      or
      collect have been duly withheld or collected, and have been timely paid over
      to
      the proper governmental authorities to the extent due and payable.

     

    (iii)       The
      Company and its Subsidiaries have not been delinquent in the payment of any
      material Tax nor is there any material Tax deficiency outstanding, proposed
      or
      assessed against the Company or its Subsidiaries, nor have the Company or its
      Subsidiaries executed any unexpired waiver of any statute of limitations on
      or
      extending the period for the assessment or collection of any Tax. The Company
      and its Subsidiaries have complied with all Legal Requirements with respect
      to
      payments made to third parties and the withholding of any payment of withheld
      Taxes and has timely withheld from employee wages and other payments and timely
      paid over in full to the proper taxing authorities all amounts required to
      be so
      withheld and paid over for all periods.

     

    
      
        
        

      

      
        -
          21 -

        
          

        

      

      
        
        

      

    

     

    (iv)       To
      the knowledge of the Company, no audit or other examination of any Return of
      the
      Company and its Subsidiaries by any Tax authority is presently in progress,
      nor
      has the Company or any Subsidiary been notified of any request for such an
      audit
      or other examination. 

     

    (v)       No
      adjustment relating to any Returns filed by the Company or any Subsidiary has
      been proposed in writing, formally or informally, by any Tax authority to the
      Company or any Subsidiary or any representative thereof.

     

    (vi)       The
      Company and its Subsidiaries have no liability for any unpaid Taxes which have
      not been accrued for or reserved on the Company’s balance sheets included in the
      Audited Financial Statements or the Unaudited Financial Statements, whether
      asserted or unasserted, contingent or otherwise, other than any liability for
      unpaid Taxes that may have accrued since the end of the most recent fiscal
      year
      in connection with the operation of the business of the Company in the ordinary
      course of business.

     

    (vii)       The
      Company has not taken any action and does not know of any fact, agreement,
      plan
      or other circumstance that is reasonably likely to prevent the Merger from
      qualifying as a reorganization within the meaning of Section 368(a) of the
      Code.

     

    (viii)       No
      current shareholder of the Company is a foreign person subject to withholding
      under Section 1445 of the Code and the regulations promulgated thereunder
      and the Company will provide certification to that effect from each shareholder
      to Delcorp at the Closing.

     

    2.16       Environmental
      Matters.

     

    (a)       Except
      as disclosed in Schedule 2.16 hereto and except for such matters that,
      individually or in the aggregate, are not reasonably likely to have a Material
      Adverse Effect: (i) the Company and/or its Subsidiaries have complied with
      all
      applicable Environmental Laws (as defined below); (ii) the properties currently
      operated or being constructed by the Company or its Subsidiaries (including
      soils, groundwater, surface water, air, buildings or other structures) are
      not
      contaminated with any Hazardous Substances (as defined below) as a result of
      the
      actions or omissions of the Company and its Subsidiaries ; (iii) the properties
      formerly owned, operated or constructed by the Company and/or its Subsidiaries
      were not contaminated with Hazardous Substances by the Company and/or its
      Subsidiaries during the period of ownership, operation or construction by the
      Company or its Subsidiaries or, to the Company’s knowledge, during any prior
      period; (iv) the Company and/or its Subsidiaries are not subject to liability
      for any Hazardous Substance disposal or contamination on any third party or
      public property (whether above, on or below ground or in the atmosphere or
      water); (vi) neither the Company nor its Subsidiaries have received any notice,
      demand, letter, claim or request for information alleging that the Company
      and/or its Subsidiaries may be in violation of or liable under any Environmental
      Law; and (vii) the Company and/or its Subsidiaries are not subject to any
      orders, decrees, injunctions or other arrangements with any Governmental Entity
      or subject to any indemnity or other agreement with any third party relating
      to
      liability under any Environmental Law or relating to Hazardous
      Substances.

     

    
      
        
        

      

      
        -
          22 -

        
          

        

      

      
        
        

      

    

     

    (b)       As
      used in this Agreement, the term “Environmental
      Law”
means
      any federal, state, local or foreign law, regulation, order, decree, permit,
      authorization, opinion, common law or agency requirement relating to: (A) the
      protection, investigation or restoration of the environment, health and safety,
      or natural resources; (B) the handling, use, presence, disposal, release or
      threatened release of any Hazardous Substance or (C) noise, odor, wetlands,
      pollution, contamination or any injury or threat of injury to persons or
      property.

     

    (c)       As
      used in this Agreement, the term “Hazardous
      Substance”
means
      any substance that is: (i) listed, classified or regulated pursuant to any
      Environmental Law; (ii) any petroleum product or by-product, asbestos-containing
      material, lead-containing paint or plumbing, polychlorinated biphenyls,
      radioactive materials or radon; or (iii) any other substance which is the
      subject of regulatory action by any Governmental Entity pursuant to any
      Environmental Law.

     

    (d)       Schedule 2.16(d)
      sets forth all environmental studies and investigations completed within the
      last five (5) years or in process with respect to the Company and/or its
      subsidiaries or their respective properties, assets or operations, including
      to
      the knowledge of the Company all phase reports. All such written reports and
      material documentation relating to any such study or investigation have been
      provided by the Company to Delcorp.

     

    2.17     Brokers;
      Third Party Expenses.
      Except
      as set forth in Schedule 2.17 hereto, the Company has not incurred, nor
      will it incur, directly or indirectly, any liability for brokerage, finders’
fees, agent’s commissions or any similar charges in connection with this
      Agreement or any transactions contemplated hereby. Except pursuant to
Section 1.5,
      and as
      disclosed in Schedule 2.17 hereto, no shares of common stock, options,
      warrants or other securities of either Company or Delcorp are payable to any
      third party by Company as a result of this Merger.

     

    2.18     Intellectual
      Property.

     

    (a)       Schedule 2.18
      hereto contains a description of all material Intellectual Property of the
      Company and its Subsidiaries. For the purposes of this Agreement, the following
      terms have the following definitions:

     

    (i)       “Intellectual
      Property”
shall
      mean any or all of the following and all worldwide common law and statutory
      rights in, arising out of, or associated therewith: (i) patents and applications
      therefor and all reissues, divisions, renewals, extensions, provisionals,
      continuations and continuations-in-part thereof (“Patents”);
      (ii)
      inventions (whether patentable or not), invention disclosures, improvements,
      trade secrets, proprietary information, know how, technology, technical data
      and
      customer lists, and all documentation relating to any of the foregoing; (iii)
      copyrights, copyrights registrations and applications therefor, and all other
      rights corresponding thereto throughout the world (“Copyrights”);
      (iv)
      software and software programs; (v) domain names, uniform resource locators
      and
      other names and locators associated with the Internet (vi) industrial designs
      and any registrations and applications therefor; (vii) trade names, logos,
      common law trademarks and service marks, trademark and service mark
      registrations and applications therefor (collectively, “Trademarks”);
      (viii) all databases and data collections and all rights therein; (ix) all
      moral
      and economic rights of authors and inventors, however denominated, and (x)
      any
      similar or equivalent rights to any of the foregoing (as
      applicable).

     

    
      
        
        

      

      
        -
          23 -

        
          

        

      

      
        
        

      

    

     

    (ii)       “Company
      Intellectual Property”
shall
      mean any Intellectual Property that is owned by, or exclusively licensed to,
      the
      Company or any of its Subsidiaries, including software and software programs
      developed by or exclusively licensed to the Company or any of its Subsidiaries
      (specifically excluding any off the shelf or shrink-wrap software).

     

    (iii)       “Registered
      Intellectual Property”
means
      all Intellectual Property that is the subject of an application, certificate,
      filing, registration or other document issued, filed with, or recorded by any
      government or other legal authority.

     

    (iv)       “Company
      Registered Intellectual Property”
means
      all of the Registered Intellectual Property owned by, or filed in the name
      of,
      the Company or any of its Subsidiaries

     

    (v)       “Company
      Products”
means
      all current versions of products or service offerings of the Company or any
      of
      its Subsidiaries.

     

    (b)       The
      Company and its Subsidiaries own or have enforceable rights to use all
      Intellectual Property required for the conduct of their respective business
      as
      presently conducted or as presently contemplated to be conducted. Except as
      disclosed in Schedule 2.18 hereto, no Company Intellectual Property or
      Company Product is subject to any material proceeding or outstanding decree,
      order, judgment, contract, license, agreement or stipulation restricting in
      any
      manner the use, transfer or licensing thereof by the Company or any of its
      Subsidiaries, or which may affect the validity, use or enforceability of such
      Company Intellectual Property or Company Product, which in any such case could
      reasonably be expected to have a Material Adverse Effect on the Company or
      any
      of its Subsidiaries.

     

    (c)       Except
      as disclosed in Schedule 2.18 hereto, the Company and its Subsidiaries owns
      and has good and exclusive title to each material item of Company Intellectual
      Property owned by it free and clear of any Liens (excluding non-exclusive
      licenses and related restrictions granted by it in the ordinary course of
      business); and the Company and its Subsidiaries are the exclusive owner of
      all
      material registered Trademarks and Copyrights used in connection with the
      operation or conduct of the business of the Company and its Subsidiaries
      including the sale of any products or the provision of any services by the
      Company and its Subsidiaries.

     

    
      
        
        

      

      
        -
          24 -

        
          

        

      

      
        
        

      

    

     

    (d)       The
      operation of the business of the Company and its Subsidiaries as such business
      currently is conducted, including the Company’s and its Subsidiaries’ use of any
      product, device or process, has not and does not infringe or misappropriate
      the
      Intellectual Property of any third party or constitute unfair competition or
      trade practices under the laws of any jurisdiction and the Company and its
      Subsidiaries have not received any claims or threats from third parties alleging
      any such infringement, misappropriation or unfair competition or trade
      practices.

     

    2.19     Agreements,
      Contracts and Commitments.

     

    (a)       Schedule 2.19
      hereto sets forth a complete and accurate list of all Material Company Contracts
      (as hereinafter defined), specifying the parties thereto. For purposes of this
      Agreement, (i) the term “Company
      Contracts”
shall
      mean all contracts, agreements, leases, mortgages, indentures, notes, bonds,
      licenses, permits, franchises, purchase orders, sales orders, and other
      understandings, commitments and obligations (including, without limitation,
      outstanding offers and proposals) of any kind, whether written or oral, to
      which
      the Company or any of its Subsidiaries is a party or by or to which any of
      the
      properties or assets of the Company or any of its Subsidiaries may be bound,
      subject or affected (including without limitation notes or other instruments
      payable to the Company or any of its Subsidiaries) and (ii) the term
“Material
      Company Contracts”
shall
      mean (x) each Company Contract (A) providing for payments (present or future)
      to
      the Company or any of its Subsidiaries in excess of $5,000,000 in the aggregate
      or (B) under or in respect of which the Company or any of its Subsidiaries
      presently have any liability or obligation of any nature whatsoever (absolute,
      contingent or otherwise) in excess of $5,000,000, (y) each Company Contract
      that
      otherwise is or may be material to the businesses, operations, assets, condition
      (financial or otherwise) or prospects of the Company or any of its Subsidiaries,
      and (z) the limitations of subclause (x) and subclause (y) notwithstanding,
      each
      of the following Company Contracts:

     

    (i)       any
      mortgage, indenture, note, installment obligation or other instrument, agreement
      or arrangement for or relating to any borrowing of money by or from the Company
      or any of its Subsidiaries and by or to any officer, director, stockholder
      or
      holder of derivative securities of the Company or any of its Subsidiaries
      (“Insider”);

     

    (ii)       any
      mortgage, indenture, note, installment obligation or other instrument, agreement
      or arrangement for or relating to any borrowing of money from an Insider by
      the
      Company;

     

    (iii)       any
      guaranty, direct or indirect, by the Company, a Subsidiary or any Insider of
      the
      Company of any obligation for borrowings, or otherwise, excluding endorsements
      made for collection in the ordinary course of business;

     

    
      
        
        

      

      
        -
          25 -

        
          

        

      

      
        
        

      

    

     

    (iv)       any
      Company Contract of employment or management;

     

    (v)       any
      Company Contract made other than in the ordinary course of business or (x)
      providing for the grant of any preferential rights to purchase or lease any
      asset of the Company or any of its Subsidiaries or (y) providing for any right
      (exclusive or non-exclusive) to sell or distribute, or otherwise relating to
      the
      sale or distribution of, any product or service of the Company or any of its
      Subsidiaries;

     

    (vi)       any
      obligation to register any shares of the capital stock or other securities
      of
      the Company or any of its Subsidiaries with any Governmental
      Entity;

     

    (vii)       any
      obligation to make payments, contingent or otherwise, arising out of the prior
      acquisition of the business, assets or stock of other Persons;

     

    (viii)       any
      collective bargaining agreement with any labor union;

     

    (ix)       any
      lease or similar arrangement for the use by the Company or any of its
      Subsidiaries of real property or Personal Property where the annual lease
      payments are greater than $100,000 (other than any lease of vehicles, office
      equipment or operating equipment made in the ordinary course of
      business);

     

    (x)       any
      Company Contract granting or purporting to grant, or otherwise in any way
      relating to, any mineral rights or any other interest (including, without
      limitation, a leasehold interest) in real property; 

     

    (xi)       any
      Company Contract to which any Insider of the Company or any of its Subsidiaries,
      or any entity owned or controlled by an Insider, is a party; and

     

    (xii)       any
      offer or proposal which, if accepted, would constitute any of the
      foregoing.

     

    (b)       Each
      Material Company Contract was entered into at arms’ length and in the ordinary
      course, is in full force and effect and, to the Company’s knowledge, is valid
      and binding upon and enforceable against each of the parties thereto, except
      insofar as enforceability may be limited by applicable bankruptcy, insolvency,
      reorganization, moratorium or similar laws affecting creditors’ rights generally
      or by principles governing the availability of equitable remedies. To the
      Company’s knowledge, no other party to a Material Company Contract is the
      subject of a bankruptcy or insolvency proceeding. True, correct and complete
      copies of all Material Company Contracts and all offers and proposals that,
      if
      accepted, would constitute Material Company Contracts (or written summaries
      in
      the case of oral Material Company Contracts or offers or proposals) have been
      made available to Delcorp or Delcorp’s counsel.

     

    
      
        
        

      

      
        -
          26 -

        
          

        

      

      
        
        

      

    

     

    (c)       Except
      as set forth in Schedule 2.19, neither the Company nor, to the best of the
      Company’s knowledge, any other party thereto is in breach of or in default
      under, and no event has occurred which with notice or lapse of time or both
      would become a breach of or default under, any Company Contract, and no party
      to
      any Company Contract has given any written notice of any claim of any such
      breach, default or event, which, individually or in the aggregate, are
      reasonably likely to have a Material Adverse Effect on the Company and its
      Subsidiaries. Each Material Company Contract that has not expired by its terms
      is in full force and effect.

     

    2.20     Insurance.
      Schedule 2.20 sets forth the Company’s and its Subsidiaries insurance
      policies and fidelity and surety bonds covering the assets, business, equipment,
      properties, operations, employees, officers and directors (collectively, the
      “Insurance
      Policies”).
      The
      insurances provided by such Insurance Policies are adequate in amount and scope
      for the Company’s and its Subsidiaries’ business and operations, including any
      insurance required to be maintained by Company Contracts.

     

    2.21     Governmental
      Actions/Filings.
      

     

    (a)       The
      Company and its Subsidiaries have been granted and hold, and have made, all
      Governmental Actions/Filings (as defined below) (including, without limitation,
      Governmental Actions/Filings required for emission or discharge of effluents
      and
      pollutants into the air and the water) necessary to the conduct by the Company
      and its Subsidiaries of their business (as presently conducted and as presently
      proposed to be conducted) or used or held for use by the Company and its
      Subsidiaries except for any thereof that if not granted, held or made, would
      not
      have, individually or in the aggregate, a Material Adverse Effect upon the
      Company and its Subsidiaries taken as a whole. Each such Governmental
      Action/Filing is in full force and effect and will be renewed in the ordinary
      course of the Company’s business and the Company and its Subsidiaries are in
      substantial compliance with all of their obligations with respect thereto.
      No
      event has occurred and is continuing which requires or permits, or after notice
      or lapse of time or both would require or permit, and consummation of the
      transactions contemplated by this Agreement or any ancillary documents will
      not
      require or permit (with or without notice or lapse of time, or both), any
      modification or termination of any such Governmental Actions/Filings except
      such
      events which, either individually or in the aggregate, would not have a Material
      Adverse Effect upon the Company or any of its Subsidiaries taken as a whole.
      No
      Governmental Action/Filing is necessary to be obtained, secured or made by
      the
      Company or any of its Subsidiaries to enable any of them to continue to conduct
      its business and operations and use its properties after the Closing in a manner
      that is consistent with current practice except for any of such that, if not
      obtained, secured or made, would not, either individually or in the aggregate,
      have a Material Adverse Effect upon the Company or any of its Subsidiaries
      taken
      as a whole.

     

    
      
        
        

      

      
        -
          27 -

        
          

        

      

      
        
        

      

    

     

    (b)       Except
      as set forth in Schedule 2.21(b), no contractors’ licenses are necessary to
      be obtained, secured or made by the Company or any of its Subsidiaries to enable
      any of them to continue to conduct its businesses and operations and use its
      properties after the Closing in a manner which is consistent with current
      practice. All of the contractors’ licenses listed on Schedule 2.21(b) have been
      obtained, secured or made and are in full force and effect.

     

    (c)       For
      purposes of this Agreement, the term “Governmental
      Action/Filing”
shall
      mean any franchise, license, certificate of compliance, authorization, consent,
      order, permit, approval, consent or other action of, or any filing, registration
      or qualification with, any federal, state, municipal, foreign or other
      governmental, administrative or judicial body, agency or authority.

     

    2.22     Interested
      Party Transactions.
      Except
      as set forth in the Schedule 2.22 hereto, no employee, officer, director or
      stockholder of the Company or any of its Subsidiaries or a member of his or
      her
      immediate family is indebted to the Company or any of its Subsidiaries, nor
      is
      the Company or any of its Subsidiaries indebted (or committed to make loans
      or
      extend or guarantee credit) to any of such Persons, other than (i) for payment
      of salary for services rendered, (ii) reimbursement for reasonable expenses
      incurred on behalf of the Company or any of its Subsidiaries, and (iii) for
      other employee benefits made generally available to all employees. Other than
      those Company shareholders who are also shareholders in Stockdale Investment
      Group, Inc., and except as set forth in Schedule 2.22, to the Company’s
      knowledge, none of such individuals has any direct or indirect ownership
      interest in any Person with whom the Company or any of its Subsidiaries is
      affiliated or with whom the Company or any of its Subsidiaries has a contractual
      relationship, or in any Person that competes with the Company or any of its
      Subsidiaries, except that each employee, stockholder, officer or director of
      the
      Company or any of its Subsidiaries and members of their respective immediate
      families may own less than 5% of the outstanding stock in publicly traded
      companies that may compete with the Company or any of its Subsidiaries. Except
      as set forth in Schedule 2.22, to the knowledge of the Company, no officer,
      director or Signing Shareholder or any member of their immediate families is,
      directly or indirectly, interested in any Material Company Contract with the
      Company or any of its Subsidiaries (other than such contracts as relate to
      any
      such Person’s ownership of capital stock or other securities of the Company or
      such Person’s employment with the Company or any of its
      Subsidiaries).

     

    2.23     Board
      Approval.
      The
      board of directors of the Company (including any required committee or subgroup
      thereof) has, as of the date of this Agreement, duly approved, subject to the
      approval of the Company’s shareholders, this Agreement and the transactions
      contemplated hereby.

     

    2.24     Signing
      Shareholder Approval.
      The
      shares of Company Common Stock owned by the Signing Shareholders and to which
      they have been granted the right to vote with respect to the Merger by other
      shareholders of the Company constitute, in the aggregate, the requisite amount
      of shares necessary for the adoption of this Agreement and the approval of
      the
      Merger by the shareholders of the Company in accordance with Applicable Nevada
      Law.

     

    
      
        
        

      

      
        -
          28 -

        
          

        

      

      
        
        

      

    

     

    2.25     No
      Illegal or Improper Transactions.
      Since
      January 1, 2002, neither the Company nor any of its Subsidiaries nor any
      Signing Shareholder or any officer, director, employee, agent or Affiliate
      of
      the Company or its Subsidiaries on its behalf has offered, paid or agreed to
      pay
      to any person or entity (including any governmental official) or solicited,
      received or agreed to receive from any such person or entity, directly or
      indirectly, any money or anything of value for the purpose or with the intent
      of
      (a) obtaining or maintaining business for the Company or any of its
      Subsidiaries, (b) facilitating the purchase or sale of any product or service,
      or (c) avoiding the imposition of any fine or penalty, in any manner which
      is in
      violation of any applicable ordinance, regulation or law, the effect of which,
      individually or in the aggregate, would reasonably be expected to be materially
      adverse to the business, assets, prospects or financial condition of the Company
      or any of its Subsidiaries, taken as a whole. To the Company’s knowledge, no
      employee of the Company or any of its Subsidiaries has provided or is providing
      information to any law enforcement agency regarding the commission or possible
      commission of any crime or the violation or possible violation of any applicable
      law. Neither the Company nor any of its Subsidiaries nor any officer, employee,
      contractor, subcontractor or agent of the Company or any of its Subsidiaries
      has
      discharged, demoted, suspended, threatened, harassed or in any other manner
      discriminated against an employee of the Company or any of its Subsidiaries
      in
      the terms and conditions of employment because of any act of such employee
      described in 18 U.S.C. Sec. 1514A(a).

     

    2.26     Representations
      and Warranties Complete.
      The
      representations and warranties of the Company and the Signing Shareholders
      included in this Agreement and any list, statement, document or information
      set
      forth in, or attached to, any Schedule provided pursuant to this Agreement
      or delivered hereunder, are true and complete in all material respects and
      do
      not contain any untrue statement of a material fact or omit to state a material
      fact required to be stated therein or necessary to make the statements contained
      therein not misleading, under the circumstance under which they were
      made.

     

    2.27     Survival
      of Representations and Warranties.
      The
      representations and warranties of the Company and the Signing Shareholders
      set
      forth in this Agreement shall survive the Closing as set forth in Section 7.3(a).

     

    ARTICLE
      III

    REPRESENTATIONS
      AND WARRANTIES OF DELCORP

     

    Subject
      to the exceptions set forth in Schedule 3 attached hereto (the
“Delcorp
      Schedule”),
      Delcorp represents and warrants to, and covenants with, the Company and the
      Signing Shareholders, as follows:

     

    3.1       Organization
      and Qualification.

     

    (a)       Delcorp
      is a corporation duly incorporated, validly existing and in good standing under
      the laws of the State of Delaware and has the requisite corporate power and
      authority to own, lease and operate its assets and properties and to carry
      on
      its business as it is now being or currently planned by Delcorp to be conducted.
      Delcorp is in possession of all Approvals necessary to own, lease and operate
      the properties it purports to own, operate or lease and to carry on its business
      as it is now being or currently planned by Delcorp to be conducted, except
      where
      the failure to have such Approvals could not, individually or in the aggregate,
      reasonably be expected to have a Material Adverse Effect on Delcorp. Complete
      and correct copies of the Charter Documents of Delcorp, as amended and currently
      in effect, have been heretofore delivered to the Company. Delcorp is not in
      violation of any of the provisions of Delcorp’s Charter Documents.

     

    
      
        
        

      

      
        -
          29 -

        
          

        

      

      
        
        

      

    

     

    (b)       Delcorp
      is duly qualified or licensed to do business as a foreign corporation and is
      in
      good standing, in each jurisdiction where the character of the properties owned,
      leased or operated by it or the nature of its activities makes such
      qualification or licensing necessary, except for such failures to be so duly
      qualified or licensed and in good standing that could not, individually or
      in
      the aggregate, reasonably be expected to have a Material Adverse Effect on
      Delcorp.

     

    3.2       Subsidiaries
      and Other Interests.

     

    (a)       Delcorp
      has no Subsidiaries and does not own, directly or indirectly, any ownership,
      equity, profits or voting interest in any Person or have any agreement or
      commitment to purchase any such interest, and Delcorp has not agreed and is
      not
      obligated to make nor is bound by any written, oral or other agreement,
      contract, subcontract, lease, binding understanding, instrument, note, option,
      warranty, purchase order, license, sublicense, insurance policy, benefit plan,
      commitment or undertaking of any nature, as of the date hereof or as may
      hereafter be in effect under which it may become obligated to make, any future
      investment in or capital contribution to any other entity.

     

    (b)       Delcorp
      does not own directly or indirectly any interest or investment (whether equity
      or debt) in any corporation, partnership, joint venture, business, trust or
      other entity (other than investments in short term investment
      securities).

     

    3.3       Capitalization.

     

    (a)       As
      of the date of this Agreement, the authorized capital stock of Delcorp consists
      of 15,000,000 shares of common stock, par value $0.0001 per share (“Delcorp
      Common Stock”)
      and
      1,000,000 shares of preferred stock, par value $0.0001 per share (“Delcorp
      Preferred Stock”),
      of
      which 6,300,000 shares of Delcorp Common Stock and no shares of Delcorp
      Preferred Stock are issued and outstanding, all of which are validly issued,
      fully paid and nonassessable and
      free of preemptive rights or rights of first refusal created by statute, the
      Certificate of Incorporation or Bylaws of Delcorp or any agreement to which
      Delcorp is a party or by which it is bound, and free of any liens or
      encumbrances other than any liens or encumbrances created by or imposed upon
      the
      holders thereof or under applicable federal or state securities or “blue sky”
laws. Delcorp has no outstanding bonds, debentures, notes or other obligations
      the holders of which have or upon the happening of certain events would have
      the
      right to vote (or which are convertible into or exercisable or exchangeable
      for
      securities having the right to vote) with the stockholders of Delcorp on any
      matter.

     

    
      
        
        

      

      
        -
          30 -

        
          

        

      

      
        
        

      

    

     

    (b)       Except
      as set forth in Schedule 3.3(b), there
      are no existing options, warrants, calls, subscriptions, convertible securities,
      or other rights, agreements, stock appreciation rights or similar derivative
      securities or instruments or commitments which obligate Delcorp to issue,
      transfer or sell any Delcorp Capital Stock or make any payments in lieu thereof.
      Other than the Voting Agreement and Lock-Up Agreement and as set forth in
      Schedule 3.3(b), there are no agreements or understandings to which Delcorp
      is a
      party with respect to the voting of any Delcorp Capital Stock or which restrict
      the transfer of any such shares, nor does Delcorp have knowledge of any such
      agreements or understandings with respect to the voting of any such shares
      or
      which restrict the transfer of any such shares. Other than the Voting Agreement
      and Lock-Up Agreement and as set forth in Schedule 3.3(b), there are no
      outstanding contractual obligations of Delcorp to repurchase, redeem or
      otherwise acquire any Delcorp Capital Stock or any other securities of Delcorp;
      and (i)
      no
      shares of Delcorp Common Stock or Delcorp Preferred Stock are reserved for
      issuance upon the exercise of outstanding options to purchase Delcorp Common
      Stock or Delcorp Preferred Stock granted to employees of Delcorp or other
      parties (“Delcorp
      Stock Options”)
      and
      there are no outstanding Delcorp Stock Options; (ii) no shares of Delcorp Common
      Stock or Delcorp Preferred Stock are reserved for issuance upon the exercise
      of
      outstanding warrants to purchase Delcorp Common Stock or Delcorp Preferred
      Stock
      (“Delcorp
      Warrants”)
      and
      there are no outstanding Delcorp Warrants; and (iii) no shares of Delcorp Common
      Stock or Delcorp Preferred Stock are reserved for issuance upon the conversion
      of the Delcorp Preferred Stock or any outstanding convertible notes, debentures
      or securities (“Delcorp
      Convertible Securities”).
      All
      shares of Delcorp Common Stock and Delcorp Preferred Stock subject to issuance
      as aforesaid, upon issuance on the terms and conditions specified in the
      instrument pursuant to which they are issuable, will be duly authorized, validly
      issued, fully paid and nonassessable. All outstanding shares of Delcorp Common
      Stock and all outstanding Delcorp Warrants have been issued and granted in
      compliance with (x) all applicable securities laws and (in all material
      respects) other applicable laws and regulations, and (y) all requirements set
      forth in any applicable Delcorp Contracts (as defined in Section 3.19).
      Delcorp has heretofore delivered to the Company true, complete and accurate
      copies of the Delcorp Warrants, including any and all documents and agreements
      relating thereto.

     

    (c)       The
      shares of Delcorp Common Stock to be issued by Delcorp in connection with the
      Merger, upon issuance in accordance with the terms of this Agreement, will
      be
      duly authorized and validly issued and such shares of Delcorp Common Stock
      will
      be fully paid and nonassessable.

     

    (d)       Except
      as set forth in Schedule 3.3(d) or as referenced in Section 1.19
      of this
      Agreement, there are no registrations rights, and there is no voting trust,
      proxy, rights plan, antitakeover plan or other agreements or understandings
      to
      which the Delcorp is a party or by which the Delcorp is bound with respect
      to
      any security of any class of the Delcorp.

     

    (e)       Except
      as provided for in this Agreement or as set forth in Schedule 3.3(e), as a
      result of the consummation of the transactions contemplated hereby, no shares
      of
      capital stock, warrants, options or other securities of the Delcorp are issuable
      and no rights in connection with any shares, warrants, options or other
      securities of the Delcorp accelerate or otherwise become triggered (whether
      as
      to vesting, exercisability, convertibility or otherwise).

     

    
      
        
        

      

      
        -
          31 -

        
          

        

      

      
        
        

      

    

     

    3.4       Authority
      Relative to this Agreement.
      Delcorp
      has full corporate power and authority to: (i) execute, deliver and perform
      this
      Agreement, and each ancillary document that Delcorp has executed or delivered
      or
      is to execute or deliver pursuant to this Agreement, and (ii) carry out
      Delcorp’s obligations hereunder and thereunder and, to consummate the
      transactions contemplated hereby (including the Merger). The execution and
      delivery of this Agreement by Delcorp and the consummation by Delcorp of the
      transactions contemplated hereby (including the Merger) have been duly and
      validly authorized by all necessary corporate action on the part of Delcorp
      (including the approval by its Board of Directors), and no other corporate
      proceedings on the part of Delcorp are necessary to authorize this Agreement
      or
      to consummate the transactions contemplated hereby, other than the Delcorp
      Stockholder Approval (as defined in Section 5.1(a)).
      This
      Agreement has been duly and validly executed and delivered by Delcorp and,
      assuming the due authorization, execution and delivery thereof by the other
      parties hereto, constitutes the legal and binding obligation of Delcorp,
      enforceable against Delcorp in accordance with its terms, except as may be
      limited by bankruptcy, insolvency, reorganization or other similar laws
      affecting the enforcement of creditors’ rights generally and by general
      principles of equity.

     

    3.5       No
      Conflict; Required Filings and Consents.

     

    (a)       The
      execution and delivery of this Agreement by Delcorp does not, and the
      performance of this Agreement by Delcorp shall not: (i) conflict with or violate
      Delcorp’s Charter Documents, (ii) conflict with or violate any Legal
      Requirements, or (iii) result in any breach of or constitute a default (or
      an
      event that with notice or lapse of time or both would become a default) under,
      or materially impair Delcorp’s rights or alter the rights or obligations of any
      third party under, or give to others any rights of termination, amendment,
      acceleration or cancellation of, or result in the creation of a Lien on any
      of
      the properties or assets of Delcorp pursuant to, any Delcorp Contracts, except,
      with respect to clauses (ii) or (iii), for any such conflicts, violations,
      breaches, defaults or other occurrences that would not, individually and in
      the
      aggregate, have a Material Adverse Effect on Delcorp.

     

    (b)       The
      execution and delivery of this Agreement by Delcorp does not, and the
      performance of it hereunder will not, require any consent, approval,
      authorization or permit of, or filing with or notification to, any Governmental
      Entity, except (i) for applicable requirements, if any, of the Securities Act,
      the Exchange Act, Blue Sky Laws, and the rules and regulations thereunder,
      and
      appropriate documents with the relevant authorities of other jurisdictions
      in
      which Delcorp is qualified to do business, (ii) for the filing of any
      notifications required under the HSR Act, if required upon advice of counsel,
      and the expiration of the required waiting period thereunder, (iii) the
      qualification of Delcorp as a foreign corporation in those jurisdictions in
      which the business of the Company makes such qualification necessary, and (iv)
      where the failure to obtain such consents, approvals, authorizations or permits,
      or to make such filings or notifications, would not, individually or in the
      aggregate, reasonably be expected to have a Material Adverse Effect on Delcorp,
      or prevent consummation of the Merger or otherwise prevent the parties hereto
      from performing their obligations under this Agreement.

     

    
      
        
        

      

      
        -
          32 -

        
          

        

      

      
        
        

      

    

     

    3.6       Compliance.
      Delcorp
      has complied with, and is not in violation of, any Legal Requirements with
      respect to the conduct of its business, or the ownership or operation of its
      business, except for failures to comply or violations which, individually or
      in
      the aggregate, have not had and are not reasonably likely to have a Material
      Adverse Effect on Delcorp. The business and activities of Delcorp have not
      been
      and are not being conducted in violation of any Legal Requirements. Neither
      Delcorp is not in default or violation of any term, condition or provision
      of
      its Charter Documents. No written notice of non-compliance with any Legal
      Requirements has been received by Delcorp.

     

    3.7       SEC
      Filings; Financial Statements.

     

    (a)       Delcorp
      has made available to the Company and the Signing Shareholders a correct and
      complete copy of each report, registration statement and definitive proxy
      statement filed by Delcorp with the SEC (the “Delcorp
      SEC Reports”),
      which
      are all the forms, reports and documents required to be filed by Delcorp with
      the SEC prior to the date of this Agreement. All Delcorp SEC Reports required
      to
      be filed by Delcorp in the twelve (12) month period prior to the date of this
      Agreement were filed in a timely manner. As of their respective dates the
      Delcorp SEC Reports: (i) were prepared in accordance and complied in all
      material respects with the requirements of the Securities Act or the Exchange
      Act, as the case may be, and the rules and regulations of the SEC thereunder
      applicable to such Delcorp SEC Reports, and (ii) did not at the time they were
      filed (and if amended or superseded by a filing prior to the date of this
      Agreement then on the date of such filing and as so amended or superseded)
      contain any untrue statement of a material fact or omit to state a material
      fact
      required to be stated therein or necessary in order to make the statements
      therein, in light of the circumstances under which they were made, not
      misleading. Except to the extent set forth in the preceding sentence, Delcorp
      makes no representation or warranty whatsoever concerning any Delcorp SEC Report
      as of any time other than the date or period with respect to which it was filed.
      The
      certifications and statements required by (A) Rule 13a-14 under the Exchange
      Act
      and (B) 18 U.S.C. Sec.1350 (Section 906 of the Sarbanes-Oxley Act) relating
      to
      the NGRU SEC Documents are accurate and complete and comply as to form and
      content with all applicable laws or rules of applicable governmental and
      regulatory authorities in all material respects.

     

    (b)       Except
      as set forth in Schedule 3.7(b), each set of financial statements
      (including, in each case, any related notes thereto) contained in Delcorp SEC
      Reports, including each Delcorp SEC Report filed after the date hereof until
      the
      Closing, complied or will comply as to form in all material respects with the
      published rules and regulations of the SEC with respect thereto, was or will
      be
      prepared in accordance with U.S. GAAP applied on a consistent basis throughout
      the periods involved (except as may be indicated in the notes thereto or, in
      the
      case of unaudited statements, do not contain footnotes as permitted by Form
      10-QSB of the Exchange Act) and each fairly presents or will fairly present
      in
      all material respects the financial position of Delcorp at the respective dates
      thereof and the results of its operations and cash flows for the periods
      indicated, except that the unaudited interim financial statements were, are
      or
      will be subject to normal adjustments which were not or are not expected to
      have
      a Material Adverse Effect on Delcorp taken as a whole.

     

    
      
        
        

      

      
        -
          33 -

        
          

        

      

      
        
        

      

    

     

    (c)       Delcorp
      maintains disclosure
      controls and procedures that satisfy the requirements of Rule 13a-15 under
      the
      Exchange Act, and such disclosure controls and procedures are designed to ensure
      that all material information concerning Delcorp is made known on a timely
      basis
      to the individuals responsible for the preparation of Delcorp’s filings with the
      SEC and other public disclosure documents. 

     

    (d)       To
      the knowledge of Delcorp, Delcorp’s auditor has at all required times since the
      date of enactment of the Sarbanes-Oxley Act been: (i) a registered public
      accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act);
      (ii)
“independent” with respect to Delcorp within the meaning of Regulation S-X under
      the Exchange Act; and (iii) in compliance with subsections (g) through (l)
      of
      Section 10A of the Exchange Act and the rules and regulations promulgated by
      the
      SEC and the Public Company Accounting Oversight Board thereunder. Schedule
      3.7(d) contains an accurate and complete description of all non-audit services
      performed by Delcorp’s auditors for Delcorp and the fees paid for such services.
      All such non-audit services were approved as required by Section 202 of the
      Sarbanes-Oxley Act.

     

    3.8       No
      Undisclosed Liabilities.
      Delcorp
      has no liabilities (absolute, accrued, contingent or otherwise) of a nature
      required to be disclosed on a balance sheet or in the related notes to the
      financial statements included in Delcorp SEC Reports that are, individually
      or
      in the aggregate, material to the business, results of operations or financial
      condition of Delcorp, except (i) liabilities provided for in or otherwise
      disclosed in Delcorp SEC Reports filed prior to the date hereof, and (ii)
      liabilities incurred since September 30, 2007 in the ordinary course of
      business, none of which would have a Material Adverse Effect on Delcorp. Delcorp
      is not and has not been a party to any securitization
      transactions or “off-balance sheet arrangements” (as defined in Item 303(c) of
      Regulation S-K under the Exchange Act).

     

    3.9       Absence
      of Certain Changes or Events.
      Except
      as set forth in Delcorp SEC Reports filed prior to the date of this Agreement,
      and except as contemplated by this Agreement, since September 30, 2007,
      there has not been: (i) any Material Adverse Effect on Delcorp, (ii) any
      declaration, setting aside or payment of any dividend on, or other distribution
      (whether in cash, stock or property) in respect of, any of Delcorp’s capital
      stock, or any purchase, redemption or other acquisition by Delcorp of any of
      Delcorp’s capital stock or any other securities of Delcorp or any options,
      warrants, calls or rights to acquire any such shares or other securities, (iii)
      any split, combination or reclassification of any of Delcorp’s capital stock,
      (iv) any granting by Delcorp of any increase in compensation or fringe benefits,
      except for normal increases of cash compensation in the ordinary course of
      business consistent with past practice, or any payment by Delcorp of any bonus,
      except for bonuses made in the ordinary course of business consistent with
      past
      practice, or any granting by Delcorp of any increase in severance or termination
      pay or any entry by Delcorp into any currently effective employment, severance,
      termination or indemnification agreement or any agreement the benefits of which
      are contingent or the terms of which are materially altered upon the occurrence
      of a transaction involving Delcorp of the nature contemplated hereby, (v) entry
      by Delcorp into any licensing or other agreement with regard to the acquisition
      or disposition of any Intellectual Property other than licenses in the ordinary
      course of business consistent with past practice or any amendment or consent
      with respect to any licensing agreement filed or required to be filed by Delcorp
      with respect to any Governmental Entity, (vi) any material change by Delcorp
      in
      its accounting methods, principles or practices, except as required by
      concurrent changes in U.S. GAAP, (vii) any change in the auditors of Delcorp,
      (vii) any issuance of capital stock of Delcorp, or (viii) any revaluation by
      Delcorp of any of its assets, including, without limitation, writing down the
      value of capitalized inventory or writing off notes or accounts receivable
      or
      any sale of assets of Delcorp other than in the ordinary course of
      business.

     

    
      
        
        

      

      
        -
          34 -

        
          

        

      

      
        
        

      

    

     

    3.10     Litigation.
      There
      are no claims, suits, actions or proceedings pending or to Delcorp’s knowledge,
      threatened against Delcorp, before any court, governmental department,
      commission, agency, instrumentality or authority, or any
      arbitrator.

     

    3.11     Employee
      Benefit Plans.
      Except
      as may be contemplated by the Delcorp Plan (as defined in Section 5.1(a)),
      Delcorp does not maintain, and has no liability under, any Plan, and neither
      the
      execution and delivery of this Agreement nor the consummation of the
      transactions contemplated hereby will (i) result in any payment (including
      severance, unemployment compensation, golden parachute, bonus or otherwise)
      becoming due to any stockholder, director or employee of Delcorp, or (ii) result
      in the acceleration of the time of payment or vesting of any such
      benefits.

     

    3.12     Labor
      Matters.
      Delcorp
      is not a party to any collective bargaining agreement or other labor union
      contract applicable to persons employed by Delcorp and Delcorp does not know
      of
      any activities or proceedings of any labor union to organize any such
      employees.

     

    3.13     Business
      Activities.
      Since
      its organization, Delcorp has not conducted any business activities other than
      activities directed toward the accomplishment of a business combination. Except
      as set forth in the Delcorp Charter Documents, there is no agreement,
      commitment, judgment, injunction, order or decree binding upon Delcorp or to
      which Delcorp is a party which has or could reasonably be expected to have
      the
      effect of prohibiting or materially impairing any business practice of Delcorp,
      any acquisition of property by Delcorp or the conduct of business by Delcorp
      as
      currently conducted other than such effects, individually or in the aggregate,
      which have not had and could not reasonably be expected to have, a Material
      Adverse Effect on Delcorp.

     

    3.14     Title
      to Property.
      Delcorp
      does not own or lease any real property or personal property. Except as set
      forth in Schedule 3.14, there are no options or other contracts under which
      Delcorp has a right or obligation to acquire or lease any interest in real
      property or personal property.

     

    3.15     Taxes.
      Except
      as set forth in Schedule 3.15 hereto:

     

    
      
        
        

      

      
        -
          35 -

        
          

        

      

      
        
        

      

    

     

    (a)       Delcorp
      has timely filed all Returns required to be filed by Delcorp with any Tax
      authority prior to the date hereof, except such Returns which are not material
      to Delcorp. All such Returns are true, correct and complete in all material
      respects. Delcorp has paid all Taxes shown to be due on such
      Returns.

     

    (b)       All
      Taxes that Delcorp is required by law to withhold or collect have been duly
      withheld or collected, and have been timely paid over to the proper governmental
      authorities to the extent due and payable.

     

    (c)       Delcorp
      has not been delinquent in the payment of any material Tax that has not been
      accrued for in Delcorp’s books and records of account for the period for which
      such Tax relates nor is there any material Tax deficiency outstanding, proposed
      or assessed against Delcorp, nor has Delcorp executed any unexpired waiver
      of
      any statute of limitations on or extending the period for the assessment or
      collection of any Tax.

     

    (d)       No
      audit or other examination of any Return of Delcorp by any Tax authority is
      presently in progress, nor has Delcorp been notified of any request for such
      an
      audit or other examination.

     

    (e)       No
      adjustment relating to any Returns filed by Delcorp has been proposed in
      writing, formally or informally, by any Tax authority to Delcorp or any
      representative thereof. 

     

    (f)       Delcorp
      has no liability for any material unpaid Taxes which have not been accrued
      for
      or reserved on Delcorp’s balance sheets included in the audited financial
      statements for the most recent fiscal year ended, whether asserted or
      unasserted, contingent or otherwise, which is material to Delcorp, other than
      any liability for unpaid Taxes that may have accrued since the end of the most
      recent fiscal year in connection with the operation of the business of Delcorp
      in the ordinary course of business, none of which is material to the business,
      results of operations or financial condition of Delcorp. 

     

    (g)       Delcorp
      has not taken any action and does not know of any fact, agreement, plan or
      other
      circumstance that is reasonably likely to prevent the Merger from qualifying
      as
      a reorganization within the meaning of Section 368(a) of the
      Code.

     

    3.16     Environmental
      Matters.
      Except
      for such matters that, individually or in the aggregate, are not reasonably
      likely to have a Material Adverse Effect: (i) Delcorp has complied with all
      applicable Environmental Laws; (ii) Delcorp is not subject to liability for
      any
      Hazardous Substance disposal or contamination on any third party property;
      (iii)
      Delcorp has not been associated with any release or threat of release of any
      Hazardous Substance; (iv) Delcorp has not received any notice, demand, letter,
      claim or request for information alleging that Delcorp may be in violation
      of or
      liable under any Environmental Law; and (v) Delcorp is not subject to any
      orders, decrees, injunctions or other arrangements with any Governmental Entity
      or subject to any indemnity or other agreement with any third party relating
      to
      liability under any Environmental Law or relating to Hazardous
      Substances.

     

    
      
        
        

      

      
        -
          36 -

        
          

        

      

      
        
        

      

    

     

    3.17     Brokers.
      Except
      as set forth in Schedule 3.17, Delcorp has not incurred, nor will it incur,
      directly or indirectly, any liability for brokerage or finders’ fees or agent’s
      commissions or any similar charges in connection with this Agreement or any
      transaction contemplated hereby.

     

    3.18     Intellectual
      Property.
      Delcorp
      does not own, license or otherwise have any right, title or interest in any
      material Intellectual Property or Registered Intellectual Property except
      non-exclusive rights to the name “Rhapsody.”

     

    3.19     Agreements,
      Contracts and Commitments.

     

    (a)       Except
      as set forth in the Delcorp SEC Reports filed prior to the date of this
      Agreement, other than confidentiality and non-disclosure agreements, there
      are
      no contracts, agreements, leases, mortgages, indentures, notes, bonds, liens,
      license, permit, franchise, purchase orders, sales orders or other
      understandings, commitments or obligations (including without limitation
      outstanding offers or proposals) of any kind, whether written or oral, to which
      Delcorp is a party or by or to which any of the properties or assets of Delcorp
      may be bound, subject or affected, which either (a) creates or imposes a
      liability greater than $25,000, or (b) may not be cancelled by Delcorp on less
      than 30 days’ or less prior notice (“Delcorp
      Contracts”).
      All
      Delcorp Contracts are listed in Schedule 3.19 other than those that are
      exhibits to the Delcorp SEC Reports.

     

    (b)       Except
      as set forth in the Delcorp SEC Reports filed prior to the date of this
      Agreement, each Delcorp Contract was entered into at arms’ length and in the
      ordinary course, is in full force and effect and is valid and binding upon
      and
      enforceable against each of the parties thereto. True, correct and complete
      copies of all Delcorp Contracts (or written summaries in the case of oral
      Delcorp Contracts) and of all outstanding offers or proposals of Delcorp have
      been heretofore made available to the Company.

     

    (c)       Neither
      Delcorp nor, to the knowledge of Delcorp, any other party thereto is in breach
      of or in default under, and no event has occurred which with notice or lapse
      of
      time or both would become a breach of or default under, any Delcorp Contract,
      and no party to any Delcorp Contract has given any written notice of any claim
      of any such breach, default or event, which, individually or in the aggregate,
      are reasonably likely to have a Material Adverse Effect on Delcorp. Each
      agreement, contract or commitment to which Delcorp is a party or by which it
      is
      bound that has not expired by its terms is in full force and effect, except
      where such failure to be in full force and effect is not reasonably likely
      to
      have a Material Adverse Effect on Delcorp.

     

    3.20     Insurance.
      Except
      for directors’ and officers’ liability insurance, Delcorp does not maintain any
      Insurance Policies.

     

    
      
        
        

      

      
        -
          37 -

        
          

        

      

      
        
        

      

    

     

    3.21     Interested
      Party Transactions.
      Except
      as set forth in the Delcorp SEC Reports filed prior to the date of this
      Agreement: (a) no employee, officer, director or stockholder of Delcorp or
      a
      member of his or her immediate family is indebted to Delcorp nor is Delcorp
      indebted (or committed to make loans or extend or guarantee credit) to any
      of
      them, other than reimbursement for reasonable expenses incurred on behalf of
      Delcorp; (b) to Delcorp’s knowledge, none of such individuals has any direct or
      indirect ownership interest in any Person with whom Delcorp is affiliated or
      with whom Delcorp has a material contractual relationship, or any Person that
      competes with Delcorp, except that each employee, stockholder, officer or
      director of Delcorp and members of their respective immediate families may
      own
      less than 5% of the outstanding stock in publicly traded companies that may
      compete with Delcorp; and (c) to Delcorp’s knowledge, no officer, director or
      stockholder or any member of their immediate families is, directly or
      indirectly, interested in any material contract with Delcorp (other than such
      contracts as relate to any such individual ownership of capital stock or other
      securities of Delcorp).

     

    3.22     Indebtedness.
      Delcorp
      has no indebtedness for borrowed money.

     

    3.23     Over-the-Counter
      Bulletin Board Quotation.
      Delcorp
      Common Stock is quoted on the Over-the-Counter Bulletin Board (“OTC
      BB”).
      There
      is no action or proceeding pending or, to Delcorp’s knowledge, threatened
      against Delcorp by NASDAQ or the Financial Industry Regulatory Authority
      (“FINRA”)
      with
      respect to any intention by such entities to prohibit or terminate the quotation
      of Delcorp Common Stock on the OTC BB.

     

    3.24     Board
      Approval.
      The
      Board of Directors of Delcorp (including any required committee or subgroup
      of
      the Board of Directors of Delcorp) has, as of the date of this Agreement,
      unanimously (i) declared the advisability of the Merger and approved this
      Agreement and the transactions contemplated hereby, (ii) determined that the
      Merger is in the best interests of the stockholders of Delcorp, and (iii)
      determined that the fair market value of the Company is equal to at least 80%
      of
      Delcorp’s net assets.

     

    3.25     Trust
      Fund.
      As of
      the date hereof and at the Closing Date, Delcorp has and will have no less
      than
      $40,000,000 invested in United States Government securities in a trust account
      administered by Continental (the “Trust
      Fund”),
      less
      such amounts, if any, as Delcorp is required to pay to (i) stockholders who
      elect to have their shares converted to cash in accordance with the provisions
      of Delcorp’s Charter Documents, (ii) deferred underwriters’ compensation in
      connection with Delcorp’s initial public offering, and (iii) third parties
      (e.g., professionals, printers, etc.) who have rendered services to Delcorp
      in
      connection with its efforts to effect a business combination, including the
      Merger.

     

    3.26     Governmental
      Filings.
      Except
      as set forth in Schedule 3.26, Delcorp has been granted and holds, and has
      made, all Governmental Actions/Filings necessary to the conduct by Delcorp
      of
      its business (as presently conducted) or used or held for use by Delcorp, and
      true, complete and correct copies of which have heretofore been delivered to
      the
      Company. Each such Governmental Action/Filing is in full force and effect and,
      except as disclosed in Schedule 3.26, will not expire prior to
      December 31, 2008, and Delcorp is in compliance with all of its obligations
      with respect thereto. No event has occurred and is continuing which requires
      or
      permits, or after notice or lapse of time or both would require or permit,
      and
      consummation of the transactions contemplated by this Agreement or any ancillary
      documents will not require or permit (with or without notice or lapse of time,
      or both), any modification or termination of any such Governmental
      Actions/Filings except such events which, either individually or in the
      aggregate, would not have a Material Adverse Effect upon Delcorp.

     

    
      
        
        

      

      
        -
          38 -

        
          

        

      

      
        
        

      

    

     

    3.27     Representations
      and Warranties Complete.
      The
      representations and warranties of Delcorp included in this Agreement and any
      list, statement, document or information set forth in, or attached to, any
      Schedule provided pursuant to this Agreement or delivered hereunder, are
      true and complete in all material respects and do not contain any untrue
      statement of a material fact or omit to state a material fact required to be
      stated therein or necessary to make the statements contained therein not
      misleading, under the circumstance under which they were made.

     

    3.28     Survival
      of Representations and Warranties.
      The
      representations and warranties of Delcorp set forth in this Agreement shall
      survive until the Closing.

     

    ARTICLE
      IV

    CONDUCT
      PRIOR TO THE EFFECTIVE TIME

     

    4.1       Conduct
      of Business by the Company, its Shareholders and
      Delcorp.
      During
      the period from the date of this Agreement and continuing until the earlier
      of
      the termination of this Agreement pursuant to its terms or the Closing, each
      of
      the Company, its Subsidiaries, and Delcorp shall, except to the extent that
      the
      other party shall otherwise consent in writing, carry on its business in the
      usual, regular and ordinary course consistent with past practices, in
      substantially the same manner as heretofore conducted and in compliance with
      all
      applicable laws and regulations (except where noncompliance would not have
      a
      Material Adverse Effect), pay its debts and taxes when due subject to good
      faith
      disputes over such debts or taxes, pay or perform other material obligations
      when due, and use its commercially reasonable efforts consistent with past
      practices and policies to (i) preserve substantially intact its present business
      organization, (ii) keep available the services of its present officers and
      employees and (iii) preserve its relationships with customers, suppliers,
      distributors, licensors, licensees, and others with which it has significant
      business dealings. In addition, except as required or permitted by the terms
      of
      this Agreement or set forth in Schedule 4.1 hereto, without the prior
      written consent of the other party, during the period from the date of this
      Agreement and continuing until the earlier of the termination of this Agreement
      pursuant to its terms or the Closing, each of the Company, its Subsidiaries
      and
      Delcorp and Merger Sub shall not do any of the following: 

     

    (a)       Waive
      any stock repurchase rights, accelerate, amend or (except as specifically
      provided for herein) change the period of exercisability of options or
      restricted stock, or reprice options granted under any employee, consultant,
      director or other stock plans or authorize cash payments in exchange for any
      options granted under any of such plans;

     

    (b)       Grant
      any severance or termination pay to any officer or employee outside the ordinary
      course of business except pursuant to applicable law, written agreements
      outstanding, or policies existing on the date hereof and as previously or
      concurrently disclosed in writing or made available to the other party, or
      adopt
      any new severance plan, or amend or modify or alter in any manner any severance
      plan, agreement or arrangement existing on the date hereof;

     

    
      
        
        

      

      
        -
          39 -

        
          

        

      

      
        
        

      

    

     

    (c)       Transfer
      or license to any person or otherwise extend, amend or modify any material
      rights to any Intellectual Property of the Company, its Subsidiaries or Delcorp,
      as applicable, or enter into grants to transfer or license to any person future
      patent rights, other than in the ordinary course of business consistent with
      past practices provided that in no event shall the Company, its Subsidiaries
      or
      Delcorp license on an exclusive basis or sell any Intellectual Property of
      the
      Company, its Subsidiaries or Delcorp as applicable;

     

    (d)       Except
      as provided in Section 5.24
      or as it
      relates to the Foreign Managers, declare, set aside or pay any dividends on
      or
      make any other distributions (whether in cash, stock, equity securities or
      property) in respect of any capital stock or split, combine or reclassify any
      capital stock or issue or authorize the issuance of any other securities in
      respect of, in lieu of or in substitution for any capital stock;

     

    (e)       Purchase,
      redeem or otherwise acquire, directly or indirectly, any shares of capital
      stock
      of the Company, its Subsidiaries and Delcorp, as applicable, including
      repurchases of unvested shares at cost in connection with the termination of
      the
      relationship with any employee or consultant pursuant to agreements in effect
      on
      the date hereof and in connection with the issuance of shares of Company Common
      Stock to the Foreign Managers;

     

    (f)       Issue,
      deliver, sell, authorize, pledge or otherwise encumber, or agree to any of
      the
      foregoing with respect to, any shares of capital stock or any securities
      convertible into or exchangeable for shares of capital stock, or subscriptions,
      rights, warrants or options to acquire any shares of capital stock or any
      securities convertible into or exchangeable for shares of capital stock, or
      enter into other agreements or commitments of any character obligating it to
      issue any such shares or convertible or exchangeable securities;

     

    (g)       Amend
      its Charter Documents;

     

    (h)       Acquire
      or agree to acquire by merging or consolidating with, or by purchasing any
      equity interest in or a portion of the assets of, or by any other manner, any
      business or any corporation, partnership, association or other business
      organization or division thereof, or otherwise acquire or agree to acquire
      any
      assets which are material, individually or in the aggregate, to the business
      of
      Delcorp, the Company or its Subsidiaries as applicable, or enter into any joint
      ventures, strategic partnerships or alliances or other arrangements that provide
      for exclusivity of territory or otherwise restrict such party’s ability to
      compete or to offer or sell any products or services. For purposes of this
      paragraph, “material” includes the requirement that, as a result of such
      transaction, financial statements of the acquired, merged or consolidated entity
      be included in the Proxy Statement (as defined in Section 5.1);

     

    
      
        
        

      

      
        -
          40 -

        
          

        

      

      
        
        

      

    

     

    (i)       Sell,
      lease, license, encumber or otherwise dispose of any properties or assets,
      except (A) sales of inventory and property, plant and equipment in the ordinary
      course of business consistent with past practice, and (B) the sale, lease or
      disposition (other than through licensing) of property or assets that are not
      material, individually or in the aggregate, to the business of such
      party;

     

    (j)       Except,
      (i) with respect to Delcorp, as permitted pursuant to Section 5.22,
      and
      (ii) with respect to the Company, or one of its Subsidiaries securing
      financing in the approximate amount of $5,000,000 for the acquisition of
      equipment, incur any indebtedness for borrowed money in excess of $3,000,000
      in
      the aggregate, other than normal usage under the existing line of credit
      facilities including the issuance of letters of credit in the ordinary course,
      or guarantee any such indebtedness of another Person or Persons in excess of
      $1,000,000 in the aggregate, issue or sell any debt securities or options,
      warrants, calls or other rights to acquire any debt securities of Delcorp,
      the
      Company or any of its Subsidiaries, as applicable, enter into any “keep well” or
      other agreement to maintain any financial statement condition or enter into
      any
      arrangement having the economic effect of any of the foregoing;

     

    (k)       Other
      than the new employment agreements to be executed prior to or concurrently
      with
      the execution of this Agreement between the Company and/or its Subsidiaries
      and
      those individuals listed in Section
      6.3(h)
      of this
      Agreement, adopt or amend any employee benefit plan, policy or arrangement,
      any
      employee stock purchase or employee stock option plan, or enter into any
      employment contract or collective bargaining agreement (other than offer letters
      and letter agreements entered into in the ordinary course of business consistent
      with past practice with employees who are terminable “at will”), pay any special
      bonus or special remuneration to any director or employee, or increase the
      salaries or wage rates or fringe benefits (including rights to severance or
      indemnification) of its directors, officers, employees or consultants, except
      in
      the ordinary course of business consistent with past practices and except as
      to;

     

    (l)       Pay,
      discharge, settle or satisfy any claims, liabilities or obligations (absolute,
      accrued, asserted or unasserted, contingent or otherwise), or litigation
      (whether or not commenced prior to the date of this Agreement) other than the
      payment, discharge, settlement or satisfaction, in the ordinary course of
      business consistent with past practices or in accordance with their terms,
      or
      liabilities recognized or disclosed in the Unaudited Financial Statements or
      in
      the most recent financial statements included in the Delcorp SEC Reports filed
      prior to the date of this Agreement, as applicable, or incurred since the date
      of such financial statements, or waive the benefits of, agree to modify in
      any
      manner, terminate, release any person from or knowingly fail to enforce any
      confidentiality or similar agreement to which the Company is a party or of
      which
      the Company is a beneficiary or to which Delcorp is a party or of which Delcorp
      is a beneficiary, as applicable;

     

    
      
        
        

      

      
        -
          41 -

        
          

        

      

      
        
        

      

    

     

    (m)       Except
      in the ordinary course of business consistent with past practices, modify,
      amend
      or terminate any Material Company Contract or Delcorp Contract, as applicable,
      or waive, delay the exercise of, release or assign any material rights or claims
      thereunder;

     

    (n)       Except
      as required by U.S. GAAP or as set forth in Schedule 4.1(n), revalue any of
      its assets or make any change in accounting methods, principles or
      practices;

     

    (o)       Except
      in the ordinary course of business consistent with past practices, incur or
      enter into any agreement, contract or commitment requiring such party to pay
      in
      excess of $2,500,000 in any 12 month period;

     

    (p)       Engage
      in any action that could reasonably be expected to cause the Merger to fail
      to
      qualify as a “reorganization” under Section 368(a)(1)(A) of the
      Code;

     

    (q)       Settle
      any litigation where the consideration given is other than monetary or to which
      an Insider is a party;

     

    (r)       Make
      or rescind any Tax elections that, individually or in the aggregate, could
      be
      reasonably likely to adversely affect in any material respect the Tax liability
      or Tax attributes of such party, settle or compromise any material income tax
      liability or, except as required by applicable law, materially change any method
      of accounting for Tax purposes or prepare or file any Return in a manner
      inconsistent with past practice, other than Company converting from an
      S Corp to a C Corp through this proposed Merger;

     

    (s)       Form,
      establish or acquire any subsidiary except as contemplated by this
      Agreement;

     

    (t)       Permit
      any Person to exercise any of its discretionary rights under any Plan to provide
      for the automatic acceleration of any outstanding options, the termination
      of
      any outstanding repurchase rights or the termination of any cancellation rights
      issued pursuant to such plans;

     

    (u)       Make
      capital expenditures except in accordance with prudent business and operational
      practices consistent with prior practice;

     

    (v)       Make
      or omit to take any action which would be reasonably anticipated to have a
      Material Adverse Effect;

     

    (w)       Enter
      into any transaction with or distribute or advance any assets or property to
      any
      of its officers, directors, partners, stockholders or other affiliates other
      than the payment of salary and benefits in the ordinary course of business
      consistent with prior practice; or

     

    
      
        
        

      

      
        -
          42 -

        
          

        

      

      
        
        

      

    

     

    (x)       Agree
      in writing or otherwise agree, commit or resolve to take any of the actions
      described in Section 4.1(a)
      through (w)
      above.

     

    ARTICLE
      V

    ADDITIONAL
      AGREEMENTS

     

    5.1       Proxy
      Statement; Special Meeting.
      

     

    (a)       As
      soon as is reasonably practicable after receipt by Delcorp from the Company
      of
      all financial and other information relating to the Company as Delcorp may
      reasonably request for its preparation, Delcorp shall prepare with the
      assistance of the Company, and after the Company has given its consent to the
      form of the prospectus/proxy statement to be included therein, which such
      consent shall not be unreasonably withheld, file with the SEC under the
      Securities Act and the Exchange Act, and with all other applicable regulatory
      bodies, a registration statement on Form S-4 with respect to the shares of
      Delcorp Common Stock to the issued in the Merger (the “Registration
      Statement”),
      which
      shall include proxy materials for the purpose of soliciting proxies from holders
      of Delcorp Common Stock to vote, at a meeting of holders of Delcorp Common
      Stock
      to be called and held for such purpose (the “Special
      Meeting”),
      in
      favor of (i) the adoption of this Agreement and the approval of the Merger
      (“Delcorp
      Stockholder Approval”),
      (ii)
      amending and restating Delcorp’s certificate of incorporation, effective upon
      the Closing, to be substantially in the form of Exhibit B hereto, providing
      for,
      among other things, (A) the change of the name of Delcorp to “Primoris
      Corporation;” (B) an increase in the number of authorized shares of Delcorp
      Common Stock to 60,000,000; (C) the existence of Delcorp to be perpetual; (D)
      and the removal of the preamble and sections A through D, inclusive, thereof
      and
      the redesignation of section E of Article Seventh as Article Seventh
      (the “Charter
      Amendment”);
      (iii)
      the adoption of an Incentive Compensation Plan (the “Delcorp
      Plan”);
      and
      (iv) an adjournment proposal, if necessary, to adjourn the Special Meeting
      if,
      based on the tabulated vote count, Delcorp is not authorized to proceed with
      the
      Merger. The Delcorp Plan shall provide that an aggregate of no less than
      1,520,000 shares of Delcorp Common Stock shall be reserved for issuance pursuant
      to the Delcorp Plan. Such proxy materials shall be in the form of a
      prospectus/proxy statement to be used for the purpose of soliciting proxies
      from
      holders of Delcorp Common Stock for the matters to be acted upon at the Special
      Meeting and also for the purpose of issuing Delcorp Common Stock to holders
      of
      Company Common Stock in connection with the Merger (the “Proxy
      Statement/Prospectus”).
      The
      Company shall furnish to Delcorp all information concerning the Company as
      Delcorp may reasonably request in connection with the preparation of the
      Registration Statement. The Company and its counsel shall be given an
      opportunity to review and comment on the preliminary Registration Statement
      prior to its filing with the SEC. Delcorp, with the assistance of the Company,
      shall promptly respond to any SEC comments on the Registration Statement and
      shall otherwise use reasonable best efforts to cause the Registration Statement
      to be declared effective by the SEC as promptly as practicable. Delcorp shall
      also take any and all actions required to satisfy the requirements of the
      Securities Act and the Exchange Act. Prior to the Closing Date, Delcorp shall
      use its reasonable best efforts to cause the shares of Delcorp Common Stock
      to
      be issued pursuant to the Merger to be registered or qualified under all
      applicable Blue Sky Laws of each of the states and territories of the United
      States in which it is believed, based on information furnished by the Company,
      holders of the Company Common Stock reside and in which such registration or
      qualification is required and to take any other such actions that may be
      necessary to enable the Delcorp Common Stock to be issued pursuant to the Merger
      in each such jurisdiction.

     

    
      
        
        

      

      
        -
          43 -

        
          

        

      

      
        
        

      

    

     

    (b)       As
      soon as practicable following the declaration of effectiveness of the
      Registration Statement by the SEC, Delcorp shall distribute the Proxy
      Statement/Prospectus to the holders of Delcorp Common Stock and, pursuant
      thereto, shall call the Special Meeting for a date no later than thirty (30)
      days following the approval of the Proxy Statement by the SEC in accordance
      with
      the DGCL and, subject to the other provisions of this Agreement, solicit proxies
      from such holders to vote in favor of the adoption of this Agreement and the
      approval of the Merger and the other matters presented to the stockholders
      of
      Delcorp for approval or adoption at the Special Meeting, including, without
      limitation, the matters described in Section 5.1(a).
      Delcorp
      shall also distribute the Proxy Statement/Prospectus to the holders of Company
      Common Stock and shall include therewith a notice, prepared by the Company,
      advising such holders of their appraisal rights pursuant to Applicable Nevada
      Law.

     

    (c)       Delcorp
      shall comply with all applicable provisions of and rules under the Exchange
      Act
      and all applicable provisions of the DGCL in the preparation, filing and
      distribution of the Registration Statement and the Proxy Statement/Prospectus,
      the solicitation of proxies thereunder, and the calling and holding of the
      Special Meeting. Without limiting the foregoing, Delcorp shall ensure that
      the
      Proxy Statement/Prospectus does not, as of the date on which the Registration
      Statement is declared effective, and as of the date of the Special Meeting,
      contain any untrue statement of a material fact or omit to state a material
      fact
      necessary in order to make the statements made, in light of the circumstances
      under which they were made, not misleading (provided that Delcorp shall not
      be
      responsible for the accuracy or completeness of any information relating to
      the
      Company or any other information furnished by the Company for inclusion in
      the
      Proxy Statement/Prospectus). The Company represents and warrants that the
      information relating to the Company supplied by the Company for inclusion in
      the
      Proxy Statement/Prospectus will not as of the date on which the Registration
      Statement (or any amendment or supplement thereto) is declared effective or
      at
      the time of the Special Meeting contain any statement which, at such time and
      in
      light of the circumstances under which it is made, is false or misleading with
      respect to any material fact, or omits to state any material fact required
      to be
      stated therein or necessary in order to make the statement therein not false
      or
      misleading. The Company shall not be responsible for the accuracy or
      completeness of any information relating to Delcorp or any other information
      furnished by Delcorp for inclusion in the Proxy
      Statement/Prospectus.

     

    
      
        
        

      

      
        -
          44 -

        
          

        

      

      
        
        

      

    

     

    (d)       Delcorp,
      acting through its board of directors, shall include in the Proxy
      Statement/Prospectus the recommendation of its board of directors that the
      holders of Delcorp Common Stock vote in favor of the adoption of this Agreement
      and the approval of the Merger, and shall otherwise use reasonable best efforts
      to obtain the Delcorp Stockholder Approval.

     

    5.2       Directors
      and Officers of Delcorp After Merger; Voting Agreement.
      The
      Parties shall take all necessary action so that the persons listed in
      Schedule 5.2 are elected for a period of three years from the date of
      Closing to the positions of officers and directors of Delcorp, as set forth
      therein, to serve in such positions effective immediately after the Closing.
      In
      addition, the person listed in Schedule 5.2 as “Observer”
shall
      be entitled to attend all meetings of the board of directors as an observer
      and
      receive all information distributed to the directors until the shorter of (i)
      such time as such person shall be elected to the board of directors and
      (ii) three years from the date of the Closing. During the aforesaid three
      year period, at any annual meeting, Delcorp may designate a person acting as
      an
      Observer for election to the board of directors in place of its then designee
      and such designee shall be entitled to be the Observer. If any Person listed
      in
      Schedule 5.2 is unable to serve, the Party appointing such Person shall
      designate a successor; provided that, if such designation is to be made after
      the Closing, any successor to a Person designated by Delcorp shall be made
      by
      the Person serving in the capacity of Chairman of Delcorp immediately prior
      to
      the Closing. Those Signing Shareholders and those stockholders of Delcorp stated
      to be parties thereto shall enter into a Voting Agreement in the form of
Exhibit F
      on or
      before the Closing Date.

     

    5.3       HSR
      Act.
      If
      required pursuant to the HSR Act, as promptly as practicable after the date
      of
      this Agreement, Delcorp and the Company shall each prepare and file the
      notification required of it thereunder in connection with the transactions
      contemplated by this Agreement and shall promptly and in good faith respond
      to
      all information requested of it by the Federal Trade Commission and Department
      of Justice in connection with such notification and otherwise cooperate in
      good
      faith with each other and such Governmental Entities. Delcorp and the Company
      shall (a) promptly inform the other of any communication to or from the Federal
      Trade Commission, the Department of Justice or any other Governmental Entity
      regarding the transactions contemplated by this Agreement, (b) give the other
      prompt notice of the commencement of any action, suit, litigation, arbitration,
      proceeding or investigation by or before any Governmental Entity with respect
      to
      such transactions and (c) keep the other reasonably informed as to the status
      of
      any such action, suit, litigation, arbitration, proceeding or investigation.
      Filing fees with respect to the notifications required under the HSR Act shall
      be paid by the Company.

     

    5.4       Other
      Actions.

     

    (a)       As
      promptly as practicable after execution of this Agreement, Delcorp will prepare
      and file a Current Report on Form 8-K pursuant to the Exchange Act to report
      the
      execution of this Agreement (“Signing
      Form 8-K”),
      which
      the Company may review and comment upon prior to filing. Any language included
      in the Signing Form 8-K that reflects the Company’s comments, as well as any
      text as to which the Company has not commented upon after being given a
      reasonable opportunity to comment, shall, notwithstanding the provisions of
      Section 5.1(a),
      be
      deemed to have been approved by the Company and may henceforth be used by
      Delcorp in other filings made by it with the SEC and in other documents
      distributed by Delcorp in connection with the transactions contemplated by
      this
      Agreement without further review or consent of the Signing Shareholders or
      the
      Company. Promptly after the execution of this Agreement, Delcorp and the Company
      shall also issue a mutually agreeable press release announcing the execution
      of
      this Agreement (the “Signing
      Press Release”).

     

    
      
        
        

      

      
        -
          45 -

        
          

        

      

      
        
        

      

    

     

    (b)       At
      least five (5) days prior to Closing, Delcorp shall prepare together with
      Company a draft Form 8-K announcing the Closing, together with, or incorporating
      by reference, the financial statements prepared by the Company and its
      accountant, and such other information that may be required to be disclosed
      with
      respect to the Merger in any report or form to be filed with the SEC
      (“Closing
      Form 8-K”),
      which
      shall be in a form reasonably acceptable to the Company. Prior to Closing,
      Delcorp and the Company shall prepare a mutually agreeable press release
      announcing the consummation of the Merger hereunder (“Closing
      Press Release”).
      Concurrently with the Closing, Delcorp shall distribute the Closing Press
      Release. Concurrently with the Closing, or as soon as practicable thereafter,
      Delcorp shall file the Closing Form 8-K with the Commission.

     

    (c)       The
      Company and Delcorp shall further cooperate with each other and use their
      respective reasonable best efforts to take or cause to be taken all actions,
      and
      do or cause to be done all things, necessary, proper or advisable on its part
      under this Agreement and applicable laws to consummate the Merger and the other
      transactions contemplated hereby as soon as practicable, including preparing
      and
      filing as soon as practicable all documentation to effect all necessary notices,
      reports and other filings and to obtain as soon as practicable all consents,
      registrations, approvals, permits and authorizations necessary or advisable
      to
      be obtained from any third party (including the respective independent
      accountants of the Company and Delcorp) and/or any Governmental Entity in order
      to consummate the Merger or any of the other transactions contemplated hereby.
      This obligation shall include, on the part of Delcorp, sending a termination
      letter to Continental in substantially the form of Exhibit A
      attached
      to the Investment Management Trust Agreement by and between Delcorp and
      Continental dated as of October 3, 2006. Subject to applicable laws relating
      to
      the exchange of information and the preservation of any applicable
      attorney-client privilege, work-product doctrine, self-audit privilege or other
      similar privilege, each of the Company and Delcorp shall have the right to
      review and comment on in advance, and to the extent practicable each will
      consult the other on, all the information relating to such party, that appear
      in
      any filing made with, or written materials submitted to, any third party and/or
      any Governmental Entity in connection with the Merger and the other transactions
      contemplated hereby. In exercising the foregoing right, each of the Company
      and
      Delcorp shall act reasonably and as promptly as practicable.

     

    
      
        
        

      

      
        -
          46 -

        
          

        

      

      
        
        

      

    

     

    5.5       Required
      Information.
      In
      connection with the preparation of the Signing Form 8-K, the Signing Press
      Release, the Registration Statement, the Proxy Statement/Prospectus, the Closing
      Form 8-K and the Closing Press Release, or any other statement, filing notice
      or
      application made by or on behalf of Delcorp and/or the Company to any Government
      Entity or other third party in connection with Merger and the other transactions
      contemplated hereby, and for such other reasonable purposes, the Company and
      Delcorp each shall, upon request by the other, furnish the other with all
      information concerning themselves, their respective directors, officers and
      stockholders (including the directors of Delcorp and the Company to be elected
      effective as of the Closing pursuant to Section 5.2
      hereof)
      and such other matters as may be reasonably necessary or advisable in connection
      with the Merger. Each party warrants and represents to the other party that
      all
      such information shall be true and correct in all material respects and will
      not
      contain any untrue statement of a material fact or omit to state a material
      fact
      required to be stated therein or necessary to make the statements contained
      therein, in light of the circumstances under which they were made, not
      misleading.

     

    5.6       Confidentiality;
      Access to Information.

     

    (a)       Confidentiality.
      Any
      confidentiality agreement previously executed by the parties shall be superseded
      in its entirety by the provisions of this Agreement. Each party agrees to
      maintain in confidence any non-public information received from the other party,
      and to use such non-public information only for purposes of consummating the
      transactions contemplated by this Agreement. Such confidentiality obligations
      will not apply to (i) information which was known to the one party or their
      respective agents prior to receipt from the other party; (ii) information which
      is or becomes generally known; (iii) information acquired by a party or their
      respective agents from a third party who was not bound to an obligation of
      confidentiality; and (iv) disclosure required by law. In the event this
      Agreement is terminated as provided in Article VIII
      hereof,
      each party (i) will destroy or return or cause to be destroyed or returned
      to
      the other all documents and other material obtained from the other in connection
      with the Merger contemplated hereby, and (ii) will use its reasonable best
      efforts to delete from its computer systems all documents and other material
      obtained from the other in connection with the Merger contemplated
      hereby.

     

    (b)       Access
      to Information.

     

    (i)       The
      Company will afford Delcorp and its financial advisors, accountants, counsel
      and
      other representatives reasonable access during normal business hours, upon
      reasonable notice, to the properties, books, records and personnel of the
      Company during the period prior to the Closing to obtain all information
      concerning the business, including the status of business development efforts,
      properties, results of operations and personnel of the Company, as Delcorp
      may
      reasonably request. No information or knowledge obtained by Delcorp in any
      investigation pursuant to this Section 5.6
      will
      affect or be deemed to modify any representation or warranty contained herein
      or
      the conditions to the obligations of the parties to consummate the
      Merger.

     

    
      
        
        

      

      
        -
          47 -

        
          

        

      

      
        
        

      

    

     

    (ii)       Delcorp
      will afford the Company and its financial advisors, underwriters, accountants,
      counsel and other representatives reasonable access during normal business
      hours, upon reasonable notice, to the properties, books, records and personnel
      of Delcorp during the period prior to the Closing to obtain all information
      concerning the business, including properties, results of operations and
      personnel of Delcorp, as the Company may reasonably request. No information
      or
      knowledge obtained by the Company in any investigation pursuant to this
Section 5.6
      will
      affect or be deemed to modify any representation or warranty contained herein
      or
      the conditions to the obligations of the parties to consummate the
      Merger.

     

    (iii)       Notwithstanding
      anything to the contrary contained herein, each party hereby agrees that, by
      proceeding with the Closing, he or it shall be conclusively deemed to have
      waived for all purposes hereunder any inaccuracy of representation or breach
      of
      warranty by another party that is actually known by him or it prior to the
      Closing, including knowledge obtained as a result of a supplement or amendment
      to a Disclosure Schedule (as hereinafter defined) pursuant to Section 5.14;
      provided that no such supplement or amendment shall preclude the Company or
      Parent from terminating this Agreement if the Disclosure Schedule, as so
      supplemented or amended, does not satisfy the provisions of Section 6.2(a)
      or
Section 6.3(a),
      as the
      case may be.

     

    5.7       Public
      Disclosure.
      From
      the date of this Agreement until Closing or termination, the parties shall
      cooperate in good faith to jointly prepare all press releases and public
      announcements pertaining to this Agreement and the transactions governed by
      it,
      and no party shall issue or otherwise make any public announcement or
      communication pertaining to this Agreement or the transaction without the prior
      consent of Delcorp (in the case of the Company and the Signing Shareholders)
      or
      the Company (in the case of Delcorp), except as required by any legal
      requirement or by the rules and regulations of, or pursuant to any agreement
      of
      a stock exchange or trading system. Each party will not unreasonably withhold
      approval from the others with respect to any press release or public
      announcement. If any party determines with the advice of counsel that it is
      required to make this Agreement and the terms of the transaction public or
      otherwise issue a press release or make public disclosure with respect thereto,
      it shall, at a reasonable time before making any public disclosure, consult
      with
      the other party regarding such disclosure, seek such confidential treatment
      for
      such terms or portions of this Agreement or the transaction as may be reasonably
      requested by the other party and disclose only such information as is legally
      compelled to be disclosed. This provision will not apply to communications
      by
      any party to its counsel, accountants and other professional
      advisors.

     

    
      
        
        

      

      
        -
          48 -

        
          

        

      

      
        
        

      

    

     

    5.8       Reasonable
      Efforts.
      Upon
      the terms and subject to the conditions set forth in this Agreement, each of
      the
      parties agrees to use its commercially reasonable efforts to take, or cause
      to
      be taken, all actions, and to do, or cause to be done, and to assist and
      cooperate with the other parties in doing, all things necessary, proper or
      advisable to consummate and make effective, in the most expeditious manner
      practicable, the Merger and the other transactions contemplated by this
      Agreement, including using commercially reasonable efforts to accomplish the
      following: (i) the taking of all reasonable acts necessary to cause the
      conditions precedent set forth in Article VI
      to be
      satisfied, (ii) the obtaining of all necessary actions, waivers, consents,
      approvals, orders and authorizations from Governmental Entities and the making
      of all necessary registrations, declarations and filings (including
      registrations, declarations and filings with Governmental Entities, if any)
      and
      the taking of all reasonable steps as may be necessary to avoid any suit, claim,
      action, investigation or proceeding by any Governmental Entity, (iii) the
      obtaining of all consents, approvals or waivers from third parties required
      as a
      result of the transactions contemplated in this Agreement, including the
      consents referred to in Schedule 2.5 of the Company Schedule, (iv) the
      defending of any suits, claims, actions, investigations or proceedings, whether
      judicial or administrative, challenging this Agreement or the consummation
      of
      the transactions contemplated hereby, including seeking to have any stay or
      temporary restraining order entered by any court or other Governmental Entity
      vacated or reversed and (v) the execution or delivery of any additional
      instruments reasonably necessary to consummate the transactions contemplated
      by,
      and to fully carry out the purposes of, this Agreement. In connection with
      and
      without limiting the foregoing, Delcorp and its board of directors and the
      Company and its board of directors shall, if any state takeover statute or
      similar statute or regulation is or becomes applicable to the Merger, this
      Agreement or any of the transactions contemplated by this Agreement, use its
      commercially reasonable efforts to enable the Merger and the other transactions
      contemplated by this Agreement to be consummated as promptly as practicable
      on
      the terms contemplated by this Agreement. Notwithstanding anything herein to
      the
      contrary, nothing in this Agreement shall be deemed to require Delcorp or the
      Company to agree to any divestiture by itself or any of its affiliates of shares
      of capital stock or of any business, assets or property, or the imposition
      of
      any material limitation on the ability of any of them to conduct their business
      or to own or exercise control of such assets, properties and stock.

     

    5.9       Treatment
      as a Reorganization.
      Neither
      Delcorp nor the Company nor the Signing Shareholders shall take any action
      prior
      to or following the Merger that could reasonably be expected to cause the Merger
      to fail to qualify as a “reorganization” within the meaning of
      Section 368(a)(i)(A) of the Code and the regulations
      thereunder.

     

    5.10     No
      Delcorp Common Stock Transactions.
      Each
      officer, director and Signing Shareholder of the Company shall agree that it
      shall not, prior to the date that is twelve months after the Closing Date,
      sell,
      transfer or otherwise dispose of an interest in any of the shares of Delcorp
      Common Stock it receives as a result of the Merger other than as permitted
      pursuant to the Lock-Up Agreement in the form of Exhibit G
      hereto
      executed by such Person prior to or on the Closing Date. Each officer and
      director of Delcorp as of the Closing Date including, but not limited to, Eric
      S. Rosenfeld, David Sgro, Arnaud Ajdler, Leonard B. Schlemm, Jon Bauer and
      Colin
      D. Watson shall agree that he shall not, prior to the date that is twelve (12)
      months after the Closing Date, sell, transfer, otherwise dispose of an interest
      in any of the shares of Delcorp Common Stock owned as of the Closing Date other
      than as permitted pursuant to the Lock-Up Agreement in the form of Exhibit G
      hereto
      executed by such person on or prior to the Closing Date.

     

    5.11     Certain
      Claims.
      

     

    (a)       As
      additional consideration for the issuance of Delcorp Common Stock pursuant
      to
      this Agreement, each of the Signing Shareholders hereby releases and forever
      discharges, effective as of the Closing Date, the Company and its directors,
      officers, employees and agents, from any and all rights, claims, demands,
      judgments, obligations, liabilities and damages, whether accrued or unaccrued,
      asserted or unasserted, and whether known or unknown arising out of or resulting
      from such Signing Shareholder’s (i) status as a holder of an equity interest in
      the Company; and (ii) employment, service, consulting or other similar agreement
      entered into with the Company prior to Closing to the extent that the basis
      for
      claims under any such agreement that survives the Closing arise prior to the
      Closing, provided, however, the foregoing shall not release any obligations
      of
      Delcorp set forth in this Agreement or any of the other documents executed
      in
      connection with the transactions contemplated hereby.

     

    
      
        
        

      

      
        -
          49 -

        
          

        

      

      
        
        

      

    

     

    (b)       As
      additional consideration for the Stockholders to enter into this Agreement,
      the
      Company hereby releases and forever discharges, effective as of the Closing
      Date, each of the Stockholders from any and all rights, claims, demands,
      judgments, obligations, liabilities and damages, whether accrued or unaccrued,
      asserted or unasserted, and whether known or unknown arising out of or resulting
      from such Stockholder’s employment, service, consulting or other similar
      agreement entered into with the Company prior to Closing to the extent that
      the
      basis for claims under any such agreement that survives the Closing arise prior
      to the Closing.

     

    5.12     No
      Securities Transactions.
      Neither
      the Company nor any Signing Shareholder or any of their affiliates, directly
      or
      indirectly, shall engage in any transactions involving the securities of Delcorp
      prior to the time of the making of a public announcement of the transactions
      contemplated by this Agreement. The Company shall use its best efforts to
      require each of its officers, directors and employees, and shall use
      commercially reasonable efforts to require each of its agents, advisors,
      contractors, associates, clients, customers and representatives, to comply
      with
      the foregoing requirement.

     

    5.13     No
      Claim Against Trust Fund.
      Notwithstanding anything else in this Agreement, the Company and the Signing
      Shareholders acknowledge that they have read Delcorp’s final prospectus dated
      October 3, 2006 and understand that Delcorp has established the Trust Fund
      for the benefit of Delcorp’s public stockholders and that Delcorp may disburse
      monies from the Trust Fund only (a) to Delcorp’s public stockholders in the
      event they elect to convert their shares into cash in accordance with Delcorp’s
      Charter Documents and/or the liquidation of Delcorp or (b) to Delcorp after
      it
      consummates a business combination. The Company and the Signing Shareholders
      further acknowledge that, if the transactions contemplated by this Agreement,
      or, upon termination of this Agreement, another business combination, are not
      consummated by October 3, 2008, Delcorp will be obligated to return to its
      stockholders the amounts being held in the Trust Fund. Accordingly, the Company
      and the Signing Shareholders, for themselves and their subsidiaries, affiliated
      entities, directors, officers, employees, stockholders, representatives,
      advisors and all other associates and affiliates, hereby waive all rights,
      title, interest or claim of any kind against Delcorp to collect from the Trust
      Fund any monies that may be owed to them by Delcorp for any reason whatsoever,
      including but not limited to a breach of this Agreement by Delcorp or any
      negotiations, agreements or understandings with Delcorp (whether in the past,
      present or future), and will not seek recourse against the Trust Fund at any
      time for any reason whatsoever. This paragraph will survive this Agreement
      and
      will not expire and will not be altered in any way without the express written
      consent of Delcorp, the Company and the Signing Shareholders.

     

    
      
        
        

      

      
        -
          50 -

        
          

        

      

      
        
        

      

    

     

    5.14     Disclosure
      of Certain Matters.
      Each of
      Delcorp, the Company and each of the Signing Shareholders will provide the
      others with prompt written notice of any event, development or condition that
      (a) would cause any of such party’s representations and warranties to become
      untrue or misleading or which may affect its ability to consummate the
      transactions contemplated by this Agreement, (b) had it existed or been known
      on
      the date hereof would have been required to be disclosed under this Agreement,
      (c) gives such party any reason to believe that any of the conditions set forth
      in Article VI
      will not
      be satisfied, (d) is of a nature that is or may be materially adverse to the
      operations, prospects or condition (financial or otherwise) of the Company,
      or
      (e) would require any amendment or supplement to the Proxy Statement/Prospectus.
      The parties shall have the obligation to supplement or amend the Company
      Schedules and Delcorp Schedules (the “Disclosure
      Schedules”)
      being
      delivered concurrently with the execution of this Agreement with respect to
      any
      matter hereafter arising or discovered which, if existing or known at the date
      of this Agreement, would have been required to be set forth or described in
      the
      Disclosure Schedules. The obligations of the parties to amend or supplement
      the
      Disclosure Schedules being delivered herewith shall terminate on the Closing
      Date. Notwithstanding any such amendment or supplementation, for purposes of
      Sections
      6.2(a), 6.3(a), 7.1(a)(i), 8.1(d) and 8.1(e),
      the
      representations and warranties of the parties shall be made with reference
      to
      the Disclosure Schedules as they exist at the time of execution of this
      Agreement, subject to such anticipated changes as are set forth in
      Schedule 4.1 or otherwise expressly contemplated by this Agreement or that
      are set forth in the Disclosure Schedules as they exist on the date of this
      Agreement.

     

    5.15     Securities
      Listing.
      Delcorp
      and the Company shall use commercially reasonable efforts to obtain the listing
      for trading on either the New York Stock Exchange or on NASDAQ of the Delcorp
      Common Stock and the Units issued in Delcorp’s initial public offering and the
      class of warrants included in such Units. If such listing is not obtained by
      the
      Closing, the parties shall continue to use their best efforts after the Closing
      to obtain such listing.

     

    5.16     Further
      Actions.
      The
      Company shall use its best efforts to take such actions as are necessary to
      fulfill its obligations under this Agreement and to enable Delcorp to fulfill
      its obligations hereunder.

     

    5.17     No
      Solicitation.

     

    (a)       The
      Company will not, and will cause its Affiliates, employees, agents and
      representatives not to, directly or indirectly, solicit or enter into
      discussions or transactions with, or encourage, or provide any information
      to,
      any corporation, partnership or other entity or group (other than Delcorp and
      its designees) concerning any merger, sale of ownership interests and/or assets
      of the Company, recapitalization or similar transaction.

     

    (b)       Delcorp
      will not, and will cause its employees, agents and representatives not to,
      directly or indirectly, solicit or enter into discussions or transactions with,
      or encourage, or provide any information to, any corporation, partnership or
      other entity or group (other than the Company and its designees) concerning
      any
      merger, purchase of ownership interests and/or assets, recapitalization or
      similar transaction.

     

    
      
        
        

      

      
        -
          51 -

        
          

        

      

      
        
        

      

    

     

    5.18     Charter
      Protections; Directors’ and Officers’ Liability
      Insurance.

     

    (a)       All
      rights to indemnification for acts or omissions occurring through the Closing
      Date now existing in favor of the current directors and officers of Delcorp
      as
      provided in the Charter Documents of Delcorp or in any indemnification
      agreements shall survive the Merger and shall continue in full force and effect
      in accordance with their terms.

     

    (b)       For
      a period of six (6) years after the Closing Date, each of Delcorp and the
      Surviving Corporation shall cause to be maintained in effect the current
      policies of directors’ and officers’ liability insurance maintained by Delcorp
      and the Company, respectively (or policies of at least the same coverage and
      amounts containing terms and conditions which are no less advantageous), with
      respect to claims arising from facts and events that occurred prior to the
      Closing Date.

     

    (c)       If
      Delcorp or any of its successors or assigns (i) consolidates with or merges
      into
      any other Person and shall not be the continuing or surviving entity of such
      consolidation or merger, or (ii) transfers or conveys all or substantially
      all
      of its properties and assets to any Person, then, in each such case, to the
      extent necessary, proper provision shall be made so that the successors and
      assigns of Delcorp assume the obligations set forth in this Section 5.18.

     

    (d)       The
      provisions of this Section 5.18
      are
      intended to be for the benefit of, and shall be enforceable by, each Person
      who
      will have been a director or officer of Delcorp for all periods ending on or
      before the Closing Date and may not be changed without the consent of Committee
      referred to in Section 1.14(a).

     

    5.19     Insider
      Loans; Equity Ownership in Subsidiaries.
      Each
      Signing Shareholder, at or prior to Closing, shall (i) repay to the Company
      any
      loan by the Company to such Signing Shareholder and any other amount owed by
      the
      Signing Shareholder to the Company; (ii) cause any guaranty or similar
      arrangement pursuant to which the Company has guaranteed the payment or
      performance of any obligations of such Signing Shareholder to a third party
      to
      be terminated; and (iii) cease to own any direct equity interests in any
      Subsidiary of the Company or in any other Person that utilizes the name
“Primoris.” The Company shall use its best efforts to enable the Signing
      Shareholders to accomplish the foregoing.

     

    5.20     Certain
      Financial Information.
      Within
      twenty (20) business days after the end of each month between the date hereof
      and the earlier of the Closing Date and the date on which this Agreement is
      terminated, the Company shall deliver to Delcorp unaudited consolidated
      financial statements of the Company and its Subsidiaries for such month,
      certified by the chief financial officer of the Company as being true and
      correct, including a balance sheet, statement of operations, and statements
      of
      stockholders’ equity and cash flow, prepared in accordance with the U.S. GAAP
      applied on a consistent basis to prior periods (except as may be indicated
      in
      the notes thereto) and that fairly present in all material respects the
      financial position of the Company at the date thereof and the results of its
      operations for the period indicated, except that statements of cash flow need
      be
      delivered only as of the end of each fiscal quarter and such statements need
      not
      contain notes and may be subject to normal adjustments that are not expected
      to
      have a Material Adverse Effect on the Company and its Subsidiaries, taken as
      a
      whole.

     

    
      
        
        

      

      
        -
          52 -

        
          

        

      

      
        
        

      

    

     

    5.21     Access
      to Financial Information.
      The
      Company will, and will cause its auditors to (a) continue to provide Delcorp
      and
      its advisors full access to all of the Company’s financial information used in
      the preparation of its Audited Financial Statements and Unaudited Financial
      Statements and the financial information furnished pursuant to Section 5.20
      hereof
      and (b) cooperate fully with any reviews performed by Delcorp or its advisors
      of
      any such financial statements or information.

     

    5.22     Delcorp
      Borrowings.
      Through
      the Closing, Delcorp shall be allowed to borrow funds from its directors,
      officers and/or stockholders to meet its reasonable capital requirements, with
      any such loans to be made only as reasonably required by the operation of
      Delcorp in due course on a non-interest bearing basis and repayable at Closing.
      The proceeds of such loans shall not be used for the payment of salaries,
      bonuses or other compensation to any of Delcorp’s directors, officers or
      stockholders.

     

    5.23     Trust
      Fund Disbursement.
      Delcorp
      shall cause the Trust Fund to be dispersed to Delcorp immediately upon the
      Closing. All liabilities of Delcorp due and owing or incurred at or prior to
      the
      Effective Time shall be paid as and when due, including all Delcorp tax
      liabilities and the payment at Closing of professional fees related to these
      transactions, and adequate reserves shall be made against amounts distributed
      from the Trust Fund therefor.

     

    5.24     Distributions
      by Company.
      The
      Company may make cash distributions as follows:

     

    (a)       From
      and after the date of this Agreement, at any time prior to the Closing Date,
      distributions (“Tax
      Distributions”)
      under
      Section 1368 of the Code to its shareholders limited, in the aggregate, to
      50%
      of the estimated Stub Period Taxable Income (as hereinafter defined). As used
      herein, “Stub
      Period Taxable Income”
means
      the income of the Company and its Subsidiaries that will be entered on Form
      1120S, Schedule K, Line 18 of the final U.S. Income Tax Return of the Company
      and its Subsidiaries for the period beginning on January 1, 2008 and ending
      on
      the Closing Date, which Tax Return shall be prepared and filed by the Surviving
      Corporation as soon as practicable after the Closing Date. The Surviving
      Corporation shall submit such final Tax Return to the Representative at least
      ten days prior to the date it intends to file such final Tax Return. The
      Surviving Corporation shall not file such final Tax Return without the consent
      of the Representative, which consent shall not be unreasonably
      withheld.

     

    (b)       From
      and after the date of this Agreement, at any time prior to the Closing Date,
      in
      addition to the distributions provided for in Section 5.24(a), distributions
      under Section 1368 of the Code in an amount not to exceed Forty-Eight Million
      Nine Hundred Forty-Six Thousand Six Hundred Sixty Dollars and Sixty-Nine Cents
      ($48,946,660.69) (the “Base
      Distribution”).
      Of
      the Base Distribution, the Company will distribute Forty-Four Million Fifty-One
      Thousand Two Hundred Eighty Dollars ($44,051,280) to its shareholders, with
      the
      balance of Four Million Eight Hundred Ninety-Five Thousand Three Hundred Eighty
      Dollars and Sixty-Nine Cents ($4,895,380.69) (the “Distribution
      Holdback”)
      to be
      held by Delcorp and distributed in accordance with the provisions of Section
      5.24(c).

     

    
      
        
        

      

      
        -
          53 -

        
          

        

      

      
        
        

      

    

     

    (c)       After
      the Stub Period Taxable Income and the Tax Distribution amount to which the
      shareholders of the Company are entitled have been finally determined, the
      Surviving Corporation shall release as a distribution to the former shareholders
      of the Company under Sections 1368 and 1371(e)(1) of the Code, no later than
      a
      date qualifying as within the post-termination transaction period defined by
      Section 1377(b)(1)(A) of the Code, such amount from the Distribution Holdback
      so
      that the total distribution payments to such Persons pursuant to this Section
      5.24, including amounts released to such Persons from the Distribution Holdback,
      shall equal the sum of (i) 50% of the Stub Period Taxable Income, as finally
      determined, plus (ii) the Base Distribution. Any amount remaining in the
      Distribution Holdback shall be retained by the Surviving
      Corporation.

     

    5.25     Dividend.
      Following the closing, Delcorp’s board of directors shall initially declare and
      pay annual dividends on the Delcorp Common Stock at a rate of not less than
      $0.10 per share; provided, however, that the board of directors shall not
      declare any such dividend unless, at the time of declaration, there is adequate
      surplus for such declaration under the DGCL or if the board of directors, in
      the
      exercise of their business judgment, believes that it would be prudent to cancel
      or modify the dividend payment.

     

    5.26     Termination
      of Shareholders’ Agreement.
      The
      Company and the Signing Shareholders shall use their reasonable best efforts
      to
      cause the Primoris Shareholders’ Agreement dated December 31, 2003 shall be
      terminated by all parties hereto.

     

    ARTICLE
      VI

    CONDITIONS
      TO THE TRANSACTION

     

    6.1      Conditions
      to Obligations of Each Party to Effect the Merger.
      The
      respective obligations of each party to this Agreement to effect the Merger
      shall be subject to the satisfaction at or prior to the Closing Date of the
      following conditions:

     

    (a)       Delcorp
      Stockholder Approval.
      The
      Delcorp Stockholder Approval and the Charter Amendment each shall have been
      duly
      approved and adopted by the stockholders of Delcorp by the requisite vote under
      the laws of the State of Delaware and the Delcorp Charter Documents.

     

    (b)       Delcorp
      Common Stock.
      Holders
      of twenty percent (20%) or more of the shares of Delcorp Common Stock issued
      in
      Delcorp’s initial public offering of securities and outstanding immediately
      before the Closing shall not have exercised their rights to convert their shares
      into a pro rata share of the Trust Fund in accordance with Delcorp’s Charter
      Documents.

     

    (c)       HSR
      Act; No Order.
      All
      specified waiting periods under the HSR Act shall have expired and no
      Governmental Entity shall have enacted, issued, promulgated, enforced or entered
      any statute, rule, regulation, executive order, decree, injunction or other
      order (whether temporary, preliminary or permanent) which is in effect and
      which
      has the effect of making the Merger illegal or otherwise prohibiting
      consummation of the Merger, substantially on the terms contemplated by this
      Agreement.

     

    
      
        
        

      

      
        -
          54 -

        
          

        

      

      
        
        

      

    

     

    (d)       Stock
      Quotation or Listing.
      The
      Delcorp Common Stock at the Closing will be quoted on the OTC BB or listed
      for
      trading on the New York Stock Exchange or NASDAQ, if the application for any
      such listing is approved, and there will be no action or proceeding pending
      or
      threatened against Delcorp by FINRA to prohibit or terminate the quotation
      of
      Delcorp Common Stock on the OTC BB or the trading thereof on the New York Stock
      Exchange or NASDAQ. 

     

    6.2       Additional
      Conditions to Obligations of the Company.
      The
      obligations of the Company to consummate and effect the Merger shall be subject
      to the satisfaction at or prior to the Closing Date of each of the following
      conditions, any of which may be waived, in writing, exclusively by the
      Company:

     

    (a)       Representations
      and Warranties.
      Each
      representation and warranty of Delcorp contained in this Agreement that is
      (i)
      qualified as to materiality shall have been true and correct (A) as of the
      date
      of this Agreement and (B) subject to the provisions of the last sentence of
      Section 5.14,
      on and
      as of the Closing Date with the same force and effect as if made on the Closing
      Date, and (ii) not qualified as to materiality shall have been true and correct
      (C) as of the date of this Agreement and (D) subject to the provisions of the
      last sentence of Section 5.14,
      in all
      material respects on and as of the Closing Date with the same force and effect
      as if made on the Closing Date. The Company shall have received a certificate
      with respect to the foregoing signed on behalf of Delcorp by an authorized
      officer of Delcorp (“Delcorp
      Closing Certificate”).

     

    (b)       Agreements
      and Covenants.
      Delcorp
      and Merger Sub shall have performed or complied with all agreements and
      covenants required by this Agreement to be performed or complied with by them
      on
      or prior to the Closing Date, except to the extent that any failure to perform
      or comply (other than a willful failure to perform or comply or failure to
      perform or comply with an agreement or covenant reasonably within the control
      of
      Delcorp) does not, or will not, constitute a Material Adverse Effect with
      respect to Delcorp, and the Delcorp Closing Certificate shall include a
      provision to such effect.

     

    (c)       No
      Litigation.
      No
      action, suit or proceeding shall be pending or threatened before any
      Governmental Entity which is reasonably likely to (i) prevent consummation
      of
      any of the transactions contemplated by this Agreement, (ii) cause any of the
      transactions contemplated by this Agreement to be rescinded following
      consummation or (iii) affect materially and adversely or otherwise encumber
      the
      title of the shares of Delcorp Common Stock to be issued by Delcorp in
      connection with the Merger and no order, judgment, decree, stipulation or
      injunction to any such effect shall be in effect.

     

    
      
        
        

      

      
        -
          55 -

        
          

        

      

      
        
        

      

    

     

    (d)       Consents.
      Delcorp
      shall have obtained all consents, waivers and approvals required to be obtained
      by Delcorp in connection with the consummation of the transactions contemplated
      hereby, other than consents, waivers and approvals the absence of which, either
      alone or in the aggregate, could not reasonably be expected to have a Material
      Adverse Effect on Delcorp and the Delcorp Closing Certificate shall include
      a
      provision to such effect.

     

    (e)       Material
      Adverse Effect.
      No
      Material Adverse Effect with respect to Delcorp shall have occurred since the
      date of this Agreement.

     

    (f)       SEC
      Compliance.
      Immediately prior to Closing, Delcorp shall be in compliance with the reporting
      requirements under the Exchange Act.

     

    (g)       Opinion
      of Counsel.
      The
      Company shall have received from Graubard Miller, counsel to Delcorp, an opinion
      of counsel in substantially the form of Exhibit H
      annexed
      hereto.

     

    (h)       Other
      Deliveries.
      At or
      prior to Closing, Delcorp shall have delivered to the Company (i) copies of
      resolutions and actions taken by Delcorp’s board of directors and stockholders
      in connection with the approval of this Agreement and the transactions
      contemplated hereunder, and (ii) such other documents or certificates as shall
      reasonably be required by the Company and its counsel in order to consummate
      the
      transactions contemplated hereunder.

     

    (i)       Resignations.
      The
      persons listed in Schedule 6.2(i) shall have resigned from all of their
      positions and offices with Delcorp.

     

    (j)       Trust
      Fund.
      Delcorp
      shall have made appropriate arrangements to have the Trust Fund, which shall
      contain no less than the amount referred to in Section 3.25,
      dispersed to Delcorp immediately upon the Closing.

     

    (k)       Lock-Up
      Agreement.
      The
      Lock-Up Agreement in the form of Exhibit G
      shall be
      executed by the Delcorp stockholders designated as parties thereto.

     

    6.3       Additional
      Conditions to the Obligations of Delcorp.
      The
      obligations of Delcorp to consummate and effect the Merger shall be subject
      to
      the satisfaction at or prior to the Closing Date of each of the following
      conditions, any of which may be waived, in writing, exclusively by
      Delcorp:

     

    (a)       Representations
      and Warranties.
      Each
      representation and warranty of the Company and the Stockholders contained in
      this Agreement that is (i) qualified as to materiality shall have been true
      and
      correct (A) as of the date of this Agreement and (B) subject to the provisions
      of the last sentence of Section 5.14,
      on and
      as of the Closing Date with the same force and effect as if made on the Closing
      Date, and (ii) not qualified as to materiality shall have been true and correct
      (C) as of the date of this Agreement and (D) subject to the provisions of the
      last sentence of Section 5.14,
      in all
      material respects on and as of the Closing Date with the same force and effect
      as if made on the Closing Date. Delcorp shall have received a certificate with
      respect to the foregoing signed on behalf of the Company by an authorized
      officer of the Company (“Company
      Closing Certificate”).

     

    
      
        
        

      

      
        -
          56 -

        
          

        

      

      
        
        

      

    

     

    (b)       Agreements
      and Covenants.
      The
      Company and the Signing Shareholders shall have performed or complied with
      all
      agreements and covenants required by this Agreement to be performed or complied
      with by them at or prior to the Closing Date except to the extent that any
      failure to perform or comply (other than a willful failure to perform or comply
      or failure to perform or comply with an agreement or covenant reasonably within
      the control of the Company) does not, or will not, constitute a Material Adverse
      Effect on the Company, and the Company Closing Certificate shall include a
      provision to such effect.

     

    (c)       Dissenters’
      Rights.
      Holders
      of no more than five percent (5%) of the shares of any class of securities
      of
      the Company outstanding immediately before the Effective Time shall have taken
      action to exercise their rights pursuant to Chapter 92A of the Nevada Revised
      Statutes and other provisions of Applicable Nevada Law.

     

    (d)       No
      Litigation.
      No
      action, suit or proceeding shall be pending or threatened before any
      Governmental Entity which is reasonably likely to (i) prevent consummation
      of
      any of the transactions contemplated by this Agreement, (ii) cause any of the
      transactions contemplated by this Agreement to be rescinded following
      consummation or (iii) affect materially and adversely the right of Delcorp
      to
      own, operate or control any of the assets and operations of the Surviving
      Corporation following the Merger and no order, judgment, decree, stipulation
      or
      injunction to any such effect shall be in effect.

     

    (e)       Consents.
      The
      Company shall have obtained all consents, waivers, permits and approvals
      required to be obtained by the Company in connection with the consummation
      of
      the transactions contemplated hereby, other than consents, waivers and approvals
      the absence of which, either alone or in the aggregate, could not reasonably
      be
      expected to have a Material Adverse Effect on the Company and the Company
      Closing Certificate shall include a provision to such effect.

     

    (f)       Material
      Adverse Effect.
      No
      Material Adverse Effect with respect to the Company shall have occurred since
      the date of this Agreement.

     

    (g)       Voting
      and Lock-Up Agreements.
      The
      Voting Agreement substantially in the form of Exhibit F
      and the
      Lock-Up Agreements substantially in the form of Exhibit G
      shall be
      in full force and effect.

     

    (h)       Employment
      Agreements.
      Employment Agreements between the Company and, separately, Brian Pratt, John
      Schauerman, John Perisich, Alfons Theeuwes, Scott Summers, Tim Healy, Mark
      Thurman, Dave Baker and Bill McDevitt in the forms of Exhibits I
      through Q,
      respectively, shall be in full force and effect.

     

    
      
        
        

      

      
        -
          57 -

        
          

        

      

      
        
        

      

    

     

    (i)       Opinion
      of Counsel.
      Delcorp
      shall have received from Rutan & Tucker, LLP, counsel to the Company,
      an opinion of counsel in substantially the form of Exhibit R
      annexed
      hereto.

     

    (j)       Other
      Deliveries.
      At or
      prior to Closing, the Company shall have delivered to Delcorp: (i) copies of
      resolutions and actions taken by the Company’s board of directors and
      stockholders in connection with the approval of this Agreement and the
      transactions contemplated hereunder, and (ii) such other documents or
      certificates as shall reasonably be required by Delcorp and its counsel in
      order
      to consummate the transactions contemplated hereunder.

     

    (k)       Derivative
      Securities.
      There
      shall be outstanding no options, warrants or other derivative securities
      entitling the holders thereof to acquire shares of Company Common Stock or
      other
      securities of the Company.

     

    (l)       Insider
      Loans; Equity Ownership in Subsidiaries.
      (i) All
      outstanding indebtedness owed by Insiders to the Company shall have been repaid
      in full, including the indebtedness and other obligations described on
      Schedule 2.22; (ii) all outstanding guaranties and similar arrangements
      pursuant to which the Company has guaranteed the payment or performance of
      any
      obligations of any Insider to a third party shall have been terminated; and
      (iii) no Insider shall own any direct equity interests in any Subsidiary of
      the
      Company or in any other Person that utilizes in its name “Primoris.”

     

    (m)       Company
      Shareholder Vote.
      The
      terms of this Agreement and the transactions referred to herein shall have
      been
      approved by the Company’s shareholders pursuant to a properly noticed meeting of
      the Company’s shareholders.

     

    (n)       Termination
      of Shareholders’ Agreement.
      The
      Primoris Shareholders’ Agreement dated December 31, 2003 shall have been
      terminated.

     

    ARTICLE
      VII

    INDEMNIFICATION

     

    7.1       Indemnification
      of Delcorp.

     

    (a)       Subject
      to the terms and conditions of this Article VII
      (including without limitation the limitations set forth in Section 7.4),
      Delcorp, the Surviving Corporation and their respective representatives,
      successors and permitted assigns (the “Delcorp
      Indemnitees”)
      shall
      be indemnified, defended and held harmless by those Persons who receive shares
      of Delcorp Company Stock from Delcorp upon consummation of the Merger, but
      only
      to the extent of the Escrow Shares, from and against all Losses asserted
      against, resulting to, imposed upon, or incurred by any Delcorp Indemnitee
      by
      reason of, arising out of or resulting from:

     

    
      
        
        

      

      
        -
          58 -

        
          

        

      

      
        
        

      

    

     

    (i)       the
      inaccuracy or breach of any representation or warranty of the Company contained
      in or made pursuant to this Agreement, any Schedule or any certificate
      delivered by the Company to Delcorp pursuant to this Agreement with respect
      hereto or thereto in connection with the Closing; and 

     

    (ii)       the
      non-fulfillment or breach of any covenant or agreement of the Company contained
      in this Agreement;

     

    (b)       As
      used in this Article VII,
      the
      term “Losses”
shall
      include on a dollar for dollar basis all losses, liabilities, damages,
      judgments, awards, orders, penalties, settlements, costs and expenses
      (including, without limitation, interest, penalties, court costs and reasonable
      legal fees and expenses) including those arising from any demands, claims,
      suits, actions, costs of investigation, notices of violation or noncompliance,
      causes of action, proceedings and assessments whether or not made by third
      parties or whether or not ultimately determined to be valid. Solely for the

      purpose of determining the amount of any Losses (and not for determining any
      breach) for which Delcorp Indemnitee may be entitled to indemnification pursuant
      to Article VII,
      any
      representation or warranty contained in this Agreement that is qualified by
      a
      term or terms such as “material,” “materially,” or “Material Adverse Effect”
shall be deemed made or given without such qualification and without giving
      effect to such words.

     

    7.2       Indemnification
      of Third Party Claims.
      The
      indemnification obligations and liabilities under this Article VII
      with
      respect to actions, proceedings, lawsuits, investigations, demands or other
      claims brought against Delcorp by a Person other than the Company (a
“Third
      Party Claim”)
      shall
      be subject to the following terms and conditions:

     

    (a)       Notice
      of Claim.
      Delcorp, acting through the Committee, will give the Representative prompt
      written notice after receiving written notice of any Third Party Claim or
      discovering the liability, obligation or facts giving rise to such Third Party
      Claim (a “Notice
      of Claim”)
      which
      Notice of Third Party Claim shall set forth (i) a brief description of the
      nature of the Third Party Claim, (ii) the total amount of the actual
      out-of-pocket Loss or the anticipated potential Loss (including any costs or
      expenses which have been or may be reasonably incurred in connection therewith),
      and (iii) whether such Loss may be covered (in whole or in part) under any
      insurance and the estimated amount of such Loss which may be covered under
      such
      insurance, and the Representative shall be entitled to participate in the
      defense of Third Party Claim at its expense.

     

    (b)       Defense.
      The
      Representative shall have the right, at its option (subject to the limitations
      set forth in subsection
      7.2(c)
      below)
      and at its own expense, by written notice to Delcorp, to assume the entire
      control of, subject to the right of Delcorp to participate (at its expense
      and
      with counsel of its choice) in, the defense, compromise or settlement of the
      Third Party Claim as to which such Notice of Claim has been given, and shall
      be
      entitled to appoint a recognized and reputable counsel reasonably acceptable
      to
      Delcorp to be the lead counsel in connection with such defense. If the
      Representative is permitted and elects to assume the defense of a Third Party
      Claim:

     

    
      
        
        

      

      
        -
          59 -

        
          

        

      

      
        
        

      

    

     

    (i)       the
      Representative shall diligently and in good faith defend such Third Party Claim
      and shall keep Delcorp reasonably informed of the status of such defense;
      provided, however, that in the case of any settlement providing for remedies
      which are not merely incidental to a primary damage claim or claims for monetary
      damages, Delcorp shall have the right to approve any settlement, which approval
      will not be unreasonably withheld, delayed or conditioned; and

     

    (ii)       Delcorp
      shall cooperate fully in all respects with the Representative in any such
      defense, compromise or settlement thereof, including, without limitation, the
      selection of counsel, and Delcorp shall make available to the Representative
      all
      pertinent information and documents under its control.

     

    (c)       Limitations
      of Right to Assume Defense.
      The
      Representative shall not be entitled to assume control of such defense and
      shall
      pay the fees and expenses of counsel retained by Delcorp if (i) the Third Party
      Claim relates to or arises in connection with any criminal proceeding, action,
      indictment, allegation or investigation; (ii) the Third Party Claim seeks an
      injunction or equitable relief against Delcorp which is not merely incidental
      to
      a primary damage claim or claims for monetary damages; or (iii) there is a
      reasonable probability that a Third Party Claim may materially and adversely
      affect Delcorp other than as a result of money damages or other money
      payments.

     

    (d)       Other
      Limitations.
      Failure
      to give prompt Notice of Claim or to provide copies of relevant available
      documents or to furnish relevant available data shall not constitute a defense
      (in whole or in part) to any Third Party Claim by Delcorp against the
      Representative and shall not affect the Representative’s duty or obligations
      under this Article VII,
      except
      to the extent (and only to the extent that) such failure shall have adversely
      affected the ability of the Representative to defend against or reduce its
      liability or caused or increased such liability or otherwise caused the damages
      for which the Representative is obligated to be greater than such damages would
      have been had Delcorp given the Representative prompt notice hereunder. So
      long
      as the Representative is defending any such action actively and in good faith,
      Delcorp shall not settle such action. Delcorp shall make available to the
      Representative all relevant records and other relevant materials required by
      them and in the possession or under the control of Delcorp, for the use of
      the
      Representative and its representatives in defending any such action, and shall
      in other respects give reasonable cooperation in such defense.

     

    (e)       Failure
      to Defend.
      If the
      Representative, promptly after receiving a Notice of Claim, fails to defend
      such
      Third Party Claim actively and in good faith, Delcorp, at the reasonable cost
      and expense of the Representative, will (upon further written notice) have
      the
      right to undertake the defense, compromise or settlement of such Third Party
      Claim as it may determine in its reasonable discretion, provided that the
      Representative shall have the right to approve any settlement, which approval
      will not be unreasonably withheld, delayed or conditioned.

     

    
      
        
        

      

      
        -
          60 -

        
          

        

      

      
        
        

      

    

     

    (f)       Delcorp’s
      Rights.
      Anything in this Section 7.2
      to the
      contrary notwithstanding, the Representative shall not, without the written
      consent of Delcorp, settle or compromise any action or consent to the entry
      of
      any judgment which does not include as an unconditional term thereof the giving
      by the claimant or the plaintiff to Delcorp of a full and unconditional release
      from all liability and obligation in respect of such action without any payment
      by Delcorp.

     

    (g)       Representative
      Consent.
      Unless
      the Representative has consented to a settlement of a Third Party Claim, the
      amount of the settlement shall not be a binding determination of the amount
      of
      the Loss and such amount shall be determined in accordance with the provisions
      of the Escrow Agreement.

     

    7.3       Insurance
      Effect.
      To the
      extent that any Losses that are subject to indemnification pursuant to this
      Article VII
      are
      covered by insurance paid for by the Company prior to or after the Closing,
      Delcorp shall use commercially reasonable efforts to obtain the maximum recovery
      under such insurance; provided that Delcorp shall nevertheless be entitled
      to
      bring a claim for indemnification under this Article VII
      in
      respect of such Losses and the time limitations set forth in Section 7.4
      hereof
      for bringing a claim of indemnification under this Agreement shall be tolled
      during the pendency of such insurance claim. The existence of a claim by Delcorp
      for monies from an insurer or against a third party in respect of any Loss
      shall
      not, however, delay any payment pursuant to the indemnification provisions
      contained herein and otherwise determined to be due and owing by the
      Representative. If Delcorp has received the payment required by this Agreement
      from the Representative in respect of any Loss and later receives proceeds
      from
      insurance or other amounts in respect of such Loss, then it shall hold such
      proceeds or other amounts in trust for the benefit of the Representative and
      shall pay to the Representative, as promptly as practicable after receipt,
      a sum
      equal to the amount of such proceeds or other amount received, up to the
      aggregate amount of any payments received from the Representative pursuant
      to
      this Agreement in respect of such Loss. Notwithstanding any other provisions
      of
      this Agreement, it is the intention of the parties that no insurer or any other
      third party shall be (i) entitled to a benefit it would not be entitled to
      receive in the absence of the foregoing indemnification provisions, or (ii)
      relieved of the responsibility to pay any claims for which it is
      obligated.

     

    7.4       Limitations
      on Indemnification.

     

    (a)       Survival:
      Time Limitation.
      The
      representations, warranties, covenants and agreements in this Agreement or
      in
      any writing delivered by the Company to Delcorp in connection with this
      Agreement (including the certificate required to be delivered by the Company
      pursuant to Section 6.3(a))
      shall
      survive the Closing for the period that ends on the Basic Escrow Termination
      Date (the “Basic
      Survival Period”)
      except
      that the right of Delcorp to bring (i) Tax Indemnification Claims and
      Environmental Indemnity Claims shall survive the Closing for the period that
      ends on the T/E Escrow Termination Date (the “T/E
      Survival Period”)
      and
      (ii) Claims for the breach of the representations and warranties in Section
      2.3
      and 1.13(d) shall survive without limitation as to time.

     

    
      
        
        

      

      
        -
          61 -

        
          

        

      

      
        
        

      

    

     

    (b)       Any
      indemnification claim made by Delcorp prior to the termination of the Basic
      Survival Period or the T/E Survival Period (each a “Survival
      Period”),
      as
      the case may be, shall be preserved despite the subsequent termination of such
      Survival Period and any claim set forth in a Notice of Claim sent prior to
      the
      expiration of such Survival Period shall survive until final resolution thereof.
      Except as set forth in the immediately preceding sentence, no claim for
      indemnification under this Article VII
      shall be
      brought after the end of the Survival Period or the T/E Survival Period, as
      the
      case may be.

     

    (c)       Deductible.
      No
      amount shall be payable under Article VII
      unless
      and until the aggregate amount of all indemnifiable Losses otherwise payable
      exceeds $1,400,000 (the “Deductible”),
      in
      which event the amount payable shall only be the full amount in excess of the
      amount of the Deductible, and, subject to the limitations set forth in
Section 7.5(c),
      all
      future amounts that become payable under Section 7.1
      from
      time to time thereafter. Notwithstanding the foregoing, the Deductible shall
      not
      apply to Losses that arise out of (i) a breach of the representations and
      warranties in Section
      1.13(d)
      or
Section
      2.3,
      or (ii)
      an T/E Indemnification Claim all of which shall be indemnifiable as to all
      Losses that so arise from the first dollar thereof. It is understood and agreed
      that to the extent that there are reserves in the Audited Financial Statements
      or Unaudited Financial Statements for any matter which may be a claim against
      the Company, any Losses shall first apply against any such applicable reserve
      and thereafter to the extent permitted herein against the
      Deductible.

     

    (d)       Aggregate
      Amount Limitation.
      The
      aggregate liability for Losses pursuant to Section 7.1
      shall
      not in any event exceed the Basic Escrow Shares in the case of Basic Indemnity
      Claims or the T/E Indemnity Shares in the case of Tax Indemnity Claims or
      Environmental Indemnity Claims and Delcorp shall have no claim against the
      Company’s shareholders other than for any of such Escrow Shares (and any
      proceeds of the shares or distributions with respect to the Escrow Shares).
      

     

    7.5       Exclusive
      Remedy.
      Delcorp, on behalf of itself and the other Delcorp Indemnitees, hereby
      acknowledges and agrees that, from and after the Closing, the sole remedy of
      the
      Delcorp Indemnitees with respect to any and all claims for money damages arising
      out of or relating to this Agreement shall be pursuant and subject to the
      requirements of the indemnification provisions set forth in this Article VII.
      Notwithstanding any of the foregoing, nothing contained in this Article VII
      shall in
      any way impair, modify or otherwise limit a Delcorp Indemnitees right to bring
      any claim, demand or suit against the other party based upon such other party’s
      actual fraud or intentional or willful misrepresentation or omission, it being
      understood that a mere breach of a representation and warranty, without
      intentional or willful misrepresentation or omission, does not constitute fraud.
      

     

    7.6       Adjustment
      to Merger Consideration.
      Amounts
      paid for indemnification under Article VII
      shall be
      deemed to be an adjustment to the value of the shares of Delcorp Common Stock
      issued by Delcorp as a result of the Merger, except as otherwise required by
      Law. 

     

    
      
        
        

      

      
        -
          62 -

        
          

        

      

      
        
        

      

    

     

    7.7       Representative
      Capacities; Application of Escrow Shares.
      The
      parties acknowledge that the Representative’s obligations under this
Article VII
      are
      solely as a representative of the Company’s stockholders in the manner set forth
      in the Escrow Agreement with respect to the obligations to indemnify Delcorp
      under this Article VII
      and that
      the Representative shall have no personal responsibility for any expenses
      incurred by him in such capacity and that all payments to Delcorp as a result
      of
      such indemnification obligations shall be made solely from, and to the extent
      of, the Escrow Shares. Out-of-pocket expenses of the Representative for
      attorneys’ fees and other costs shall be borne in the first instance by Delcorp,
      which may make a claim for reimbursement thereof against the Escrow Shares
      upon
      the claim with respect to which such expenses are incurred becoming an
      Established Claim (as defined in the Escrow Agreement). The parties further
      acknowledge that all actions to be taken by Delcorp pursuant to this
Article VII
      shall be
      taken on its behalf by the Committee in accordance with the provisions of the
      Escrow Agreement. The Escrow Agent, pursuant to the Escrow Agreement after
      the
      Closing, may apply all or a portion of the Escrow Shares to satisfy any claim
      for indemnification pursuant to this Article VII.
      The
      Escrow Agent will hold the remaining portion of the Escrow Shares until final
      resolution of all claims for indemnification or disputes relating
      thereto.

     

    7.8       Tax
      Benefits.
      The
      amount of any Losses for which indemnification is provided shall be reduced
      by
      any net Tax benefit to such indemnified party and its Affiliates, to the extent
      realized by such party as a result of such Losses, including the present value
      (determined by discounting at 8%) of the benefit arising from an increase in
      the
      Tax basis of assets, net of any Tax costs incurred by the indemnified party
      as a
      result of the receipt of the indemnification payments hereunder. In calculating
      the amount of net Tax benefit, the indemnified party and its Affiliates shall
      be
      presumed to pay Taxes at a forty percent (40%) Tax rate. The indemnified party
      shall provide the indemnifying party with such documentation as may be
      reasonably requested in order to ascertain or confirm the amount of any net
      Tax
      benefit or net Tax cost referred to herein.

     

    7.9       Mitigation.
      A
      Delcorp Indemnitee shall use commercially reasonably efforts to mitigate Losses
      suffered, incurred or sustained by it arising out of any matter for which it
      is
      entitled to indemnification hereunder; provided that no Delcorp Indemnitee
      shall
      be required to (i) take any action or refrain from taking any action that is
      contrary to any applicable Contract, order or law binding on it or any Affiliate
      thereof or (ii) incur any out-of-pocket expense in connection with such
      mitigation (other than de minimus incidental expenses).

     

    7.10       No
      Double Recovery.
      To the
      extent that any of the items or matters that would otherwise constitute a Loss
      pursuant to Section 7.1(b) of this Agreement have been incurred and have already
      been incorporated in the calculation of EBITDA for the purposes of Section
      1.18
      of this Agreement, such items or matters shall not also be a Loss for purposes
      of indemnity under this Article VII and shall not apply against the Deductible.
      Conversely, to the extent any Loss has been incurred that has applied against
      the Deductible or has been indemnified, such Loss shall not be included in
      the
      calculation of EBITDA for the purposes of Section
      1.18
      of this
      Agreement.

     

    
      
        
        

      

      
        -
          63 -

        
          

        

      

      
        
        

      

    

     

    ARTICLE
      VIII

    TERMINATION

     

    8.1       Termination.
      This
      Agreement may be terminated at any time prior to the Closing:

     

    (a)       by
      mutual written agreement of Delcorp and the Company at any time;

     

    (b)       by
      either Delcorp or the Company if the Merger shall not have been consummated
      by
      October 3, 2008 for any reason; provided, however, that the right to
      terminate this Agreement under this Section 8.1(b)
      shall
      not be available to any party whose action or failure to act has been a
      principal cause of or resulted in the failure of the Merger to occur on or
      before such date and such action or failure to act constitutes a breach of
      this
      Agreement;

     

    (c)       by
      either Delcorp or the Company if a Governmental Entity shall have issued an
      order, decree, judgment or ruling or taken any other action, in any case having
      the effect of permanently restraining, enjoining or otherwise prohibiting the
      Merger, which order, decree, ruling or other action is final and
      nonappealable;

     

    (d)       by
      the Company, upon a material breach of any representation, warranty, covenant
      or
      agreement on the part of Delcorp set forth in this Agreement, or if any
      representation or warranty of Delcorp shall have become untrue, in either case
      such that the conditions set forth in Article VI
      would
      not be satisfied as of the time of such breach or as of the time such
      representation or warranty shall have become untrue, provided, that if such
      breach by Delcorp is curable by Delcorp prior to the Closing Date, then the
      Company may not terminate this Agreement under this Section 8.1(d)
      for
      thirty (30) days after delivery of written notice from the Company to Delcorp
      of
      such breach, provided Delcorp continues to exercise commercially reasonable
      efforts to cure such breach (it being understood that the Company may not
      terminate this Agreement pursuant to this Section 8.1(d)
      if it
      shall have materially breached this Agreement or if such breach by Delcorp
      is
      cured during such thirty (30)-day period);

     

    (e)       by
      Delcorp, upon a material breach of any representation, warranty, covenant or
      agreement on the part of the Company set forth in this Agreement, or if any
      representation or warranty of the Company shall have become untrue, in either
      case such that the conditions set forth in Article VI
      would
      not be satisfied as of the time of such breach or as of the time such
      representation or warranty shall have become untrue, provided, that if such
      breach is curable by the Company prior to the Closing Date, then Delcorp may
      not
      terminate this Agreement under this Section 8.1(e)
      for
      thirty (30) days after delivery of written notice from Delcorp to the Company
      of
      such breach, provided the Company continues to exercise commercially reasonable
      efforts to cure such breach (it being understood that Delcorp may not terminate
      this Agreement pursuant to this Section 8.1(e)
      if it
      shall have materially breached this Agreement or if such breach by the Company
      is cured during such thirty (30)-day period); 

     

    
      
        
        

      

      
        -
          64 -

        
          

        

      

      
        
        

      

    

     

    (f)       by
      either Delcorp or the Company, if, at the Special Meeting (including any
      adjournments thereof), this Agreement and the transactions contemplated thereby
      shall fail to be approved and adopted by the affirmative vote of the holders
      of
      Delcorp Common Stock required under Delcorp’s certificate of incorporation, or
      the holders of 20% or more of the number of shares of Delcorp Common Stock
      issued in Delcorp’s initial public offering and outstanding as of the date of
      the record date of the Special Meeting exercise their rights to convert the
      shares of Delcorp Common Stock held by them into cash in accordance with
      Delcorp’s certificate of incorporation; or

     

    (g)       by
      the Company if the Special Meeting is not called to be held within thirty (30)
      days after the declaration by the SEC of the effectiveness of the Registration
      Statement.

     

    8.2       Notice
      of Termination; Effect of Termination.
      Any
      termination of this Agreement under Section 8.1
      above
      will be effective immediately upon (or, if the termination is pursuant to
Section 8.1(d)
      or
Section 8.1(e)
      and the
      proviso therein is applicable, thirty (30) days after) the delivery of written
      notice of the terminating party to the other parties hereto. In the event of
      the
      termination of this Agreement as provided in Section 8.1,
      this
      Agreement shall be of no further force or effect and the Merger shall be
      abandoned, except for and subject to the following: (i) Sections
      5.6, 5.13, 8.2 and 8.3
      and
Article X
      (General
      Provisions) shall survive the termination of this Agreement, and (ii) nothing
      herein shall relieve any party from liability for any breach of this Agreement,
      including a breach by a party electing to terminate this Agreement pursuant
      to
Section 8.1(b)
      caused
      by the action or failure to act of such party constituting a principal cause
      of
      or resulting in the failure of the Merger to occur on or before the date stated
      therein.

     

    8.3       Fees
      and Expenses.
      All
      fees and expenses incurred in connection with this Agreement and the
      transactions contemplated hereby shall be paid by the party incurring such
      expenses whether or not the Merger is consummated.

     

    ARTICLE
      IX

    DEFINED
      TERMS

     

    Terms
      defined in this Agreement are organized alphabetically as follows, together
      with
      the Section and, where applicable, paragraph, number in which definition of
      each
      such term is located: 

     

    
      
        	 	
                “Affiliate”

              	
                Section 10.2(f)

              
	 	
                “Agreement”

              	
                Section 1.2

              
	 	
                “Applicable
                  Nevada Law”

              	
                Section 1.3

              
	 	
                “Approvals”

              	
                Section 2.1(a)

              
	 	
                “Articles
                  of Merger

              	
                Section 1.2

              
	 	
                “Audited
                  Financial Statements”

              	
                Section 2.7(a)

              

      

       

      
        
          
          

        

        
          -
            65 -

          
            

          

        

        
          
          

        

      

       

       

      
        	 	
                “Base
                  Distribution”

              	
                Section 5.24(b)

              
	 	
                “Base
                  Shares”

              	
                Section 1.5(b)

              
	 	
                “Basic
                  Escrow Termination Date”

              	
                Section 1.11

              
	 	
                “Basic
                  Survival Period”

              	
                Section 7.4(a)

              
	 	
                “Blue
                  Sky Laws”

              	
                Section 1.13(c)

              
	 	
                “Certificate
                  of Merger”

              	
                Section 1.2

              
	 	
                “Charter
                  Amendment”

              	
                Section 5.1(a)

              
	 	
                “Charter
                  Documents”

              	
                Section 2.1(a)

              
	 	
                “Closing”

              	
                Section 1.2

              
	 	
                “Closing
                  Date”
                  

              	
                Section 1.2

              
	 	
                “Closing
                  Form 8-K

              	
                Section 5.4

              
	 	
                “Code”

              	
                Recital
                  C

              
	 	
                “Company”

              	
                Heading

              
	 	
                “Company
                  Certificates”

              	
                Section 1.5(b)

              
	 	
                “Company
                  Closing Certificate”

              	
                Section 6.3(a)

              
	 	
                “Company
                  Common Stock”

              	
                Section 1.5(a)

              
	 	
                “Company
                  Contracts”

              	
                Section 2.19(a)

              
	 	
                “Company
                  Intellectual Property”
                  

              	
                Section 2.18

              
	 	
                “Company
                  Products”
                  

              	
                Section 2.18

              
	 	
                “Company
                  Registered Intellectual Property”

              	
                Section 2.18

              
	 	
                “Company
                  Schedule”

              	
                Article II
                  Preamble

              
	 	
                “Company
                  Stock Options”

              	
                Section 2.3(a)

              
	 	
                “Continental”

              	
                Section 1.11

              
	 	
                “Copyrights”

              	
                Section 2.18

              
	 	
                “Corporate
                  Records”
                  

              	
                Section 2.1(c)

              
	 	
                “DGCL”
                  

              	
                Recital
                  A

              
	 	
                “Deductible”
                  

              	
                Section 7.4(c)

              
	 	
                “Delcorp”

              	
                Heading

              
	 	
                “Delcorp
                  Closing Certificate”

              	
                Section 6.2(a)

              
	 	
                “Delcorp
                  Common Stock”

              	
                Section 1.5(a)

              
	 	
                “Delcorp
                  Contracts”

              	
                Section 3.19(a)

              
	 	
                “Delcorp
                  Convertible Securities”

              	
                Section 3.3(b)

              
	 	
                “Delcorp
                  Indemnitees”

              	
                Section 7.1

              
	 	
                “Delcorp
                  Plan”

              	
                Section 5.1(a)

              
	 	
                “Delcorp
                  Preferred Stock”

              	
                Section 3.3(a)

              
	 	
                “Delcorp
                  SEC Reports”

              	
                Section 3.7(a)

              
	 	
                “Delcorp
                  Schedule”

              	
                Article III
                  Preamble

              
	 	
                “Delcorp
                  Stock Options”

              	
                Section 3.3(b)

              
	 	
                “Delcorp
                  Stockholder Approval”

              	
                Section 5.1(a)

              
	 	
                “Delcorp
                  Warrants”

              	
                Section 3.3(b)

              
	 	
                “Disclosure
                  Schedules”

              	
                Section 5.14

              
	 	
                “Dissenter”

              	
                Section 1.17(a)

              
	 	
                “Dissenting
                  Shares”

              	
                Section 1.17(b)

              
	 	
                “Distribution
                  Holdback”

              	
                Section 5.24(b)

              
	 	
                “EBITDA”

              	
                Section 1.18(c)

              
	 	
                “EBITDA
                  Shares”

              	
                Section 1.18(c)

              

      

       

       

      
        
          
          

        

        
          -
            66 -

          
            

          

        

        
          
          

        

      

       

      
        	 	
                “Effect
                  of the Merger”

              	
                Section 1.3

              
	 	
                “Effective
                  Time”

              	
                Section 1.2

              
	 	
                “Environmental
                  Indemnification Claim”

              	
                Section 1.11

              
	 	
                “Environmental
                  Law”

              	
                Section 2.16(b)

              
	 	
                “Escrow
                  Agreement”
                  

              	
                Section 1.11

              
	 	
                “Escrow
                  Termination Date”
                  

              	
                Section 1.11

              
	 	
                “Escrow
                  Shares”

              	
                Section 1.11

              
	 	
                “Exchange
                  Act”

              	
                Section 1.11

              
	 	
                “FINRA”

              	
                Section 3.23

              
	 	
                “Foreign
                  Managers”

              	
                Section 2.3(a)

              
	 	
                “Governmental
                  Action/Filing”

              	
                Section 2.21

              
	 	
                “Governmental
                  Entity”

              	
                Section 1.13(c)

              
	 	
                “Hazardous
                  Substance”

              	
                Section 2.16(c)

              
	 	
                “HSR
                  Act”

              	
                Section 2.5(b)

              
	 	
                “Insider”

              	
                Section 2.19(a)(i)

              
	 	
                “Insurance
                  Policies”

              	
                Section 2.20

              
	 	
                “Intellectual
                  Property”

              	
                Section 2.18

              
	 	
                “Knowledge”
                  

              	
                Section 10.2(d)

              
	 	
                “Legal
                  Requirements”

              	
                Section 10.2(b)

              
	 	
                “Lien”

              	
                Section 10.2(e)

              
	 	
                “Losses”

              	
                Section 7.1(b)

              
	 	
                “Material
                  Adverse Effect”

              	
                Section 10.2(a)

              
	 	
                “Material
                  Company Contracts”
                  

              	
                Section 2.19(a)

              
	 	
                “Merger”

              	
                Section 1.1

              
	 	
                “NGCL

              	
                Recital
                  A

              
	 	
                “Notice
                  of Claim”
                  

              	
                Section 7.2(a)

              
	 	
                “OTC
                  BB”

              	
                Section 3.23

              
	 	
                “Outstanding
                  Company Stock Number”

              	
                Section 1.5(a)

              
	 	
                “Patents”

              	
                Section 2.18

              
	 	
                “Person”

              	
                Section 10.2(c)

              
	 	
                “Personal
                  Property”

              	
                Section 2.14(b)

              
	 	
                “Plans”

              	
                Section 2.11(a)

              
	 	
                “Press
                  Release”

              	
                Section 5.4(a)

              
	 	
                “Proxy
                  Statement/Prospectus”

              	
                Section 5.1(a)

              
	 	
                “Registered
                  Intellectual Property”

              	
                Section 2.18

              
	 	
                “Registration
                  Statement”

              	
                Section 5.1

              
	 	
                “Representative”

              	
                Section 1.14(b)

              
	 	
                “Returns”

              	
                Section 2.15(b)(i)

              
	 	
                “Securities
                  Act”

              	
                Section 1.13(b)

              
	 	
                “Special
                  Meeting”

              	
                Section 5.1(a)

              
	 	
                “Signing
                  Form 8-K

              	
                Section 5.4

              
	 	
                “Signing
                  Press Release”

              	
                Section 5.4

              
	 	
                “Signing
                  Shareholder/Signing Shareholders”

              	
                Heading

              
	 	
                “Stub
                  Period”

              	
                Section 5.24(a)

              
	 	
                “Stub
                  Period Taxable Income”

              	
                Section 5.24(a)

              
	 	
                “Subsidiary/Subsidiaries”

              	
                Section 2.2

              

      

       

       

      
        
          
          

        

        
          -
            67 -

          
            

          

        

        
          
          

        

      

       

      
        	 	
                “Survival
                  Period”

              	
                Section 7.4(b)

              
	 	
                “Surviving
                  Corporation”

              	
                Section 1.1

              
	 	
                “Tax/Taxes”

              	
                Section 2.15(a)

              
	 	
                “Tax
                  Distributions”

              	
                Section 5.24(a)

              
	 	
                “Tax
                  Indemnification Claim”

              	
                Section 1.11

              
	 	
                “T/E
                  Indemnity Shares”

              	
                Section 1.11

              
	 	
                “T/E
                  Survival Period”

              	
                Section 7.4(a)

              
	 	
                “T/E
                  Termination Date”

              	
                Section 1.11

              
	 	
                “Third
                  Party Claim”

              	
                Section 7.2

              
	 	
                “Trademarks”

              	
                Section 2.18

              
	 	
                “Trust
                  Fund”
                  

              	
                Section 3.25

              
	 	
                “U.S.
                  GAAP”

              	
                Section 2.7(a)

              
	 	
                “Unaudited
                  Financial Statements”

              	
                Section 2.7(b)

              

      

       

      ARTICLE
        X

      GENERAL
        PROVISIONS

       

      10.1  
        Notices.
        All
        notices and other communications hereunder shall be in writing and shall
        be
        deemed given if delivered personally or by commercial delivery service, or
        sent
        via telecopy (receipt confirmed) to the parties at the following addresses
        or
        telecopy numbers (or at such other address or telecopy numbers for a party
        as
        shall be specified by like notice):

       

      
        
          	 	
                  if
                    to Delcorp, to:

                	
                  Rhapsody
                    Acquisition Corp.

                
	 	 	
                  825
                    Third Avenue, 40th Floor

                
	 	 	
                  New
                    York, New York 10022

                
	 	 	
                  Attention:
                    Eric Rosenfeld

                
	 	 	
                  Telephone:
                    212-319-7676

                
	 	 	
                  Telecopy:
                    212-319-0760

                
	 	 	
                  E-mail:
                    erosenfeld@crescendopartners.com

                
	 	 	 
	 	
                  with
                    a copy to:

                	
                  David
                    Alan Miller, Esq.

                
	 	 	
                  Graubard
                    Miller

                
	 	 	
                  405
                    Lexington Avenue

                
	 	 	
                  New
                    York, New York 10174-1901

                
	 	 	
                  Telephone:
                    212-818-8880

                
	 	 	
                  Telecopy:
                    212-818-8881

                
	 	 	
                  Email:
                    dmiller@graubard.com

                
	 	 	 
	 	
                  if
                    to the Company or

                	 
	 	
                  Signing
                    Shareholders, to:

                	
                  John
                    M. Perisich

                
	 	 	
                  Primoris
                    Corporation

                
	 	 	
                  26000
                    Commercecentre Drive

                
	 	 	
                  Lake
                    Forest, CA 92630

                
	 	 	
                  Telephone:
                    949 454-7110

                
	 	 	
                  Telecopy:
                    949 599-5532

                
	 	 	
                  E-mail:
                    JPerisich@arbinc.com

                

        

         

        
          
            
            

          

          
            -
              68 -

            
              

            

          

          
            
            

          

        

         

        
          	 	
                  with
                    a copy to:

                	
                  Rutan
                    & Tucker, LLP

                
	 	 	
                  611
                    Anton Boulevard, Suite 1400

                
	 	 	
                  Costa
                    Mesa, CA 92626-5100

                
	 	 	
                  Attention:
                    George J. Wall, Esq.

                
	 	 	
                  Telephone:
                    714 662-4673

                
	 	 	
                  Telecopier
                    No.: 714-546-9035

                
	 	 	
                  E-mail:
                    gwall@rutan.com

                

        

      

       

      10.2   
        Interpretation.
        The
        definitions of the terms herein shall apply equally to the singular and plural
        forms of the terms defined. Whenever the context shall require, any pronoun
        shall include the corresponding masculine, feminine and neuter forms. When
        a
        reference is made in this Agreement to an Exhibit or Schedule, such reference
        shall be to an Exhibit or Schedule to this Agreement unless otherwise
        indicated. When a reference is made in this Agreement to Sections or
        subsections, such reference shall be to a Section or subsection of this
        Agreement. Unless otherwise indicated the words “include,” “includes” and
“including” when used herein shall be deemed in each case to be followed by the
        words “without limitation.” The table of contents and headings contained in this
        Agreement are for reference purposes only and shall not affect in any way
        the
        meaning or interpretation of this Agreement. When reference is made herein
        to
“the business of” an entity, such reference shall be deemed to include the
        business of all direct and indirect Subsidiaries of such entity. Reference
        to
        the Subsidiaries of an entity shall be deemed to include all direct and indirect
        Subsidiaries of such entity. For purposes of this Agreement:

       

      
        (a)       the
          term “Material
          Adverse Effect”
when
          used in connection with an entity means any change, event, violation,
          inaccuracy, circumstance or effect, individually or when aggregated with
          other
          changes, events, violations, inaccuracies, circumstances or effects, that
          is
          materially adverse to the business, assets (including intangible assets),
          revenues, financial condition or results of operations of such entity,
          it being
          understood that none of the following alone or in combination shall be
          deemed,
          in and of itself, to constitute a Material Adverse Effect: (i) changes
          attributable to the public announcement or pendency of the transactions
          contemplated hereby, (ii) changes in general national or regional economic
          conditions, or (iii) any SEC rulemaking requiring enhanced disclosure of
          reverse
          merger transactions with a public shell;

         

        (b)       the
          term “Legal
          Requirements”
means
          any federal, state, local, municipal, foreign or other law, statute,
          constitution, principle of common law, resolution, ordinance, code, edict,
          decree, rule, regulation, ruling or requirement issued, enacted, adopted,
          promulgated, implemented or otherwise put into effect by or under the authority
          of any Governmental Entity and all requirements set forth in applicable
          Company
          Contracts or Delcorp Contracts;

         

        
          
            
            

          

          
            -
              69 -

            
              

            

          

          
            
            

          

        

         

        (c)       the
          term “Person”
shall
          mean any individual, corporation (including any non-profit corporation),
          general
          partnership, limited partnership, limited liability partnership, joint
          venture,
          estate, trust, company (including any limited liability company or joint
          stock
          company), firm or other enterprise, association, organization, entity or
          Governmental Entity;

         

        (d)       the
          term “knowledge”
means
          actual knowledge or awareness as to a specified fact or event of Brian
          Pratt,
          John Schauerman, John Perisich and Alfons Theeuwes;

         

        (e)       the
          term “Lien”
means
          any mortgage, pledge, security interest, encumbrance, lien, restriction
          or
          charge of any kind (including, without limitation, any conditional sale
          or other
          title retention agreement or lease in the nature thereof, any sale with
          recourse
          against the seller or any Affiliate of the seller, or any agreement to
          give any
          security interest);

         

        (f)       the
          term “Affiliate”
means,
          as applied to any Person, any other Person directly or indirectly controlling,
          controlled by or under direct or indirect common control with, such Person.
          For
          purposes of this definition, “control” (including with correlative meanings, the
          terms “controlling,” “controlled by” and “under common control with”), as
          applied to any Person, means the possession, directly or indirectly, of
          the
          power to direct or cause the direction of the management and policies of
          such
          Person, whether through the ownership of voting securities, by contract
          or
          otherwise; and

         

        (g)       all
          monetary amounts set forth herein are referenced in United States dollars,
          unless otherwise noted.

      

       

      10.3   
        Counterparts;
        Facsimile Signatures.
        This
        Agreement and each other document executed in connection with the transactions
        contemplated hereby, and the consummation thereof, may be executed in one
        or
        more counterparts, all of which shall be considered one and the same document
        and shall become effective when one or more counterparts have been signed
        by
        each of the parties and delivered to the other party, it being understood
        that
        all parties need not sign the same counterpart. Delivery by facsimile to
        counsel
        for the other party of a counterpart executed by a party shall be deemed
        to meet
        the requirements of the previous sentence.

       

      10.4   
        Entire
        Agreement; Third Party Beneficiaries.
        This
        Agreement and the documents and instruments and other agreements among the
        parties hereto as contemplated by or referred to herein, including the Exhibits
        and Schedules hereto (a) constitute the entire agreement among the parties
        with
        respect to the subject matter hereof and supersede all prior agreements and
        understandings, both written and oral, among the parties with respect to
        the
        subject matter hereof, it being understood that the letter of intent between
        Delcorp and the Company dated January 14, 2008 is hereby terminated in its
        entirety and shall be of no further force and effect (except to the extent
        expressly stated to survive the execution of this Agreement and the consummation
        of the transactions contemplated hereby); and (b) are not intended to confer
        upon any other person any rights or remedies hereunder (except as specifically
        provided in this Agreement).

       

      
        
          
          

        

        
          -
            70 -

          
            

          

        

        
          
          

        

      

       

      10.5   
        Severability.
        In the
        event that any provision of this Agreement, or the application thereof, becomes
        or is declared by a court of competent jurisdiction to be illegal, void or
        unenforceable, the remainder of this Agreement will continue in full force
        and
        effect and the application of such provision to other persons or circumstances
        will be interpreted so as reasonably to effect the intent of the parties
        hereto.
        The parties further agree to replace such void or unenforceable provision
        of
        this Agreement with a valid and enforceable provision that will achieve,
        to the
        extent possible, the economic, business and other purposes of such void or
        unenforceable provision.

       

      10.6   
        Other
        Remedies; Specific Performance.
        Except
        as otherwise provided herein, any and all remedies herein expressly conferred
        upon a party will be deemed cumulative with and not exclusive of any other
        remedy conferred hereby, or by law or equity upon such party, and the exercise
        by a party of any one remedy will not preclude the exercise of any other
        remedy.
        The parties hereto agree that irreparable damage would occur in the event
        that
        any of the provisions of this Agreement were not performed in accordance
        with
        their specific terms or were otherwise breached. It is accordingly agreed
        that
        the parties shall be entitled to seek an injunction or injunctions to prevent
        breaches of this Agreement and to enforce specifically the terms and provisions
        hereof in any court of the United States or any state having jurisdiction,
        this
        being in addition to any other remedy to which they are entitled at law or
        in
        equity.

       

      10.7   
        Governing
        Law.
        This
        Agreement shall be governed by and construed in accordance with the law of
        the
        State of Delaware regardless of the law that might otherwise govern under
        applicable principles of conflicts of law thereof.

       

      10.8   
        Rules
        of Construction.
        The
        parties hereto agree that they have been represented by counsel during the
        negotiation and execution of this Agreement and, therefore, waive the
        application of any law, regulation, holding or rule of construction providing
        that ambiguities in an agreement or other document will be construed against
        the
        party drafting such agreement or document.

       

      10.9   
        Assignment.
        No
        party may assign either this Agreement or any of its rights, interests, or
        obligations hereunder without the prior written approval of the other parties.
        Subject to the first sentence of this Section 10.9,
        this
        Agreement shall be binding upon and shall inure to the benefit of the parties
        hereto and their respective successors and permitted assigns.

       

      10.10  Amendment.
        This
        Agreement may be amended by the parties hereto at any time by execution of
        an
        instrument in writing signed on behalf of each of the parties.

       

      10.11
        Extension;
        Waiver.
        At any
        time prior to the Closing, any party hereto may, to the extent legally allowed,
        (i) extend the time for the performance of any of the obligations or other
        acts
        of the other parties hereto, (ii) waive any inaccuracies in the representations
        and warranties made to such party contained herein or in any document delivered
        pursuant hereto and (iii) waive compliance with any of the agreements or
        conditions for the benefit of such party contained herein. Any agreement
        on the
        part of a party hereto to any such extension or waiver shall be valid only
        if
        set forth in an instrument in writing signed on behalf of such party. Delay
        in
        exercising any right under this Agreement shall not constitute a waiver of
        such
        right.

       

      
        
          
          

        

        
          -
            71 -

          
            

          

        

        
          
          

        

      

    

     

    
      10.12   Arbitration.
        Except
        as otherwise provided in this Agreement, any controversy or claim arising
        out of
        or relating to this Agreement or the breach thereof shall be settled by
        arbitration in Orange County, California.

       

      (a)       Judicial
        Arbitration and Mediation Services.
        The
        arbitration shall be administered by Judicial Arbitration and Mediation Services
        (“JAMS”)
        in its
        Orange County, California, office.

       

      (b)       Arbitrator.
        The
        arbitrator shall be a retired superior or appellate court judge of the State
        of
        California affiliated with JAMS. The award of the arbitrator shall be binding,
        final, and nonappealable.

       

      (c)       Provisional
        Remedies and Appeals.
        Each of
        the parties reserves the right to file with a court of competent jurisdiction
        an
        application for temporary or preliminary injunctive relief, writ of attachment,
        writ of possession, temporary protective order and/or appointment of a receiver
        on the grounds that the arbitration award to which the applicant may be entitled
        may be rendered ineffectual in the absence of such relief. 

       

      (d)       Enforcement
        of Judgment.
        Judgment upon the award rendered by the arbitrator may be entered in any
        court
        having jurisdiction thereof.

       

      (e)       Discovery.
        The
        parties may obtain discovery in aid of the arbitration to the fullest extent
        permitted under law, including California Code of Civil Procedure Section
        1283.05. All discovery disputes shall be resolved by the
        arbitrator.

       

      (f)       Consolidation.
        Any
        arbitration hereunder may be consolidated by JAMS with the arbitration of
        any
        other dispute arising out of or relating to the same subject matter when
        the
        arbitrator determines that there is a common issue of law or fact creating
        the
        possibility of conflicting rulings by more than one arbitrator. Any disputes
        over which arbitrator shall hear any consolidated matter shall be resolved
        by
        JAMS.

       

      (g)       Power
        and Authority of Arbitrator.
        The
        arbitrator shall not have any power to alter, amend, modify or change any
        of the
        terms of this Agreement nor to grant any remedy which is either prohibited
        by
        the terms of this Agreement, or not available in a court of law.

       

      (h)       Governing
        Law.
        All
        questions in respect of procedure to be followed in conducting the arbitration
        as well as the enforceability of this Agreement to arbitrate which may be
        resolved by state law shall be resolved according to the law of the state
        of
        California. Any action brought to enforce the provisions of this Section
        shall
        be brought in the Orange County Superior Court. All other questions in respect
        to this Agreement, including but not limited to the interpretation, enforcement
        of this Agreement (other than the right to arbitrate), and the rights, duties
        and liabilities of the parties to this Agreement shall be governed by California
        law.

       

      
        
          
          

        

        
          -
            72 -

          
            

          

        

        
          
          

        

      

       

      (i)       Costs.
        The
        costs of the arbitration, including any JAMS administration fee, and
        arbitrator’s fee, and costs of the use of facilities during the hearings, shall
        be borne equally by the parties in the first instance. Upon issuance of an
        award, costs shall be awarded to the prevailing party.

       

      (j)       Attorneys’
        Fees.
        If a
        party to this Agreement shall bring any action, suit, counterclaim, appeal,
        arbitration, or mediation for any relief against the other parties, declaratory
        or otherwise, to enforce the terms hereof or to declare rights hereunder
        (referred to herein as an “Action”),
        the
        non-prevailing party in such Action shall pay to the prevailing party in
        such
        Action a reasonable sum for the prevailing party’s attorneys’ fees and expenses
        (at the prevailing party’s attorneys’ then-current rates, as increased from time
        to time by the giving of advance written notice by such counsel to such party)
        incurred in prosecuting or defending such Action and/or enforcing any judgment,
        order, ruling or award (referred to herein as a “Decision”),
        granted therein, all of which shall be deemed to have accrued from the
        commencement of such Action, and shall be paid whether or not such Action
        is
        prosecuted to a Decision. Any Decision entered into in such Action shall
        contain
        a specific provision providing for the recovery of attorneys’ fees and expenses
        incurred in enforcing such Decision. The court or arbitrator may fix the
        amount
        of reasonable attorneys’ fees and expenses upon the request of any party. For
        purposes of this Section, attorneys’ fees shall include, without limitation,
        fees incurred in connection with (1) postjudgment motions and collection
        actions, (2) contempt proceedings, (3) garnishment, levy and debtor
        and third party examination, (4) discovery and (5) bankruptcy
        litigation.

       

      10.13   Currency.
        All
        references to currency amounts in this Agreement shall mean United States
        dollars.

       

      10.14   Power
        of Attorney; Proxy.
        Each
        Signing Shareholder hereby appoints Brian Pratt and John P. Schauerman, and
        each
        of them acting without the other, as his, her or its (a) true and lawful
        attorney-in-fact to execute and deliver, in his, her or its name, place and
        stead, in any and all capacities, any and all amendments to this Agreement
        and
        any and all other agreements, instruments and other documents deemed necessary
        or desirable by such attorney-in-fact to effectuate the transactions
        contemplated by this Agreement, including the agreements in the forms of
        the
        exhibits hereto, and (b) proxy and hereby authorizes either of them to represent
        and to vote all shares of Company Common Stock owned by such Signing Shareholder
        in the manner such proxy deems desirable in his sole judgment on all matters
        pertaining to the transactions contemplated by this Agreement that may be
        presented to the holders of Company Common Stock for their vote or consent.
        The
        power-of-attorney granted herein is coupled with an interest and it and the
        proxy granted herein shall be irrevocable to the full extent allowed by
        applicable law.

    

     

    
      [The
        Signature Page is the following page.]

       

      
        
          
          

        

        
          -
            73 -

          
            

          

        

        
          
          

        

      

       

       

      IN
        WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
        as
        of the date first written above.

      
        	 	 	 
	 	
                RHAPSODY
                  ACQUISITION CORP.

              
	 
 	 
 	 
 
	 	By:  	
                s/
                  Eric Rosenfeld

              
	 	
                

                Eric
                  Rosenfeld, Chairman, CEO and
                  President

              

      

       

      
        
          	 	 	 
	 	
                  PRIMORIS
                    CORPORATION

                
	 
 	 
 	 
 
	 	By:  	By: s/
                  Brian Pratt
	 	
                  

                  Brian
                    Pratt, Chief Executive Officer

                

        

         

      

      

        
          	
                  SIGNING
                    SHAREHOLDERS:

                	
                  s/
                    Brian Pratt

                
	 	
                  
                    

                  

                  Brian
                    Pratt

                
	 	 
	
                	
                  Pratt
                    Family Trust

                
	 	 
	
                	
                  
                    By: 
                      s/
                      Arline Pratt

                  

                
	 	
                  
                    

                  

                  Arline
                    Pratt, Trustee

                
	 	 
	
                	
                  Pratt
                    Family Bypass Trust

                
	 	 
	
                	
                  
                    By: 
                      s/Arline
                      Pratt

                  

                
	 	
                  
                    

                  

                  Arline
                    Pratt, Trustee

                
	 	 
	
                	
                  s/
                    John P. Schauerman

                
	
                	
                  
                    

                  

                  John
                    P. Schauerman

                
	 	 
	
                	
                  Summers
                    Trust

                
	 	 
	
                	
                  
                    By:  s/Scott
                      E. Summers

                  

                
	 	
                  
                    

                  

                  Scott
                    E. Summers, Trustee

                
	 	 
	
                   

                	
                  s/
                    Timothy R. Healy

                
	
                	
                  

                  Timothy
                    R. Healy

                

        

      

    

    
       

       

      
        
          
          

        

        
          -
            74 -

          
            

          

        

        
          
          

        

      

       

      
         

        INDEX
          OF EXHIBITS AND SCHEDULES

         

        
          	
                  Exhibits

                	 
	 	 
	
                  Exhibit A

                	
                  Second
                    Amended and Restated Certificate of Incorporation of
                    Delcorp

                
	 	 
	
                  Exhibit B

                	
                  Bylaws
                    of Delcorp

                
	 	 
	
                  Exhibit
                    C

                	
                  Outstanding
                    Common Stock Number 

                
	 	 
	
                  Exhibit D

                	
                  Form
                    of Escrow Agreement

                
	 	 
	
                  Exhibit E

                	
                  Sample
                    EBITDA Calculations

                
	 	 
	
                  Exhibit F

                	
                  Form
                    of Voting Agreement

                
	 	 
	
                  Exhibit G

                	
                  Form
                    of Lock-Up Agreement

                
	 	 
	
                  Exhibit H

                	
                  Form
                    of Opinion of Graubard Miller

                
	 	 
	
                  Exhibit I

                	
                  Form
                    of Employment Agreement for Brian Pratt

                
	 	 
	
                  Exhibit J

                	
                  Form
                    of Employment Agreement for John Schauerman

                
	 	 
	
                  Exhibit K

                	
                  Form
                    of Employment Agreement for John Perisich

                
	 	 
	
                  Exhibit L

                	
                  Form
                    of Employment Agreement for Alfons Theeuwes

                
	 	 
	
                  Exhibit M

                	
                  Form
                    of Employment Agreement for Scott Summers

                
	 	 
	
                  Exhibit N

                	
                  Form
                    of Employment Agreement for Tim Healy

                
	 	 
	
                  Exhibit O

                	
                  Form
                    of Employment Agreement for Mark Thurman

                
	 	 
	
                  Exhibit P

                	
                  Form
                    of Employment Agreement for Dave Baker

                
	 	 
	
                  Exhibit Q

                	
                  Form
                    of Employment Agreement for Bill McDevitt

                
	 	 
	
                  Exhibit R

                	
                  Form
                    of Opinion of Rutan & Tucker, LLP

                
	 	 
	
                  Schedules

                	 
	 	 
	
                  Schedule 1.12

                	
                  Affiliates
                    of the Company

                
	
                  Schedule 2

                	
                  Company
                    Schedule

                
	
                  Schedule 3

                	
                  Delcorp
                    Schedule

                
	
                  Schedule 4.1

                	
                  Company
                    and Delcorp Permitted Actions

                
	
                  Schedule 5.2

                	
                  Directors
                    and Officers of Delcorp

                
	
                  Schedule 6.2(i)

                	
                  Delcorp
                    Resignations

                

        

        
          
            
            

          

          
            -
              75 -

            
              

            

          

          
            
            

          

        

         

        SCHEDULE
          1.12

         

        RULE
          145 AFFILIATES OF THE COMPANY

        

        Directors

        Brian
          Pratt

        John
          Schauerman

        Alfons
          Theeuwes

        John
          Perisich

        Scott
          Summers

        Timothy
          Healy

        Arline
          Pratt

        Tony
          Leggio

        Mark
          Thurman

        David
          Baker

        Mike
          McGowan

        Martha
          Walda

        

        Officers

        Brian
          Pratt

        John
          Schauerman

        Alfons
          Theeuwes

        John
          Perisich

        Scott
          Summers

        Timothy
          Healy

        Mark
          Thurman

        David
          Baker

        Bill
          McDevitt

        

        The
          inclusion of any Officer on this list is not an admission that such Officer
          is
          in fact an “Affiliate”
for
          the
          purposes of Rule 145 promulgated under the Securities Act.

        

        Significant
          Shareholders

        

        
          	
                  Name

                	 	
                  Shares
                    Owned

                	
                   

                	
                  Percent

                	 
	
                  Brian
                    Pratt

                	 	 	
                  2,606

                	 	 	
                  58.4

                	
                  %

                
	
                  Pratt
                    Family Trust

                	 	 	
                  409

                	 	 	
                  9.2

                	
                  %

                
	
                  Pratt
                    Family Bypass Trust

                	 	 	
                  57

                	 	 	
                  1.3

                	
                  %

                

        

        

        
          
            
            

          

          
            -
              76 -

            
              

            

          

          
            
            

          

        

      

       

      
        

           

          SCHEDULE
            2

           

          COMPANY
            SCHEDULE

          (Information
            Furnished Separately)

          

          
            	
                    Schedule 2.1
                      

                  	
                    -

                  	
                    Organization
                      and Qualification

                  
	
                    Schedule 2.2

                  	
                    -

                  	
                    Subsidiaries

                  
	
                    Schedule 2.3

                  	
                    -

                  	
                    Capitalization

                  
	
                    Schedule 2.5

                  	
                    -

                  	
                    Required
                      Consents

                  
	
                    Schedule 2.6

                  	
                    -

                  	
                    Compliance

                  
	
                    Schedule 2.7

                  	
                    -

                  	
                    Financial
                      Statements

                  
	
                    Schedule 2.8

                  	
                    -

                  	
                    No
                      Undisclosed Liabilities

                  
	
                    Schedule 2.9

                  	
                    -

                  	
                    Absence
                      of Certain Changes or Events

                  
	
                    Schedule 2.10

                  	
                    -

                  	
                    Litigation

                  
	
                    Schedule 2.11

                  	
                    -

                  	
                    Employee
                      Benefit Plans

                  
	
                    Schedule 2.13

                  	
                    -

                  	
                    Restrictions
                      on Business Activities

                  
	
                    Schedule 2.14

                  	
                    -

                  	
                    Title
                      to Property

                  
	
                    Schedule 2.15

                  	
                    -

                  	
                    Taxes

                  
	
                    Schedule 2.16

                  	
                    -

                  	
                    Environmental
                      Matters

                  
	
                    Schedule 2.17

                  	
                    -

                  	
                    Brokers;
                      Third Party Expenses

                  
	
                    Schedule 2.18

                  	
                    -

                  	
                    Intellectual
                      Property

                  
	
                    Schedule 2.19

                  	
                    -

                  	
                    Agreements,
                      Contracts and Commitments

                  
	
                    Schedule 2.20

                  	
                    -

                  	
                    Insurance

                  
	
                    Schedule 2.21

                  	
                    -

                  	
                    Governmental
                      Actions/Filings

                  
	
                    Schedule 2.22

                  	
                    -

                  	
                    Interested
                      Party Transactions

                  

          

           

          
            
              
              

            

            
              -
                77 -

              
                

              

            

            
              
              

            

          

           

          SCHEDULE
            3

           

          DELCORP
            SCHEDULE

          (Information
            Furnished Separately)

          

          
            	
                    Schedule 3.3

                  	
                    -

                  	
                    Capitalization

                  
	 	 	 
	
                    Schedule
                      3.7

                  	
                    -

                  	
                    SEC
                      Filings; Financial Statements

                  
	 	 	 
	
                    Schedule 3.14

                  	
                    -

                  	
                    Title
                      to Property

                  
	 	 	 
	
                    Schedule 3.15

                  	
                    -

                  	
                    Taxes

                  
	 	 	 
	
                    Schedule
                      3.17

                  	
                    -

                  	
                    Brokers

                  
	 	 	 
	
                    Schedule 3.19

                  	
                    -

                  	
                    Agreements,
                      Contracts and Commitments

                  
	 	 	 
	
                    Schedule 3.26

                  	
                    -

                  	
                    Governmental
                      Filings

                  

          

        

      

       

      
        
          
          

        

        
          -
            78 -

          
            

          

        

        
          
          

        

      

       

      
         

        SCHEDULE
          4.1

         

        COMPANY
          AND DELCORP PERMITTED ACTIONS

        

        The
          Company has reduced the value on its balance sheet of its investment in
          ARB/Arendal during the 2007 fiscal year, by writing down its balance sheet
          value
          by $3,588,000 to a value of $0. This write down is due to the uncertainty
          of
          ARB/Arendal’s to collect on a claim on an existing project.

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

        SCHEDULE
          5.2

        

        DIRECTORS
          AND OFFICERS OF DELCORP

         

        Directors
          and officers of Delcorp will be determined by the parties prior to the
          Closing.
          Five directors shall be designated by the Company and the Signing Shareholders
          and two directors shall be designated by the current directors of
          Delcorp.

        
          
            
            

          

          
            
            

            
              

            

          

          
            
            

          

        

         

        SCHEDULE
          6.2(i)

        

        DELCORP
          RESIGNATIONS

        

        All
          officers of Delcorp in office immediately prior to the Closing shall resign
          from
          all of their positions as officers.

        

        All
          directors of Delcorp in office immediately prior to the Closing other than
          those
          designated to be directors after the Closing shall resign from their
          directorships.Exhibit
      10.2

     

    ESCROW
      AGREEMENT

     

    ESCROW
      AGREEMENT (“Agreement”) dated [Closing Date] by and among RHAPSODY ACQUISITION
      CORP., a Delaware corporation (“Delcorp”), BRIAN PRATT, as the Target
      Stockholders’ Representative, being the representative of the former
      stockholders of PRIMORIS CORPORATION, a Nevada corporation (the
“Representative”), and CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as escrow
      agent (the “Escrow Agent”).

     

    Delcorp,
      Primoris Corporation (“Target”) and certain stockholders of Target are the
      parties to an Agreement and Plan of Merger and Reorganization dated as of
      February 19, 2008 (the “Merger Agreement”) pursuant to which Target has merged
      into Delcorp, with Delcorp being the surviving entity of such merger. Pursuant
      to the Merger Agreement, Delcorp is to be indemnified in certain respects.
      The
      parties desire to establish an escrow fund as collateral security for the
      indemnification obligations under the Merger Agreement. The Representative
      has
      been designated pursuant to the Merger Agreement to represent all of the former
      stockholders of Target (the “Stockholders”) and each Permitted Transferee (as
      hereinafter defined) of the Stockholders (the Stockholders and all such
      Permitted Transferees are hereinafter referred to collectively as the “Owners”),
      and to act on their behalf for purposes of this Agreement. Capitalized terms
      used herein that are not otherwise defined herein shall have the meanings
      ascribed to them in the Merger Agreement.

     

    The
      parties agree as follows:

     

    1.      (a)      Concurrently
      with the execution hereof, each of the Stockholders is delivering to the Escrow
      Agent, to be held in escrow pursuant to the terms of this Agreement, stock
      certificates issued in the name of such Stockholder representing seven and
      one-half percent (7.5%) of the total number of Base Shares received by such
      Stockholder pursuant to the Merger Agreement, together with two (2) assignments
      separate from certificate executed in blank by such Stockholder, with medallion
      signature guaranties. The shares of Delcorp Common Stock represented by the
      stock certificates so delivered by the Stockholders to the Escrow Agent are
      herein referred to in the aggregate as the “Escrow Fund.” The Escrow Agent shall
      maintain a separate account for each Stockholder’s, and, subsequent to any
      transfer permitted pursuant to Paragraph 1(e) hereof, each Owner’s, portion of
      the Escrow Fund. 

     

    (a)      The
      Escrow Agent hereby agrees to act as escrow agent and to hold, safeguard and
      disburse the Escrow Fund pursuant to the terms and conditions hereof. It shall
      treat the Escrow Fund as a trust fund in accordance with the terms of this
      Agreement and not as the property of Delcorp. The Escrow Agent’s duties
      hereunder shall terminate upon its distribution of the entire Escrow Fund in
      accordance with this Agreement.

     

    (b)      Except
      as herein provided, the Owners shall retain all of their rights as stockholders
      of Delcorp with respect to shares of Delcorp Common Stock constituting the
      Escrow Fund during the period the Escrow Fund is held by the Escrow Agent (the
      “Escrow Period”), including, without limitation, the right to vote their shares
      of Delcorp Common Stock included in the Escrow Fund.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (c)      During
      the Escrow Period, all dividends payable in cash with respect to the shares
      of
      Delcorp Common Stock included in the Escrow Fund shall be paid to the Owners,
      but all dividends payable in stock or other non-cash property (“Non-Cash
      Dividends”) shall be delivered to the Escrow Agent to hold in accordance with
      the terms hereof. As used herein, the term “Escrow Fund” shall be deemed to
      include the Non-Cash Dividends distributed thereon, if any.

     

    (d)      During
      the Escrow Period, no sale, transfer or other disposition may be made of any
      or
      all of the shares of Delcorp Common Stock in the Escrow Fund except (i) to
      a
“Permitted Transferee” (as hereinafter defined), (ii) by virtue of the laws of
      descent and distribution upon death of any Owner, or (iii) pursuant to a
      qualified domestic relations order; provided, however, that such permissive
      transfers may be implemented only upon the respective transferee’s written
      agreement to be bound by the terms and conditions of this Agreement. As used
      in
      this Agreement, the term “Permitted Transferee” shall include: (x) members of a
      Stockholder’s “Immediate Family” (as hereinafter defined); (y) an entity in
      which (A) a Stockholder and/or members of a Stockholder’s Immediate Family
      beneficially own 100% of such entity’s voting and non-voting equity securities,
      or (B) a Stockholder and/or a member of such Stockholder’s Immediate Family is a
      general partner and in which such Stockholder and/or members of such
      Stockholder’s Immediate Family beneficially own 100% of all capital accounts of
      such entity; and (z) a revocable trust established by a Stockholder during
      his
      lifetime for the benefit of such Stockholder or for the exclusive benefit of
      all
      or any of such Stockholder’s Immediate Family. As used in this Agreement, the
      term “Immediate Family” means, with respect to any Stockholder, a spouse,
      Delcorp, lineal descendants, the spouse of any lineal descendant, and brothers
      and sisters (or a trust, all of whose current beneficiaries are members of
      an
      Immediate Family of the Stockholder). In connection with and as a condition
      to
      each permitted transfer, the Permitted Transferee shall deliver to the Escrow
      Agent an assignment separate from certificate executed by the transferring
      Stockholder, with medallion signature guaranty, or where applicable, an order
      of
      a court of competent jurisdiction, evidencing the transfer of shares to the
      Permitted Transferee, together with two (2) assignments separate from
      certificate executed in blank by the Permitted Transferee, with medallion
      signature guaranties, with respect to the shares transferred to the Permitted
      Transferee. Upon receipt of such documents, the Escrow Agent shall deliver
      to
      Delcorp’s transfer agent the original stock certificate out of which the
      assigned shares are to be transferred, together with the executed assignment
      separate from certificate executed by the transferring Stockholder, or a copy
      of
      the applicable court order, and shall request that Delcorp issue new
      certificates representing (m) the number of shares, if any, that continue to
      be
      owned by the transferring Stockholder, and (n) the number of shares owned by
      the
      Permitted Transferee as the result of such transfer. Delcorp, the transferring
      Stockholder and the Permitted Transferee shall cooperate in all respects with
      the Escrow Agent in documenting each such transfer and in effectuating the
      result intended to be accomplished thereby. During the Escrow Period, no Owner
      shall pledge or grant a security interest in such Owner’s shares of Delcorp
      Common Stock included in the Escrow Fund or grant a security interest in such
      Owner’s rights under this Agreement.

     

    
      
        
        

      

      
        -
          2 -

        
          

        

      

      
        
        

      

    

     

    2.      (a)      Delcorp,
      acting through the current or former member or members of Delcorp’s Board of
      Directors who has or have been appointed by Delcorp to take all necessary
      actions and make all decisions on behalf of Delcorp with respect to its rights
      to indemnification under Article VII of the Merger Agreement (the “Committee”),
      may make a claim for indemnification pursuant to the Merger Agreement
      (“Indemnification Claim”) against the Escrow Fund by giving notice (a “Notice”)
      to the Representative (with a copy to the Escrow Agent) specifying (i) the
      covenant, representation, warranty, agreement, undertaking or obligation
      contained in the Merger Agreement which it asserts has been breached or
      otherwise entitles Delcorp to indemnification, (ii) in reasonable detail, the
      nature and dollar amount of any Indemnification Claim, (iii) whether the
      Indemnification Claim is a claim is a Basic Indemnification Claim, a Tax
      Indemnification Claim or an Environmental Indemnification Claim, and (iv)
      whether the Indemnification Claim results from a Third Party Claim against
      Delcorp or Target. The Committee also shall deliver to the Escrow Agent (with
      a
      copy to the Representative), concurrently with its delivery to the Escrow Agent
      of the Notice, a certification as to the date on which the Notice was delivered
      to the Representative. As used herein, “Basic Indemnification Claim” means an
      Indemnification Claim other than a Tax Indemnification Claim or an Environmental
      Indemnification Claim.

     

    (b)      If
      the Representative shall give a notice to the Committee (with a copy to the
      Escrow Agent) (a “Counter Notice”), within 30 days following the date of receipt
      (as specified in the Committee’s certification) by the Representative of a copy
      of the Notice, disputing whether the Indemnification Claim is indemnifiable
      under the Merger Agreement, the Committee and the Representative shall attempt
      to resolve such dispute by voluntary settlement as provided in paragraph 2(c)
      below. If no Counter Notice with respect to an Indemnification Claim is received
      by the Escrow Agent from the Representative within such 30-day period, the
      Indemnification Claim shall be deemed to be an Established Claim (as hereinafter
      defined) for purposes of this Agreement.

     

    (c)      If
      the Representative delivers a Counter Notice to the Escrow Agent, the Committee
      and the Representative shall, during the period of 60 days following the
      delivery of such Counter Notice or such greater period of time as the parties
      may agree to in writing (with a copy to the Escrow Agent), attempt to resolve
      the dispute with respect to which the Counter Notice was given. If the Committee
      and the Representative shall reach a settlement with respect to any such
      dispute, they shall jointly deliver written notice of such settlement to the
      Escrow Agent specifying the terms thereof. If the Committee and the
      Representative shall be unable to reach a settlement with respect to a dispute,
      such dispute shall be resolved by arbitration pursuant to paragraph 2(d)
      below.

     

    (d)      If
      the Committee and the Representative cannot resolve a dispute prior to
      expiration of the 60-day period referred to in paragraph 2(c) above (or such
      longer period as the parties may have agreed to in writing), then such dispute
      shall be submitted (and either party may submit such dispute) for arbitration
      before the Judicial Arbitration and Medication Service (“JAMS”) in Orange
      County, California, pursuant to Section 10.12 of the Merger
      Agreement.

     

    
      
        
        

      

      
        -
          3 -

        
          

        

      

      
        
        

      

    

     

    (e)      As
      used in this Agreement, “Established Claim” means any (i) Indemnification Claim
      deemed established pursuant to the last sentence of paragraph 2(b) above, (ii)
      Indemnification Claim resolved in favor of Delcorp by settlement pursuant to
      paragraph 2(c) above, resulting in a dollar award to Delcorp, (iii)
      Indemnification Claim established by the decision of an arbitrator pursuant
      to
      paragraph 2(d) above, resulting in a dollar award to Delcorp, (iv) Third Party
      Claim that has been sustained by a final determination (after exhaustion of
      any
      appeals) of a court of competent jurisdiction, or (v) Third Party Claim that
      the
      Committee and the Representative have jointly notified the Escrow Agent has
      been
      settled in accordance with the provisions of the Merger Agreement.

     

    (f)      (i)      Promptly
      after an Indemnification Claim becomes an Established Claim, the Committee
      and
      the Representative shall jointly deliver a notice to the Escrow Agent (a “Joint
      Notice”) directing the Escrow Agent to pay to Delcorp, and the Escrow Agent
      promptly shall pay to Delcorp, an amount equal to the aggregate dollar amount
      of
      the Established Claim (or, if at such time there remains in the Escrow Fund
      less
      than the full amount so payable, the full amount remaining in the Escrow
      Fund).

     

    (ii)      Payment
      of an Established Claim shall be made from Escrow Shares pro rata from the
      account maintained on behalf of each Owner. For purposes of each payment, such
      shares shall be valued at the “Fair Market Value” (as defined below). However,
      in no event shall the Escrow Agent be required to calculate Fair Market Value
      or
      make a determination of the number of shares to be delivered to Delcorp in
      satisfaction of any Established Claim; rather, such calculation shall be
      included in and made part of the Joint Notice. The Escrow Agent shall transfer
      to Delcorp out of the Escrow Fund that number of shares of Delcorp Common Stock
      necessary to satisfy each Established Claim, as set out in the Joint Notice.
      Any
      dispute between the Committee and the Representative concerning the calculation
      of Fair Market Value or the number of shares necessary to satisfy any
      Established Claim, or any other dispute regarding a Joint Notice, shall be
      resolved between the Committee and the Representative in accordance with the
      procedures specified in paragraph 2(d) above, and shall not involve the Escrow
      Agent. Each transfer of shares in satisfaction of an Established Claim shall
      be
      made by the Escrow Agent delivering to Delcorp one or more stock certificates
      held in each Owner’s account evidencing not less than such Owner’s pro rata
      portion of the aggregate number of shares specified in the Joint Notice,
      together with assignments separate from certificate executed in blank by such
      Owner and completed by the Escrow Agent in accordance with instructions included
      in the Joint Notice. Upon receipt of the stock certificates and assignments,
      Delcorp shall deliver to the Escrow Agent new certificates representing the
      number of shares owned by each Owner after such payment. The parties hereto
      (other than the Escrow Agent) agree that the foregoing right to make payments
      of
      Established Claims in shares of Delcorp Common Stock may be made notwithstanding
      any other agreements restricting or limiting the ability of any Owner to sell
      any shares of Delcorp stock or otherwise. The Committee and the Representative
      shall be required to exercise utmost good faith in all matters relating to
      the
      preparation and delivery of each Joint Notice. As used herein, “Fair Market
      Value” means the average reported closing price for the Delcorp Common Stock for
      the ten trading days ending on the last trading day prior to (x) the day the
      Established Claim is paid with respect to Indemnification Claims paid on or
      before the Basic Escrow Termination Date, (y) the Basic Escrow Termination
      Date
      with respect to shares constituting the Pending Claims Reserve (as hereinafter
      defined) on the Basic Escrow Termination Date, and (z) with respect to shares
      placed in the Pending Claims Reserve for a Tax Indemnification Claim or
      Environmental Indemnification Claim asserted after the Basic Escrow Termination
      Date, the day such Tax Indemnification Claim or Environmental Indemnification
      Claim is asserted. 

     

    
      
        
        

      

      
        -
          4 -

        
          

        

      

      
        
        

      

    

     

    (iii)      Notwithstanding
      anything herein to the contrary, at such time as an Indemnification Claim has
      become an Established Claim, the Representative shall have the right to
      substitute for the Escrow Shares that otherwise would be paid in satisfaction
      of
      such claim (the “Claim Shares”), cash in an amount equal to the Fair Market
      Value of the Claim Shares (“Substituted Cash”). In such event (i) the Joint
      Notice shall include a statement describing the substitution of Substituted
      Cash
      for the Claim Shares, and (ii) substantially contemporaneously with the delivery
      of such Joint Notice, the Representative shall cause currently available funds
      to be delivered to the Escrow Agent in an amount equal to the Substituted Cash.
      Upon receipt of such Joint Notice and Substituted Cash, the Escrow Agent shall
      (y) in payment of the Established Claim described in the Joint Notice, deliver
      the Substituted Cash to Delcorp in lieu of the Claim Shares, and (z) cause
      the
      Claim Shares to be returned to the Representative. 

     

    3.      (a)      On
      the first Business Day after the Basic Escrow Termination Date, upon receipt
      of
      a Joint Notice, the Escrow Agent shall distribute and deliver to each Owner
      certificates representing shares of Delcorp Common Stock then in such Owner’s
      account in the Escrow Fund equal to four-fifths of the original number of shares
      placed in such Owner’s account less that number of shares in such Owner’s
      account equal to the sum of (i) the number of shares applied in satisfaction
      of
      Indemnification Claims made prior to that date and (ii) the number of shares
      in
      the Pending Claims Reserve allocated to such Owner’s account, as provided in the
      following sentence, and shall continue to hold the remaining shares in such
      Owner’s account as T/E Indemnity Shares. If, at such time, there are any
      Indemnification Claims with respect to which Notices have been received but
      which have not been resolved pursuant to Section 2 hereof or in respect of
      which
      the Escrow Agent has not been notified of, and received a copy of, a final
      determination (after exhaustion of any appeals) by a court of competent
      jurisdiction, as the case may be (in either case, “Pending Claims”), and which,
      if resolved or finally determined in favor of Delcorp, would result in a payment
      to Delcorp, the Escrow Agent shall retain in the Pending Claims Reserve that
      number of shares of Delcorp Common Stock having a Fair Market Value equal to
      the
      dollar amount for which indemnification is sought in such Indemnification Claim,
      allocated pro rata from the account maintained on behalf of each Owner. The
      Committee shall certify to the Escrow Agent the Fair Market Value to be used
      in
      calculating the Pending Claims Reserve and the number of shares of Delcorp
      Common Stock to be retained therefor. Thereafter, if any Pending Claim becomes
      an Established Claim, the Committee and the Representative shall deliver to
      the
      Escrow Agent a Joint Notice directing the Escrow Agent to deliver to Delcorp
      the
      number of shares in the Pending Claims Reserve in respect thereof determined
      in
      accordance with paragraph 2(f) above and to deliver to each Owner the remaining
      shares in the Pending Claims Reserve allocated to such Pending Claim, all as
      specified in a Joint Notice. If any Pending Claim is resolved against Delcorp,
      the Committee and the Representative shall deliver to the Escrow Agent a Joint
      Notice directing the Escrow Agent to pay to each Owner its pro rata portion
      of
      the number of shares allocated to such Pending Claim in the Pending Claims
      Reserve. 

     

    (b)      On
      the first Business Day after the T/E Escrow Termination Date, upon receipt
      of a
      Joint Notice, the Escrow Agent shall distribute and deliver to each Owner
      certificates representing the shares of Delcorp Common Stock then in such
      Owner’s account in the Escrow Fund that are T/E Indemnity Shares other than T/E
      Indemnity Shares in the Pending Claims Reserve. Upon the subsequent resolution
      of a Claim for which shares remain in the Pending Claims Reserve, upon receipt
      of a Joint Notice, the Escrow Agent shall distribute and deliver such shares
      to
      the Delcorp, if the Claim is resolved in favor of Delcorp, or, if resolved
      against Delcorp, to the Owners pro rata to the accounts maintained for them.
      Upon resolution of all Pending Claims, the Committee and the Representative
      shall deliver to the Escrow Agent a Joint Notice directing the Escrow Agent
      shall pay to each Owner the remaining portion of his or her account in the
      Escrow Fund.

     

    
      
        
        

      

      
        -
          5 -

        
          

        

      

      
        
        

      

    

     

    (c)      As
      used herein, the “Pending Claims Reserve” shall mean, at the time any such
      determination is made, that number of shares of Delcorp Common Stock in the
      Escrow Fund having a Fair Market Value equal to the sum of the aggregate dollar
      amounts claimed to be due with respect to all Pending Claims (as shown in the
      Notices of such Claims).

     

    4.     The
      Escrow Agent, the Committee and the Representative shall cooperate in all
      respects with one another in the calculation of any amounts determined to be
      payable to Delcorp and the Owners in accordance with this Agreement and in
      implementing the procedures necessary to effect such payments.

     

    5.     (a)      The
      Escrow Agent undertakes to perform only such duties as are expressly set forth
      herein. It is understood that the Escrow Agent is not a trustee or fiduciary
      and
      is acting hereunder merely in a ministerial capacity.

     

    (b)      The
      Escrow Agent shall not be liable for any action taken or omitted by it in good
      faith and in the exercise of its own best judgment, and may rely conclusively
      and shall be protected in acting upon any order, notice, demand, certificate,
      opinion or advice of counsel (including counsel chosen by the Escrow Agent),
      statement, instrument, report or other paper or document (not only as to its
      due
      execution and the validity and effectiveness of its provisions, but also as
      to
      the truth and acceptability of any information therein contained) which is
      believed by the Escrow Agent to be genuine and to be signed or presented by
      the
      proper person or persons. The Escrow Agent shall not be bound by any notice
      or
      demand, or any waiver, modification, termination or rescission of this Agreement
      unless evidenced by a writing delivered to the Escrow Agent signed by the proper
      party or parties and, if the duties or rights of the Escrow Agent are affected,
      unless it shall have given its prior written consent thereto.

     

    (c)      The
      Escrow Agent’s sole responsibility upon receipt of any notice requiring any
      payment to Delcorp pursuant to the terms of this Agreement or, if such notice
      is
      disputed by the Committee or the Representative, the settlement with respect
      to
      any such dispute, whether by virtue of joint resolution, arbitration or
      determination of a court of competent jurisdiction, is to pay to Delcorp the
      amount specified in such notice, and the Escrow Agent shall have no duty to
      determine the validity, authenticity or enforceability of any specification
      or
      certification made in such notice.

     

    (d)      The
      Escrow Agent shall not be liable for any action taken by it in good faith and
      believed by it to be authorized or within the rights or powers conferred upon
      it
      by this Agreement, and may consult with counsel of its own choice and shall
      have
      full and complete authorization and indemnification under Section 5(g), below,
      for any action taken or suffered by it hereunder in good faith and in accordance
      with the opinion of such counsel.

     

    (e)      The
      Escrow Agent may resign at any time and be discharged from its duties as escrow
      agent hereunder by its giving the other parties hereto written notice and such
      resignation shall become effective as hereinafter provided. Such resignation
      shall become effective at such time that the Escrow Agent shall turn over the
      Escrow Fund to a successor escrow agent appointed jointly by the Committee
      and
      the Representative. If no new escrow agent is so appointed within the 60 day
      period following the giving of such notice of resignation, the Escrow Agent
      may
      deposit the Escrow Fund with any court it reasonably deems
      appropriate.

     

    
      
        
        

      

      
        -
          6 -

        
          

        

      

      
        
        

      

    

     

    (f)      The
      Escrow Agent shall be indemnified and held harmless by Delcorp from and against
      any expenses, including counsel fees and disbursements, or loss suffered by
      the
      Escrow Agent in connection with any action, suit or other proceeding involving
      any claim which in any way, directly or indirectly, arises out of or relates
      to
      this Agreement, the services of the Escrow Agent hereunder, or the Escrow Fund
      held by it hereunder, other than expenses or losses arising from the gross
      negligence or willful misconduct of the Escrow Agent. Promptly after the receipt
      by the Escrow Agent of notice of any demand or claim or the commencement of
      any
      action, suit or proceeding, the Escrow Agent shall notify the other parties
      hereto in writing. In the event of the receipt of such notice, the Escrow Agent,
      in its sole discretion, may commence an action in the nature of interpleader
      in
      the United States District Court for the Central Division of California in
      Orange County, California.

     

    (g)      The
      Escrow Agent shall be entitled to reasonable compensation from Delcorp for
      all
      services rendered by it hereunder. The Escrow Agent shall also be entitled
      to
      reimbursement from Delcorp for all expenses paid or incurred by it in the
      administration of its duties hereunder including, but not limited to, all
      counsel, advisors’ and agents’ fees and disbursements and all taxes or other
      governmental charges. 

     

    (h)      From
      time to time on and after the date hereof, the Committee and the Representative
      shall deliver or cause to be delivered to the Escrow Agent such further
      documents and instruments and shall do or cause to be done such further acts
      as
      the Escrow Agent shall reasonably request to carry out more effectively the
      provisions and purposes of this Agreement, to evidence compliance herewith
      or to
      assure itself that it is protected in acting hereunder.

     

    (i)      Notwithstanding
      anything herein to the contrary, the Escrow Agent shall not be relieved from
      liability hereunder for its own gross negligence or its own willful
      misconduct.

     

    6.      This
      Agreement expressly sets forth all the duties of the Escrow Agent with respect
      to any and all matters pertinent hereto. No implied duties or obligations shall
      be read into this Agreement against the Escrow Agent. The Escrow Agent shall
      not
      be bound by the provisions of any agreement among the parties hereto except
      this
      Agreement and shall have no duty to inquire into the terms and conditions of
      any
      agreement made or entered into in connection with this Agreement, including,
      without limitation, the Merger Agreement.

     

    7.      This
      Agreement shall inure to the benefit of and be binding upon the parties and
      their respective heirs, successors, assigns and legal representatives, shall
      be
      governed by and construed in accordance with the law of Delaware applicable
      to
      contracts made and to be performed therein except that issues relating to the
      rights and obligations of the Escrow Agent shall be governed by and construed
      in
      accordance with the law of New York applicable to contracts made and to be
      performed therein. This Agreement cannot be changed or terminated except by
      a
      writing signed by the Committee, the Representative and the Escrow
      Agent.

     

    
      
        
        

      

      
        -
          7 -

        
          

        

      

      
        
        

      

    

     

    8.      The
      Committee and the Representative each hereby consents to the exclusive
      jurisdiction of the federal and state courts sitting in Orange County,
      California, with respect to any claim or controversy arising out of this
      Agreement. Service of process in any action or proceeding brought against the
      Committee or the Representative in respect of any such claim or controversy
      may
      be made upon it by registered mail, postage prepaid, return receipt requested,
      at the address specified in Section 9, with copies delivered by nationally
      recognized overnight carrier to Graubard Miller, The Chrysler Building, 405
      Lexington Avenue, New York, N.Y. 10174-1901, Attention: David Alan Miller,
      Esq.,
      and to Rutan & Tucker, 611 Anton Boulevard, Suite 1400, Costa Mesa, CA
      92626-1931, Attention: George Wall, Esq.

     

    9.      All
      notices and other communications under this Agreement shall be in writing and
      shall be deemed given if given by hand or delivered by nationally recognized
      overnight carrier, or if given by telecopier and confirmed by mail (registered
      or certified mail, postage prepaid, return receipt requested), to the respective
      parties as follows:

     

    
      
        	 	
                A.

              	
                If
                  to the Committee, to it at:

              
	 	 	
                Eric
                  Rosenfeld

              
	 	 	
                825
                  Third Avenue, 40th Floor

              
	 	 	
                New
                  York, New York 10022

              
	 	 	
                Telecopier
                  No.: 212-319-0760

              
	 	 	 
	 	 	
                with
                  a copy to:

              
	 	 	 
	 	 	
                Graubard
                  Miller

              
	 	 	
                The
                  Chrysler Building

              
	 	 	
                405
                  Lexington Avenue

              
	 	 	
                New
                  York, New York 10174-1901

              
	 	 	
                Attention:
                  David Alan Miller, Esq.

              
	 	 	
                Telecopier
                  No.: 212-818-8881

              
	 	 	 
	 	
                B.

              	
                If
                  to the Representative, to him at:

              
	 	 	 
	 	 	
                [To
                  follow]

              
	 	 	 
	 	 	
                with
                  a copy to:

              
	 	 	 
	 	 	
                Rutan
                  & Tucker

              
	 	 	
                611
                  Anton Boulevard, Suite 1400

              
	 	 	
                Costa
                  Mesa, CA 92626-5100

              
	 	 	
                Attention:
                  George Wall, Esq.

              
	 	 	
                Telecopier
                  No.: 714-546-9035

              

      

       

      
        
          
          

        

        
          -
            8 -

          
            

          

        

        
          
          

        

      

       

      
        	
                 

              	
                C.

              	
                If
                  to the Escrow Agent, to it at:

              
	 	 	
                Continental
                  Stock Transfer & Trust Company

              
	 	 	
                2
                  Broadway

              
	 	 	
                New
                  York, New York 10004

              
	 	 	
                Attention:
                  Steven G. Nelson

              
	 	 	
                Telecopier
                  No.: 212-509-5150

              

      

    

     

    or
      to
      such other person or address as any of the parties hereto shall specify by
      notice in writing to all the other parties hereto.

     

    10.          (a)      If
      this Agreement requires a party to deliver any notice or other document, and
      such party refuses to do so, the matter shall be submitted to arbitration
      pursuant to paragraph 2(d) of this Agreement.

     

    (b)      All
      notices delivered to the Escrow Agent shall refer to the provision of this
      Agreement under which such notice is being delivered and, if applicable, shall
      clearly specify the aggregate dollar amount due and payable to
      Delcorp.

     

    (c)      This
      Agreement may be executed in any number of counterparts, each of which shall
      be
      deemed to be an original instrument and all of which together shall constitute
      a
      single agreement.

     

    IN
      WITNESS WHEREOF, each of the parties hereto has duly executed this Agreement
      on
      the date first above written.

     

    [Signatures
      are on following page]

     

    
      
        
        

      

      
        -
          9 -

        
          

        

      

      
        
        

      

    

     

    [Signature
      Page to Escrow Agreement]

    
      	 	 	 	 
	 	 	 	
              RHAPSODY
                ACQUISITION CORP.

            
	 	 	 	 
	 	 	 	By: 
	
            	 	 	
              
                

              

            
	 	 	 	 
	 	 	 	Name:
	 	 	 	
              
                
 

            
	 	 	 	Title: 
	 	 	 	
              
                
 

            

    

     

    
      	
            	 	 	
              THE
                REPRESENTATIVE

            
	 	 	 	 
	 	 	 	
            
	 	 	 	
              
                

              
Brian Pratt

    

     

     

    
      	 	 	 	ESCROW AGENT
	 	 	 	 
	 	 	 	
              CONTINENTAL
                STOCK TRANSFER & 

              TRUST
                COMPANY

            
	 	 	 	 
	 	 	 	By: 
	
            	 	 	
              
                

              

            
	 	 	 	 
	 	 	 	Name:
	 	 	 	
              
                
 

            
	 	 	 	Title: 
	 	 	 	
              
                

              

            

    

     

    
      
        
        

      

      
        -
          10 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]